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Ten geleide 
Malaria is een ziekte die veroorzaakt wordt door Plasmodium, een 
eencellige parasiet die voor een deel van zijn levenscyclus leeft in 
de rode bloedcellen en die wordt overgebracht door muggen. De ziekte 
komt zeer veel voor, vooral in ontwikkelingslanden in tropen en 
subtropen. Grote problemen bij de bestrijding zijn de uitgebreid 
voorkomende resistentie zowel van de parasiet tegen diverse genees-
middelen als van de muggen tegen veel gebruikte insecticiden. Ook 
de socio-economische struktuur van vele malaria gebieden staat een 
efficiënte aanpak van de bestrijding in de weg. 
Mede ten gevolge van malaria is er in endemische gebieden (ge-
bieden waar malaria voorkomt) een hoge kindersterfte. De volwassenen 
hebben een zekere graad van immuniteit opgebouwd. Zij zijn vaak wel 
drager van de malaria parasiet, worden ook regelmatig geinfekteerd 
als ze door een mug gestoken worden, maar het afweersysteem in het 
lichaam voorkomt dat de parasiet zich sterk kan vermenigvuldigen 
en ziekteverschijnselen veroorzaakt. Deze vorm van immuniteit wordt 
premuniteit genoemd. Voor het in stand houden van zo'n premuniteit 
is het belangrijk regelmatig geinfekteerd te worden, zodat de para-
siet door zijn aanwezigheid de afweerreakties in het lichaam steeds 
weer aktiveert. Het komt voor dat inwoners van endemische gebieden, 
die een immuniteit tegen malaria hadden opgebouwd, na een lang-
durig verblijf in malaria-vrije landen bij terugkeer in hun eigen 
land weer problemen krijgen met malaria omdat hun immuniteit ge-
heel of gedeeltelijk verdwenen is. 
Malaria veroorzaakt in endemische gebieden vaak komplikaties 
tijdens zwangerschap, met name tijdens de eerste zwangerschap. 
Vrouwen in verwachting hebben meer last van malaria, terwijl ze 
vooraf toch immuun waren. Het lijkt erop dat tijdens zwangerschap 
de afweerreaktie van het lichaam tegen malaria min of meer onder-
drukt wordt zodat de parasiet zich weer kan vermenigvuldigen en 
de zwangere vrouw ziek maakt. Overigens, ook bij zwangere vrouwen 
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uit malaria-vrije gebieden verloopt de ziekte ernstiger dan bij met-
zwangeren, als zij malaria gebieden bezoeken. Komplikaties tijdens 
zwangerschap zijn o.a. sterke bloedarmoede, intra-uterine dood van 
de foetus of abortus, voortijdige geboorte en een te laag geboorte 
gewicht. In het algemeen wordt weinig melding gemaakt van over­
dracht van malaria van moeder op kind (zgn. congenitale malaria). 
Ook van een aantal andere ziekten is bekend dat zij ernstiger 
kunnen verlopen tijdens zwangerschap. Dit wijst erop dat het af­
weersysteem van de vrouw verctndert als zij in verwachting is. Waar­
om dit gebeurt is m e t met zekerheid bekend, en ook m e t welke af-
weerreakties onderdrukt worden en welke faktoren in het lichaam 
daarvoor verantwoordelijk zijn. In het algemeen wordt gedacht dat 
een afname in de immunologi sene reaktiviteit van de moeder ervoor 
zorgt dat de foetus m e t als een vreemd transplantaat wordt afge­
stoten. De foetus heeft immers kenmerken van de vader, die voor de 
moeder als lichaai is vreemd gelden. 
Veel malaria onderzoek in het laboratorium wordt gedaan in 
proefdiermodellen, vooral apen, ratten en muizen. In ons labora­
torium wordt onderzoek gedaan aan het malaria model: Ріавтоагші 
berght- in muizen. Deze knaagdier parasiet komt van nature in boom-
ratten чтг o.a. in Zaïre en is van daaruit geadapteerd aan muizen. 
Een ¡nfektie in de door ons gebruikte muizenstammen is altijd dode-
lijk, tenzij geneesmiddelen worden toegediend. Geholpen door genees-
middelen zijn de muizen in staat een immuniteit tegen de parasiet 
te ontwikkelen, waardoor ze achteraf ook zelfstandig een nieuwe in-
fektie kunnen weerstaan zonder ziek te worden. Net als de mens blijft 
de muis ook drager van de parasiet, dus hier is ook sprake van pre-
mumteit. 
In dit mui zen-mal ari a model wordt ook gevonden dat tijdens 
zwangerschap de immumteit afneemt, zodat veel drachtige muizen, 
die vooraf immuun waren, ziek worden en zelfs doodgaan ten gevolge 
van de weer opkomende malaria. 
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Het onderzoek, beschreven in dit proefschrift, gaat over dit 
verlies van malaria immuniteit, hoe dit tot stand komt en welke 
faktoren erbij betrokken zijn. De resultaten zijn achter in dit 
proefschrift in een samenvatting bijeen gezet. 
9 
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Chapter I 
General Introduction 
and 
Aim of this Study 
General introduction 
In endemie areas malaria is a serious complication of pregnancy. 
Clinical manifestations of malaria become more important during preg-
nancy among members of communities where immunity has been established. 
Studies in several countries show that malaria infection in general, 
and particularly Plasmodium falciparum infection is more severe during 
pregnancy (27, 83, 96, 98, 147). Parasite rate and parasite density 
are higher in pregnant women as compared to the same individuals be-
fore pregnancy or to an age-matched, non-pregnant group (23, 71). 
Pregnant women, especially Primigravidae show enlargement of the spleen 
which is not otherwise common in adults in holoendemic areas (93, 96). 
Cerebral malaria with a high mortality rate is more common in pregnant 
women (109), though Lawson (96) believes that it is uncommon, but 
repeatedly diagnosed in stead of ecciampsia. The highest infection rate 
of both peripheral blood and placenta is observed in Primigravidae (22, 
23, 106, 130). 
Neither the mechanism of loss of malaria immunity during pregnancy, 
nor the mechanism of the parity dependent decrease of the infection 
rate are known. A proposed age dependent increase in maternal immuno-
logical maturity (93) is less likely in view of the usually short time 
interval between first and second pregnancy (107). It is more likely 
that infection in Primigravidae enhances immune reactivity or induces 
additional immune reactions, that are less sensitive to depression 
during subsequent pregnancy (22; see chapter 4 of this thesis). 
Malaria prevalence is not constant throughout pregnancy (151). 
Loss of immunity and febril attacks are reported to be more common as 
pregnancy advances (83, 96, 109), though a decline of malaria pre-
valence and parasite density from the middle of the second trimester 
towards term has been reported as well (23, 122). This apparent con-
tradiction has been explained by differences in acquired states of 
immunity. In women living in holoendemic areas the recovery rate ex-
ceeds the infection rate later in pregnancy. This is in contrast to 
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women living in areas with lower endemicity, or to non-immune women 
visiting endemic areas (22). 
Pathological examinations suggest a direct correlation between 
malaria infection and second trimester abortion (98), but no clear 
association is seen between stillbirth and placental infection (107, 
130). Malaria infection of the placenta is suggested to be one of 
the causes of low birthweight and prematurity in malaria endemic 
areas (26, 31, 107, 143) and maternal chemoprophylaxis during preg-
nancy leads to higher infant birthweight (22). Placental infection 
and low birthweight are more frequently observed in Primigravidae 
(22, 107). Placental parasitaemia and the cellular reactions against 
it may affect the function of the placenta (109), and cause lower 
birthweight and early delivery of the infant (107), but placenta 
weight itself is not influenced by malaria. 
Frequent observation of a heavy infection in the placenta asso-
ciated with a much lower parasitaemia in the peripheral blood may be 
related to a local immunosuppression in the uterus during pregnancy, 
which is described by Gottesman (74), or to local escape from inmune 
destruction in that the newly developing vasculature of the placenta 
forms a privileged site, especially for P. falaipavum with its pre-
dilection for capillaries in deep tissues (107). Results of histolo-
gical studies are contradictory. Osunkoya et al. (117) describe pre-
ferential binding of P. falatparum infected cells to the trophoblastic 
xeils uf Lhe chorionic v1Ui, but this sequësTFaiiön i s "not found in 
light- and electronmicroscopical analysis by others (24). 
Malaria not only has a direct, but also an indirect effect on 
pregnancy. Infection is associated with a more or less severe de-
pression of the immune system of the host, both in human as well as 
in animal malaria (75, 167), resulting in an increased susceptibility 
to other infections (129). 
Though a pregnancy dependent loss of malaria immunity was noted 
over 60 years (compare 22), hardly any progress is made regarding ana-
lysis of the underlying mechanism. An important factor may have been 
that a suitable experimental model system was not available. Most 
studies on experimental malaria and pregnancy are carried out with 
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rodents, and deal primarily with transfer of immunity from mother 
to offspring (5, 28, 53, 137, 153, 173). Oduola et al. (115) observe 
a more virulent malaria infection during pregnancy with enhanced 
anaemia, and a severely compromised maternal-fetal relationship 
leading to abortion, resorption of fetuses, or low birthweights of 
offspring when infection was started late in pregnancy. 
PREGNANCY AND DISEASE 
Enhanced prevalence and morbidity during pregnancy is not re-
stricted to malaria, but is observed for an increasing number of 
viral, bacterial and parasitic infections. In addition enhanced tumor 
growth and increased mortality rates during pregnancy are described 
for Burkitt's lymphoma (12) and breast cancer (125). A list of diseases 
being enhanced during pregnancy is given in Table I. In these studies 
suggestions on possible factors in the underlying mechanism are des-
cribed. 
Naturally occurring changes in serum corticoid (amoebic colitis, 
malaria, encephalomyocarditis), oestrogen (hepatitis, encephalomyo-
carditis) and progesterone (herpes infection) are considered to affect 
host resistance. Enhanced susceptibility to infection or an enhanced 
virulence depends on the day of pregnancy when primary infections are 
started. 
A local reduction of resistance is described for malaria (pla-
cental parasitaemia higher and more frequent than infections of peri-
pheral blood) and herpes infection (enhancement of infection started 
by the intravaginal, not by the intraperitoneal, intravenous or intra-
nasal route). Reduction of specific cell mediated immune responsive-
ness is observed against rubella and cytomegalovirus, whereas the 
humoral response against cytomegalovirus remains intact (94), and 
is enhanced against Escherichia coli. Loss of a previously existing 
immunity during pregnancy is described for leprosy, tuberculosis, 
amoebic colitis, toxoplasmosis, malaria, and trypanosomiasis. 
In sunmary several observations suggest that a pregnancy asso-
ciated reduction of part of the immune reactivity caused enhanced 
prevalence and virulence of infection during pregnancy. 
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Table I. Pregnancy and disease 
DISEASE HOST REFERENCE 
Viral infections: 
encephalomyocardi 
hepatitis 
herpes 
poliomyelitis 
polyoma 
rubella 
¡tis 
Bacterial infections: 
mouse 
man 
mouse 
mouse 
man 
man 
64 
116 
11, 
92 
46 
158 
171 
Escherichia coli infection 
leprosy 
listeriosis 
tuberculosis 
mouse 
man 
mouse 
91 
57 
101 
man 119 
Parasitic infections: 
amoebic colitis 
babesiosis 
malaria 
toxoplasmosis 
II 
trypanosomiasis 
man 
man 
mouse 
man 
mouse 
man 
mouse 
1 
127 
115, 163, 164 
22, 23, 27, 71, 83, 93, 
98, 106, 107, 109, 122, 
151 
101 
162 
165 
96, 
130, 
Tumors: 
breast cancer 
Burkitt's lymphoma 
man 
man 
125 
12 
15 
IMMUNE REACTIVITY DURING PREGNANCY 
Suppression of the maternal immune system during pregnancy is 
thought to be functional in protection of the fetal graft, bearing 
paternal antigens, from rejection by the mother (15, 78, 141). De-
pression especially concerns the cell mediated immune response (125), 
the humoral immune response is not decreased, or even increased 
during pregnancy (8, 34, 141). At the same time when during preg-
nancy an inhibition of T-cell reactivity is measured, no impairment 
of development of antibody-secreting lymphocytes, of maturation of 
helper T-cells, or of the B-cell dependent LPS response is found 
(40, 74). 
Histological changes in lymphoid organs are observed during 
pregnancy. Thymus weight decreases in pregnant mice (118, 121), the 
involution occurs in late pregnancy and reaches a maximum at partu-
rition (86, 108). Involution is associated with reduction of steroid-
sensitive cortical cells, and can be considered as a non-specific 
phenomenon, independent of immunization against paternal histocom-
patibility antigens (105, 121). Decrease of weight of the superficial 
lymph nodes is also reported, but is less marked compared to the 
thymus (118). Lymph nodes draining the uterine area exhibit weight 
increase, especially in allogeneic pregnancy (6, 15, 105), but no 
concomittant transplantation immunity to the fetus is elicited. En-
largement may be connected to stimulation of humoral immunity (pro-
duction of antibodies) (15). Depression of at least part of cellular 
immune responsiveness during pregnancy is demonstrated both in vivo 
and in vitro. Cardiac allografts expressing paternal antigens sur-
vive longer in pregnant than in virgin mice (10). Skin grafts with 
paternal antigens showed prolonged survival time when transplanted 
into the uterus of pregnant rats, but not when transplanted to the 
trunks, indicating a local immunosuppression (15). A decrease of 
the tuberculin reaction in pregnant women (66), and of the contact 
allergic reaction to picryl chloride in pregnant mice (62) are 
other indications of impaired cell mediated immunity in vivo. 
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Several reports mention a significant reduction in the lympho-
cyte response to PHA in pregnant individuals (66, 97, 125, 158). 
Gottesman (74) describes a decrease in T-cell proliferative capacity 
in the area of the uterus but not in the rest of the body. A rapid 
increase in PHA stimulation activity early in pregnancy (73) followed 
by a decrease afterwards until delivery (94) indicates that this 
immune reactivity is not constant throughout pregnancy and therefore 
apparently is not a vital factor to prevent fetal graft rejection 
(73). 
Other in vitro T-cell assays also indicate an inhibition of T-
cell activity during pregnancy. The mixed lymphocyte reaction (MLR) 
of maternal lymphocytes (158), and in particular the MLR response 
from mother to child (20, 159) is depressed. Harrison (81), however, 
finds no alteration of the MLR in lymphocytes from primigravid rats, 
unless serum from pregnant rats was added to the culture. Others des-
cribe a normal capability to develop in vitro a MLR and CTL to allo-
geneic cells, but specific immunosuppression towards paternal anti-
gens is apparent from the absence of cytotoxic T-lymphocytes specific 
for paternal antigens in allopregnant primi- or multigravidae (37, 
160). Several authors note a locally suppressed capacity to generate 
a CTL (41, 141), especially in cells from the lymph nodes draining 
the uterus during pregnancy (40, 41). 
The suppression of T-cell activity during pregnancy is thought 
4o-be-exerted by treïls (141)~r~SFrteen~céTTs~öF TTlopregnänt muTti-
parous mice were able to suppress in vitro MLR response and CTL ge-
neration against paternal cells (36, 37). With monoclonal antibodies 
a subpopulation of splenic T-cells with suppressive activity can be 
identified (36, 160). Others suggest that suppressive activity has 
to be ascribed to B-cells or B-cell-like lymphoid cells (84), cells 
of the trophoblast (40) or to suppressor lymphocytes in the neonatal 
blood (159). The cellular suppression function is also clear from 
the observation that the enhancement effect on allograft survival 
during pregnancy could be transferred by para-aortic lymph node 
cells, but not by maternal serum (10). 
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Immunosuppression during pregnancy is not only dependent on 
(suppressor) cell activity, but is also related to the presence of 
serum factors. These suppressive factors may act directly on the tar-
get cell, or indirectly by inducing a suppressor cell population (20, 
41). Serum factors with immunosuppressive properties are: - an early 
pregnancy factor that appears in the serum within a few hours after 
fertilization (110, 111), - alpha-fetoprotein (51, 122), though this 
is not supported by observations from Wajner (166), and - alpha2-
macroglobulins (67, 144, 145, 154). The significantly decreased serum 
levels of alpha2-macroglobulins in pregnant women with spontaneous 
abortion and fetal death (67, 156) underline the immunosuppressive 
action of this substance. 
Changes in hormone levels during pregnancy are also related to 
immunosuppression. HCG has been reported to suppress the prolifera-
tive T- and B-cell response induced by different mitogens, to inhibit 
MLR development, and to induce generation of suppressor T-cells (4, 
47, 70, 79, 80). Others show, however, that HCG, when highly purified, 
no longer suppresses T-cell activity (14, 30, 104) 
Oestrogen, administered in pharmacological doses, suppresses in-
flammation, delays allograft rejection and decreases in vitro blasto-
genic responses (95, 102), but oestriol has no blocking effect on 
lymphocyte cytotoxicity to embryonic fibroblast cells, not even at 
supraphysiological concentrations (149). Mice treated with increasing 
amounts of diethylstilbestrol (DES) exhibit a progressive loss of 
cortical thymic lymphocytes and T-cells in the splenic white pulp and 
a stimulated RES-activity (21, 99, 102). Other reports mention re-
duced resistance to bacterial or parasitic infections, and suppressed 
immunoreactivity to tumor cells and tumor associated antigens after 
DES treatment in mice (52), and men (2). It is doubted, however, 
whether this occurs at physiologic concentrations of free circulating 
oestrogens (95). 
Progesterone inhibits T-cell reactivity in vitro also (42, 146), 
but Clark (41) doubts whether a reduced capacity to generate CTL , 
activity in cells of pregnant mice is a direct effect of progesterone, 
since maximum suppression was measured during the first half of 
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pregnancy and the blood progesterone level is maximal in the second 
half. Serum levels of progesterone in the second and third trimester 
of pregnancy can suppress lymphocyte reactivity in vitro (11, 149), 
but not the serum concentration alone, also a pregnancy dependent 
change in the binding capacity of the lymphocytes for progesterone 
may be an important factor in the development of the immunosuppressive 
effect (150). 
Since progesterone is produced by the placenta, the local con-
centration may be high enough to suppress an immunological rejection 
of the "allograft" fetus. On the other hand progesterone production 
by the human placenta does not start until 6 to 7 weeks of pregnancy, 
and placentae of rabbits and goats do not produce progesterone yet 
no fetal rejection occurs (146). 
Progesterone affinity for corticosteroid-binding globuline (CBG) 
is almost equal to that of Cortisol and corticosterone (146, 169). 
The high concentration of free progesterone produced in the placenta 
can locally release glucocorticoid from CBG thereby increasing at 
least locally the free concentration glucocorticoid; the immunosup-
pressive action of glucocorticoids is well established. In this way 
the immunosuppressive action of progesterone is indirect. 
During pregnancy the total and free concentration of glucocorti-
coid increases in man (25, 114, 142) and mice (13). Pregnancy levels 
of Cortisol inhibit the PHA mitogenic response, but the concentration 
of unbound Cortisol in these sera is not high enough (149). In addi-
tion, the inhibition of MLR by added plasma from pregnant women is 
correlated to the period of gestation, but not to the concentration 
Cortisol in the plasma (90). The day-night variation of unbound Cor-
tisol, however, is much diminished in late pregnancy (29, 35, 114). 
Thus, maternal lymphoid tissue is exposed to an average daily concen-
tration of Cortisol two and a half times normal (29), and apart from 
an increased concentration a continuous exposure to increased levels 
may have an immunoregulatory effect during pregnancy as well. 
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IMMUNITY AND GLUCOCORTICOIDS 
Glucocorticoids have a wide range of effects on the immune and 
inflammatory response in both animals and man (9), and are used in 
the treatment of many diseases with autoimmune or inflammatory 
features. Patients treated with large doses of corticosteroids develop 
an impaired immunological status, and are more susceptible to a wide 
variety of infections (17). Regarding parasitic diseases increased sus-
ceptibility and exacerbation of latent infections during corticoid 
treatment are reported for Giardia muris and Strongyloides ratti in 
mice (76, 113), and Entamoeba histolytica in man, the latter leading 
to acute amoebic dysentery and fulminating hepatic amoebiasis (148). 
The immunosuppression produced by corticosteroids rapidly alters the 
stable host-parasite relationship, but it is unknown how the steroids 
produce this effect. At pharmacological doses, glucocorticoids have a 
lympholytic effect (9). Sensitivity of lymphocytes to lysis is species 
dependent, e.g. mouse and rat lymphocytes are more sensitive than those 
of guinea pigs or man. But also within corticoid-sensitive species, 
differences in sensitivity are observed between subpopulations of 
lymphocytes and between young and mature cells. 
In mice and rats, corticoid treatment induces depletion of blood 
lymphocytes and atrophy of most lymphoid organs at variable degree, 
most dramatically of the thymus (9, 56). In man, lymphopenia following 
corticosteroid administration is attributed to a redistribution of 
the recirculating lymphocytes, preferentially to the bone marrow (50, 
72, 82). Certain lymphocyte subsets, however, may be sensitive to 
the lytic effect of corticosteroids, and this may be another impor-
tant aspect of corticosteroid-mediated immunoregulation in man (50). 
At physiological levels glucocorticoids are also functional in immuno-
regulation. There is an inverse relationship between lymphocyte levels 
in the peripheral blood and plasma Cortisol concentrations in humans. 
Patients with adrenal deficiency, and subsequently low plasma corti-
sol levels do not exhibit circadian changes in blood lymphocyte num-
bers (157). Moreover, variations in PHA induced blastogenesis and 
antibody-dependent cellular cytotoxicity are related to endogenous 
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serum Cortisol (3, 152). A regulatory circuit is suggested between 
the magnitude of the immune response, ACTH release by the adenohypo-
physis, glucocorticoid production of the adrenals and its modulating 
effect on lymphocyte activity, acting as a centrally mediated immuno-
regulatory circuit (19). 
A major effect of glucocorticoid treatment is the inhibition of 
T-lymphocyte proliferation and function. Glucocorticoids especially 
inhibit the functional activity of the suppressor/cytotoxic T-cell 
subsets (38), subsets with a high number of glucocorticoid receptors 
(54). The dose-dependent inhibition of T-cell function by corticoid 
parallels the inhibition of interleukin 2 production in vitro, and 
exogenous interleukin 2 restores normal function (38, 50). Interfer-
ence with production of other soluble mediators from lymphocytes such 
as lymphotoxin and a monocytechemotactic factor have been reported 
also (50). Thus, modulation of the release of soluble mediators 
may be an important potential mechanism of corticosteroid-mediated 
immunoregulation both in man and animal. 
Not only lymphocytes, but also eosinophils, monocytes and macro-
hages are sensitive to glucocorticoids (50, 168). Corticoid treat-
ment suppresses the colloid clearance function of the reticulo-endo-
thelial system in mice (18), and in man it reduces the number of circu-
lating monocytes, and causes a marked impairment of the bactericidal 
and fungicidal activity (131, 155). A decrease of the plasma cortico-
sterone level in mice leads to an enhanced cellular response, paral-
leled by a specific increase of the number of blood monocytes (161). 
Studies in vitro suggest that glucocorticoids reduce the population 
of inflammatory macrophages by suppressing lymphokine production 
(e.g. macrophage mitogenic factor) (58). Glucocorticoids also in-
hibit secretion of monokines, e.g. interleukin 1, a lymphocyte-
activating factor (50). Since monocytes serve important accessory 
cell functions in T- and B-lymphocyte responses, corticosteroid-
induced effects on monocytes may therefore indirectly alter the 
functional activity of other cell subsets. 
The humoral immune response is also sensitive to glucocorti-
coids. Administration of corticoids inhibits the production of IgG, 
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IgA and to a lesser extent of IgM (50). In general, the secondary 
antibody response is less susceptible to corticoid-mediated suppression 
than the primary response (9, 16). 
In conclusion, the glucocorticoids have profound and complex effects 
on the immune response and at physiological levels they already seem to 
exert a regulatory effect on immunological processes. 
MALARIA IMMUNITY AND GLUCOCORTICOIDS 
The life cycle of the malaria parasite in the vertebrate host 
comprises different stages, the sporozoite, the exoerythrocytic stages 
in the liver, and the erythrocytic stages including the gametocytes. 
The erythrocytic stages are directly harmful to the host, and our stu-
dies and discussions only consider these stages. 
In experimental malaria, the severity of an infection depends on 
the host-parasite combination (87). Some forms of malaria evoke a self-
limiting infection, spontaneously resulting in protection of the host, 
but other forms are lethal. A number of experimental immunization pro-
cedures are described and in most instances, immunity to malaria, de-
veloped under "natural" conditions, but also in experimental models, 
is of the premunition type, with small numbers of parasites persisting 
in the immune host (87). 
The immune response to malaria is complex, with both activation 
of cellular immune mechanisms and production of antibodies (123). The 
cell-mediated immune response is evident from the ability to transfer 
immunity by cells, and from the positive DTH to parasitized erythro-
cytes in mice immune to P. yoelii. The intensity of the DTH response 
closely correlates with the immune status of the host (48, 89). 
Playfair (124) observes an accumulation of lymphoid cells in the spleen, 
and especially in the liver of P. yoelii infected mice, and there is 
a close correlation between the timing of cell accumulation and re-
covery from infection. This pattern of accelerated cell accumulation 
can be transferred·to normal mice by lymphoid cells, but not by serum 
of protected mice. 
Development of protective immunity is T-cell dependent (89). 
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T-cell deficient "nude" mice are unable to develop protection to the 
malar-ia parasite (39, 132), and injection with anti-T-cell serum 
given during the immunization procedure decreases the percentage of 
mice developing immunity (60). 
Monocytes and macrophages are involved in the response to 
malaria. Parasitized erythrocytes are more rapidly removed from the 
circulation than normal red cells (55, 126). Mice, infected with P. 
yoelii, showed a massive increase in the number of blood monocytes 
(88) and accelerated carbon clearance (133). Both these processes 
were not observed in infected athymic mice. Macrophages from P. berghei 
infected mice were more phagocytic for parasitized cells in vitro (138). 
Whether phagocytosis of parasitized erythrocytes plays an important 
role in vivo, however, is questionable since recovery from blood-
stage infections is not correlated with enhanced phagocytosis (33, 
100). Moreover, attempts at in vivo depletion of macrophages do not 
have a significant effect on the course of the infection (124). 
The role of antibodies in malaria is controversial. Immunoglo-
bulins, possibly autoantibodies, have been demonstrated on the sur-
face of red cells in murine (85, 103) and human malaria (63, 135). 
Anaemia in malaria is partly due to loss of uninfected red cells by 
autoantibodies (172). 
Specific antibodies in immune serum can passively protect against 
blood-stage malaria infection (44, 59, 120). Results from in vitro ex-
periments show that immune serum acts mainly by blocking the invasion 
of red cells by merozoites(45). Recent studies in mice with monoclonal 
antibodies support the idea that the specific anti-merozoite action 
is a major feature of protection in vivo (43, 68, 69). 
There is other evidence that antibodies may be important in 
controlling the early phase of a primary infection, but that they 
are not essential for maintenance of immunity (89). B-cell deficient 
mice cannot overcome the primary infection, but if cured by chemo-
therapy they are resistant to reinfection (132, 134). Moreover, Grun 
(77) shows that B-cell deficient mice are able to terminate acute 
P. chabaudi infections, and become resistant to homologous challenge. 
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In summary, the malaria parasite triggers many immune responses 
in the host. Which of these are protective is unclear, and may vary 
from one host-parasite combination to another, though it is evident 
that the induction of immunity is T-cell dependent. Mostly, the de-
velopment of protective immunity implies achievement of a new level 
of equilibrium in the host-parasite interplay, allowing a small 
number of parasites to persist, yet the host is resistant to challenge 
(premunition). Premunition is a dynamic state, this is emphasized by 
the fact that small numbers oí persisting parasites provide the sig-
nal for maintenance of immunity and that reduction of the immunocom-
petence of the host, e.g. during malnutrition or pregnancy, can dis-
rupi the equilibrium res.ñtino in loss of immunity (87). 
Results of studies on the effect of glucocorticoids on malaria 
infection are controversial. Findlay (65) describes that corticoster-
one injection enhances P. berghei infection in mice with a faster in-
crease of parasitaemia and shorter mean survival time. The smaller 
spleens of corticosterone-treated mice suggest inhibition of the 
cellular reaction. Singer (139) and Cantre!! (32), on the other hand, 
observe a reduction of parasitaemia and an increased survival time 
in P. oargkei infected mice, treated with cortisone. These results 
are related to a decrease in reticulocyte count in cortisone treated 
animals, since P. berihe-L shows a definite predilection for these 
cells. In mice, infected with P. vinakei (predilection for adult ery-
throcytes), betamethasone has no significant effect on the normal 
course of infection (49). Betamethasone prevents development o f ac-
quired immunity in infected mice cured by chloroquine treatment. 
Once immunity is established, however, no breakthrough is provoked 
by betamethasone treatment (49). El ing (61) describes an increased 
survival time in some P. berghei - mouse strains treated with dexa-
methasone, but not in others. In this study increased survival 
is explained by a dexamethasone-mediated suppression of immunopatho-
logical reactions. 
The results in other parasite-host combinations are equally di-
vergent. A primary infection of P. aynomolgi in monkeys is not altered 
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by cortisone injections, but in monkeys with a chronic low grade in­
fection, the number and the intensity of relapses is increased by 
cortisone treatment (136). 
In avian malaria, the primary infection of P. reliction in 
pigeons is enhanced, but no relapse can be elicited in birds with 
a chronic, latent infection (128). Latent chronic infections of 
P. relicbwr in sparrows, however, tend to relapse after treatment 
with corticosterone (7). 
For malaria in man, it is reported that in patients with a 
relapse of p. νίυαχ malaria, cortisone injections do not influence 
appreciably the clinical expression of the relapse (170). 
In conclusion, the effect of glucocorticoid treatment on a 
malaria infection is not clearly defined, and probably depends on 
the parasite-host combination. Glucocorticoids seem to influence es­
pecially the generation of acquired immunity, but the effect on an 
established immunity is small. Differences in the type of gluco­
corticoids used, and in the way of administration may be important 
factors for the effect of the hormone in ю. 
AIM OF THIS STUDY 
This thesis comprises studies on malaria immunity in the Plas­
modium Ъегдкеі - mouse model in relation to pregnancy and plasma 
corticosterone levels. Since in this node! an unprotected primary 
infection was always lethal, immunity was induced by a drug con­
trolled infection, followed by a challenge. Acquired immunity was 
of the premunition type with low numbers of surviving parasites in 
the host. Repeated challenges throughout life prevented fading of 
immunity, and cases of spontaneous recrudescences were very rare. 
When immune mice became pregnant, a considerable percentage 
lost their immunity, and developed a frequently fatal recrudescent 
infection. The main topic of this thesis was the study of this preg­
nancy associated loss of malaria immunity in mice and the factors 
involved. The features of the pregnancy associated loss of malaria 
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immunity were studied in several P. ЪетдНег - mouse strain combi­
nations to define common and strain specific aspects (chapter 2 and 
3). Since in human malaria the problem is particularly important 
in Primigravidae, particular attention has been paid to the effect 
of parity and the role of the parasite in the establishment of this 
effect (chapter 3 and 4). Parallelism with human malaria was also 
looked for with regard to the severity of a primary infection during 
pregnancy (chapter 5). 
In view of changes in blood corticosterone levels during preg­
nancy, and the well known immunosuppressive properties of corticoid, 
a possible relation with loss of immunity during pregnancy was ana­
lysed (chapter 6 and 7). Establishment of a relation between plasma 
corticosterone and loss of immunity prompted analysis of an immuno-
regulatory role of corticosterone in non-pregnant mice. The influ­
ence of ACTH treatment on endogenous corticosterone levels was corre­
lated to loss of immunity (chapter 8). 
Since not only corticosterone but also other hormones are 
thought to exert immunosuppression during pregnancy, experiments were 
started to evaluate the effect of progesterone and oestrogen on ma­
laria immunity (chapter 9). 
Immune reactivity of spleen cells in vitro was investigated to 
define immune reactions involved in the pregnancy associated immune 
suppression. Furthermore, the study of the effect of serum and cor­
ticosterone in serum on this in vitro response was carried out to 
correlate the in vitro and in vivo situation (chapter 10). 
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A proportion of mice solidly immune to the rodent malaria parasite Plasmo­
dium berghci exhibited a preg:>ancv-as<wiated depressed immunity with a tran­
sient or oven lethal recrudt'sceiire 
Attenuated immunity and analysis of the im-
munodepressive effect of pregnancy-associated 
substances have been the subject of many inves­
tigations In human malaria a pregnancy-asso­
ciated depression of immunity was inferrn/ froin 
an observed increase in parasite rate ant' para­
site density in pregnant woinun Η a ^olocndemic 
area and from an increased ке іміу oí" mojaría 
during pregnancy {e.g.. cerebral maiuria) in areas 
with unstable malaria (13. 17,21;. й о т е authors 
reported that primigrávida? are at an especially 
high risk (2, 3,17, 20; H. Kurtmann, M.D. thesii, 
Hoyal Tropical Institute, Amsterdam, 1972), 
whereas a decline in tlv- prevalence and density 
of malaria parasites in pregnam as well as ¡n 
nonpregnant women with increasing age has 
been described (2, (). Prematurity and possibly 
abortion were also found to be associated with 
malaria during pregnancy in humans (3, 4, 17, 
18, 21, 28). Comparable phenomena were ob-
served in mice immunized against the rodent 
malaria p-.m^ite Plasmodium berghei during 
pregnancy. Moreover, with recrudescence as a 
markei for depressed immunity, this model can 
be used to analyze the relevance to the immune 
status of pregnancy-associated changes in im-
mune responsiveness and levels of immunologi-
cally activp. iwoteins and hormones during preg-
nancy. 
Approximately 6-week-old mice of several 
strains (Swiss outbred, СЗН/StZ, and B10LP 
inbred) were immunized against P. ber^hei 
(strain K173) by an intraperitoneal injection oí 
10' parasitized erythrocytes, followed by sulfa-
diazine treatment (30 mg/liter of drinking water: 
estimated daily consumption, 3 ml per mouse) 
from days 2 to 33 after infection. Two days laier 
mice were challenged with 10s parasitized eryth-
rocytes given intraperitoneally to assess immu-
nity (9). The acquired immunity was of the 
premunition type with low, subclinical numbers 
of persisting parasites. Spontaneous recrudes-
cences were rare (7). A considerable proportion 
of such immune mice, however, suffered a recru-
descence during pregnancy (Table 1). Patent 
infection (parasites are readily observed in a thin 
blood smear) was found in approximately the 
same proportion of mice in all strains tested. 
A parasitemia of more than 5% infected eryth-
rocytes, as determined from thin blood films, 
was taken to indicate depressed immunity. Pat-
ency was not observed before the last, i.e., third, 
week of pregnancy. As a prepatent period (pe-
riod between infection and patency) of several 
days is common for P. berghei infection in mice, 
presumably the actual breakdown of malarial 
immunity occurred before the third week of 
pregnancy in at least a considerable proportion 
of the mice. In human malaria the situation is 
even less dear as some authors reported a prev-
alence of malaria early in pregnancy (2, 26), and 
others reported it late in pregnancy (17, 21). 
The results of Table 1 also show that, depend-
ing on the strain, a varying proportion of mice 
recovered from a pregnancy-associated recru-
descence. Recovery was never observed before 
parturition. These resul's seem to indicate that 
at least in a proportion of the mice the immu-
nodepressed state is abrogated after parturition, 
in accordance with changes in many other im-
munological phenomena observed during preg-
nancy. Although the mechanism of recovery of 
mice suíí'ering a recrudescence during pregnancy 
is unki.own, a possible mechanism was discjssed 
in relation to a time-dependent waning of im-
munity (8, 9a). 
A proportion of mice did not suffer a recru-
descence during pregnancy, possibly due to the 
clearance of parasites before the immunodepres-
sive period. The clearance of parasites in an 
increasing proportion of mice in relation to in-
creasing periods since the last challenge has been 
described (7). For evaluating the status of non-
recrudescing mice, blood was subinoculated im-
mediately after parturition. Of 28 Swiss mice 
without a recrudescence during pregnancy, 19 
were found to harbor parasites after parturition. 
Such mice may either have developed better 
immunity or a less severe immunodepression 
during pregnancy. 
The P. berghei mouse model also revealed 
malaria-associated prematurity and abortion. 
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The results of Table 2 indicate that 10% of the 
mice with a recrudescence delivered prema­
turely (before day 20) Abortion was also ob­
served 
Though the percentage of premature deliver­
ies was low (10%), 204 of the recrudescing mice 
died from malaria before parturition and were 
not included m the count 
As to the prevalence of recrudescences in Pri­
migravidae, the situation in the Ρ berghei 
mouse model is complicated Though the inci­
dence of recrudescences was much lower in mul-
tigravidae, a high proportion of the mice that 
recrudescenred during their first pregnancy died 
from the infection and could not be studied as 
multigravidae In a different approach to the 
problem, the possibility of a change in the im­
mune status ol the mouse from the first to 
subsequent pregnancies was investigated A 
group of 24 immune Swiss mice recei\ ed curative 
treatment with chloroqume (0 β mg per mouse 
intrapentoneall) for 5 days before mating, sup­
plemented with 100 mg of chloroqume per liter 
of drinking water for the duration of the first 
pregnancy) After parturition the mice were 
reinfected and allowed to mate again During 
the second pregnancy 46% (11 mice) exhibited a 
recrudescence, and this percentage was the same 
as that observed in Primigravidae (Table 1) A 
fundamental difference in -he immunological ca­
pacity of the host between the first ι ad subse­
quent pregnancies is, therefore, not indicated by 
these results 
In older mice a decreased proportion of recru­
descences was observed (Fig 1) Although this 
result is comparable with the situation in hu­
mans (2, 4), the enhanced clearame of parasites 
in older mice (9a) mav have been influential 
Our results show that the Ρ berghei mouae 
moael is an excellent experimental model for the 
anahsis of the mechanism of depressed malarial 
immunity during pregnane), exhibiting several 
similarities with the human rroHel Moreover, it 
is lbo suitable for the study of the reli i n t e of 
I ABLE 1 Ftecrudetience rnd recoicry m pregnant 
/шее" 
No of mice No of mice 
No of with a recru recovering 
Mouse strain pregnant defence from a re 
mice during preg crudescence 
nancy C» (<}) 
CdH/St7, 63 31 (49) 6(19) 
D10L1' 94 3« (40) 2J (61) 
hwiss 21J 107(46) 32(30) 
" Age ol mice at mating varied from 11 to 22 weeks 
(te mliuediateU to 11 weeks after immunization) 
ApproximateK ¿5^ of Swiss mice wpre older at mating 
lup to 4b weeks,) 
TABLE 2 Recrudescence and prematurity in Stiiss 
mice 
% with parturition on day % Dead 
No recrudescence 50 33 17 0 
(n -48 ) 
Recrudescence (n 2 4 4 33 37 20 
= 46) 
mice with ret ruOescence d u n ^ pinone y — 
100 
50 " · 
О к- 1 1 . , . 
'5 20 25 30 Зь чо 45 weens 
0 9 e „f г- * 
Fie 1 Effect of age on the recrudescence of ma 
laria in Primigravidae The figure shows the results 
of 22 groups, each containing from J2 to 5b pregnant 
Suiss mice Mice aere immunized at the age of 6 
weeks (9) Before the mice uere allowed to mate, 
immunity was (re)confirmed by the resistance to chai 
lenge (1& PL·) The Urne indicated in the figure 
reßects the age at mating 
changes of immunological responses in general 
or of immunologically active substances to "n-
munitv The potential immunodepressive activ-
it\ of substances like prolactin (15) a-macro-
globuhns (29 30 J l ) , a fetoproteins (6, 24r ¿5), 
soluble fetal antigens in the maternal circulation 
(1), progesteione (27), and corticoids (14, 19), 
which are present during pregnancy, has been 
established, but is not directly related to the 
actual immunological status of the host With 
recrudescence as a marker for depressed immu-
mt> a direct correlation is possible The same 
holds true for pregnancy-associated changes in 
lymphocyte reactivity (5, 11, 12, 22, 23) or anti-
body responses (10, 16, 24) As to changes in 
antibody responses during a malaria-associated 
pregnancy in humans, the situation is not clear 
The inhibition of an antiparasitic immunoglob-
ulin G response has been suggested (2), but 
others did not observe changes in anti-parasitic 
antibody titers during pregnancy (13, Kortmann, 
M D thesis) 
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Summary 
Depending on the strain, a variable proportion of 
mice solidly immune to the rodent malaria parasite 
Plasmodium berghei developed a recrudescence dur-
ing pregnancy that was either transient or lethal. 
Recrudescence was not observed in all mice, and the 
rate was lower in gravida II as compared to gravida 
I mice On the other hand a proportion of the mice 
that did not develop recrudescence exhibited a preg-
nancy associated clearance of persisting parasites in 
immune mice (premunition-sterilc immunity), being 
more pronounced in gravida II than gravida I mice 
Development of the mechanism of enhanced clear-
ance is apparently parasite dependent Enhanced 
clearance was manifest until day 4 of pregnancy 
Pregnancy associated immunodepression was observed 
most strongly between day 4 and 16 of pregnancy, 
when the highest rates of recrudescence and associ-
ated mortality were found Immunodepression ap-
parently disappears at the end of pregnancy or short-
ly after parturition 
Rekrudeszenz (Wiederaufflammen) der Màuse-Malaiia 
{Plasmodium berghei) wahrend der Trachtigkeit 
Abhangig vom Mausestamm verliert wahrend der 
Trachtigkeit speri ode cine unterschiedlich große An-
zahl der Tiere eine früher erworbene Immunitat gegen 
Plasmodium berghei Das Wiederaufflammen der Ma-
laria ist entweder nur vorübergehend oder entwickelt 
sich zu einer todlich verlaufenden Infektion Nicht 
alle schwangeren Mause erleiden jedoch cine Rekru-
deszenz, wobei der Prozentsatz in Zweit-Graviden-
Tieren niedriger ist als m Erst-Graviden-Mausen. 
Andererseits fallt auf, daß ein Teil derjenigen Mause, 
die wahrend der Trachtigkeit keinen Ruckfall erlei-
den, die sonst fur langere Zeit überlebenden Parasiten 
eliminieren (Premunitat wird zur sterilen Immunitat) 
Dieses Phänomen ist in Zweit-Graviden-Mausen auf-
fälliger als in Erst-Graviden-Mausen. 
Der Mechanismus, der den Wirt befähigt, überlebende 
Parasiten besser zu eliminieren, wird anscheinend von 
den Parasiten selbst induziert, und wirkt sich beson-
ders wahrend der ersten 4 Tage der Trachtigkeit aus. 
Andererseits ist die Immunitat zwischen dem 4 und 
16 Tag der Trachtigkeit am deutlichsten abgeschwächt, 
weil in dieser Zeit die höchsten Rekrudeszenz- und 
Lüthalitatsraten beobachtet werden Die Unterdruk-
kung von Immunreaktionen endet vermutlich bereits 
gegen Ende der Schwangerschaft oder jedenfalls kurz 
nach der Geburl 
Introduction 
The increased prevalence and morbidity of 
human malaria during pregnancy and especial-
ly in gravida I is well documented (Bruce-
Chwatt 1952, Lawson 1967, Gilles et al 1969, 
Kortman 1972, Bray and Anderson 1979) In 
humans acquired malarial immunity is of the 
piemunition type (Sergent 1963) The period 
*This investigation received financial support from 
the World Health Organization, Geneva, Switzerland, 
and the Dutch Government through the Internation-
al Cooperative Research Project for Malarial Immuni-
ty and Immunopathology 
of persistence of parasites, however, varies 
greatly (Brown 1976) and may account for ob-
served differences in prevalence and morbidity 
of malaria between the dry and wet season 
(Kortman 1972, Bray and Anderson 1979). 
Analysis of the role of the parasite as to pres-
ence. absence or clearance before or during 
pregnancy, in the mechanism of pregnancy as-
sociated malaria is difficult to assess in humans. 
Recrudescence of malaria during pregnancy was 
recently observed in a Plasmodium berghei — 
mouse model (van Zon and Eling 1980). Im-
munity to malaria in mice is also of the pre-
0303-4208/80 1600-0402 S 03.00 ) 19B0 Georg Thieme Verleg, Stuttgart · New York 
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munition type (Eling 1978a, 1980a) and the 
presence of parasites can be demonstrated by 
subinoculation. The experiments described in 
this paper analyse parasite persistence during 
pregnancy in relation to malaria recrudescence 
in mice. 
Materials and Methods 
Animals Four to seven week old random-bred Swiss, 
and inbred СЗН/StZ and Balb/c mice were obtained 
from the animal facilities of the University of Nijme­
gen, and inbred B10LP mice from T.N.O Zeist, The 
Netherlands Mice were kept m plastic cages, and fed 
a standard diet (RMH-Hope Farms, The Netherlands) 
and drinking water ad libitum 
Parasite Plasmodium berhei. stram K173, was pas­
saged weekly m the different strams of mice by in­
traperitoneal injection of 10s parasitized erythro­
cytes (PE) Characteristics of the primary infection, 
which was always lethal in unprotected mice, have 
been described elsewhere (Eling et al 1977) 
Immunization Swiss, СЗН/StZ, B10LP and Balb/c 
mice were immunized to Ρ berghei by sulfadiazine 
treatment (30 mg/1 of drinking water), starting 2 
days after injection of 107 parasitized erythrocytes, 
as described previously (Eling 1979) In addition I 
group of Balb/c mice was immunized by chloroqume 
therapy (300 mg/l of drinking water) starting 14 
days after infection with 10s parasitized erythro­
cytes (Poels et al. 1977) Immunity was assessed by 
challenge infection In cases of prolonged periods 
between immunization and pregnancy, experimental 
mice were rechallenged shortly before mating Rein­
fection of pregnancy mice was carried out intraven­
ously. 
Pregnant mice Animals (12-20 week old) were 
housed in a separate unit. Two to 3 females were 
placed with 1 male for 4 to 5 days, and examined 
for the presence of a vaginal plug every morning 
After this period non-mated females were removed, 
and 3 days later the mated females were separated 
from the males and rehoused in groups The day of 
finding the vaginal plug was day one of pregnancy. 
In another mating schedule, 2 to 3 females were 
housed with 1 male contmuously. Pregnancy was de­
termined by repeated palpation starting 14 days af­
ter mating. Newborn mice were removed after par-
tuntion 
ТаЫ 1 Recrudescence in Primigravidae with persistir 
strain pregnant positive isodiagnosis 
Swiss 137 7 7 % ( 1 0 6 / 1 3 7 l 
B10LP 27 8 2 % ( 2 2 / 2 7 ) 
Balb/c 57 65% ( 3 7 /57) 
Recrudescence A parasitemia of S % or more in a 
previously solidly immune animal was considered a 
recrudescence Parasitemia was determined in May-
Gmnwald-Giemsa stained thm smears prepared 3 
times a week either until 4 days after parturition or, 
m mice with a recrudescence, until death or recovery 
Radical cure Persisting parasites in immune mice 
were eliminated by 5 daily injections of chloroqume 
(Nivaquine®, 0 8 mg/mouse ι ρ ) supplemented with 
100 mg/1 chloroqume in the drmking water for 7 
days. 
Isodiagnosis Persistence of parasites was assayed by 
subinoculation (ι ρ ) of 0.05 ml tail blood in 0.2 ml 
salme + heparin (S U/mi) into a clean mouse, which 
was exammed for patency 2 weeks later In all groups 
m which persistence of parasites during pregnancy 
was determined by isodiagnosis, subinoculation was 
performed either during the penod of day 14-18 or 
immediately after delivery 
Results 
Stram specificities m gravida I mice 
Previous results showed that in the majority 
of immune Swiss mice parasites survived for a 
considerable period after challenge (Eling 
1978a, 1980a) Thus, reinfection wjthm 2 
weeks before mating was considered satisfac­
tory to assure presence of parasites, and re­
crudescence in case of pregnancy associated 
immunosuppression. However, a variable and 
strain specific proportion of gravida 1 mice ex­
hibited persistence of parasites (positive iso­
diagnosis) during pregnancy, thereby having 
the opportunity to recrudescence (Table 1) 
In view of results from gravida II mice (see 
below, Table 3) it is interesting to note that 
23 % of Primigravidae Swiss mice had cleared 
their parasites 
The percentage of recrudescence, and even 
more of associated mortality in mice with per­
sisting parasites varied strongly in different 
strains (Table 1) Moreover, these results also 
show that mice with persisting parasites do 
not necessarily recrudescence 
parasites 
recrudescence lethal recrudescence 
6 7 % ( 7 1 / 1 0 6 ) 80% 
55% ( 1 2 /22) 17% 
35% ( 1 3 /37) 23% 
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Table 2 Recrudescence in gravida II mice 
stram 
B10LP1 
СЗН/StZ1 
Swiss1 
SWISS2 
Swiss3 
Swiss2+3 
number 
of mice 
45 
21 
64 
42 
19 
61 
recrudescence 
3( 7%) 
0 
12(19%) 
13(31%) 
7 (37%) 
20 (33%) 
lethal re­
crudescence 
33% 
75% 
95% 
43% 
70% 
'Persistence of parasites was not considered in these 
groups 
2Mice were challenged between 1st and 2nd preg 
nancy, 
э
Місе with positive isodiagnosis between 1st and 
2nd pregnancy. 
Recrudescence m gravida II mice 
Quantitative analysis of recrudescence in mul-
tigravidae is complicated by several factors, 
such as lethal recrudescence during the First 
pregnancy as well as pregnancy associated en­
hanced clearance of parasites (see above) 
Observations on recrudescence in gravida II 
mice were therefore differentiated with re­
gard to measures taken to promote presence 
of parasites during pregnancy (Table 2) Since 
neither of the measures taken in Swiss-2 and 
Swiss-3 mice assured presence of parasites at 
the relevant, immunodepressive phase of preg­
nancy, and the percentage of recrudescence 
in these groups was very similar, these results 
were also summarized. 
The results of B10LP, СЗН/StZ and Swiss-1 
mice suggest a low incidence of recrudescence 
in gravida II mice, whereas associated mortali­
ty was close to that observed in Primigravidae 
(compare Table 1). Measures taken to pro­
mote presence of parasites during the second 
pregnancy resulted in a markedly increased re­
crudescence rate (Swiss 2+3 mice), which was 
considerably lower, however, than in Primigra­
vidae (compare Table 1). but with an equal 
associated mortality rate. The results of Swiss-3 
mice indicate that gravida II mice may develop 
a recrudescence, which did not occur dunng 
the first pregnancy, despite an apparent pres­
ence of parasites. 
So far pnmigravid mice with a lethal recrudes­
cence were lost for further observation. Wheth­
er such mice would resist recrudescence during 
their second pregnancy when the infection dur­
ing the first was cured, was investigated in the 
following experiment. In the first group para­
sitemia in gravida I mice with a recrudescence 
was suppressed by treatment with sulfadiazine 
(30 mg/l drinking water) After parturition 
sulfadiazine treatment was stopped, the mice 
were reinfected (10 5 PE), allowed to mate, 
and observed for recrudescence during their 
second pregnancy. Additionally, subinoculation 
was performed on these mice during their sec­
ond pregnancy to monitor the presence of 
parasites. 
In the second group, mice were treated with 
sulfadiazine during the entire period of their 
first pregnancy After parturition sulfadiazine 
was replaced by normal drinking water, and 
subinoculation was performed for the selection 
of mice with persisting parasites Then the 
mice were again allowed to mate, and ob­
served for recrudescence during their second 
pregnancy Only mice with persisting parasites 
during their first pregnancy were considered 
The results of this experiment are given in 
Table 3 
A considerable proportion (17/26 = 65%) of 
mice from group I cleared the challenge given 
Table 3 Recrudescence in gravida II mice in relation to recrudescence during first pregnancy 
grou 
1 
2 
ρ sulfa treatment 
during recrudescence 
of first pregnancy 
throughout first 
pregnancy 
number 
of mice 
26 
8 
positive isodi 
(gravida III 
9/26 
not done 
agnosis recrudescence 
in gravida 
5 ( 1 9 % ) 
5 ( 6 3 % ) 
II 
lethal 
recrudescence 
5 
5 
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between the first and second pregnancy quick-
ly, which can be compared to a value of 23% 
observed during first pregnancy (see above). 
Moreover, 4 out of 9 mice did not recrudes-
cence despite presence of parasites Taken to-
gether, only 19% of the mice developed an 
infection during their second pregnancy, which 
is in contrast to 63% of mice in the second 
group, which in tum is close to the percent-
age observed dunng a first pregnancy (com-
pare Table 1). The results also show that in 
the second group clearance of parasites asso-
ciated with the second pregnancy occurred 
only about half as frequently as in the first 
group. 
Recrudescence in relation to challenge during 
pregnancy 
Previous section described that a proportion 
of mice cleared persisting parasites during 
pregnancy, which may prevent recrudescence 
by the simple process of eliminating parasites 
before the immunodepressive phase associated 
with pregnancy. Therefore, the effect of rein-
fection during pregnancy was determined. It 
had previously been shown that mice retain 
their immunity for a time after radical cure 
(Eling 1978b). Immune mice were radically 
cured with chloroquine (materials and meth-
ods) and allowed to mate On different days 
during pregnancy separate groups were rein-
fected (10 s P.E.) and the percentage of mice 
with patent parasitemias and associated mor-
tality determined (Figure 1). To relate the ef-
fect of the day of reinfection to pregnancy 
the results were plotted for that day. The 
patency rate was distinctly higher when rein-
fection was carried out between day 4 and 14 
of pregnancy, being around 70%, as compared 
to approximately 45 % before and after this 
period. Patency after reinfection on day 16 
or thereafter became manifest only after par-
tunlion (for comparison It takes 4 to 5 days 
for a primary infection [10 s P.E.] to develop 
a parasitemia of S % or more). 
The day of reinfection appeared also to exert 
considerable influence on the associated mor-
tality. The low mortality rate when mice were 
reinfected on day 1 of pregnancy is remark-
RecrudMCffnce in gravida I Swiss mice — 
parturition 
nuiTiber of tniçt 
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Doy ot challenge infection dunng pnpgnancy 
Fig. 1 Recrudescflncfi m Primigravidae Swiss mice 
in relation to the day of reinfection Immune mice 
were radically cured with chloroquine and allowed 
to mate At different days during pregnancy sepa 
rate groups were reinfected (10 s Ρ E.)r and the per­
centage of mice with recrudescence and associated 
mortality of each group were plotted for the day of 
reinfection The number m the figure refer to the 
number of mica in that group 
о percentage of pregnant mice with recrudescence 
• mortality of recrudescent mice 
able The mortality rate is higher in groups re­
infected on day 2 and 4, but still lower than 
that observed in groups reinfected shortly be­
fore pregnancy (Table 1) The mortality rate 
varies greatly when mice were reinfected in 
the period from day 5 till immediately after 
parturition 
Discussion 
Pregnancy associated recrudescence of malaria 
has been observed in humans (Lawson 1967, 
Gilles et al. 1969, Kortman 1972, Bray and 
Anderson 1979) as well as in mice (van Zon 
and Eling 1980, and Table 1). 
In previous experiments (van Zon and Eling 
1980) the observed long term persistence of 
parasites in immune mice (Eling 1978a, 1980a) 
led to the assumption of presence of parasites 
dunng pregnancy when a challenge was given 
within 2 weeks before maling. Subinoculation 
experiments, however, revealed a total clear­
ance of parasites in a considerable proportion 
of mice (Table 1). Therefore, m these expen-
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ments (Table 1) the rate of recrudescence in 
mice with a proven persistence ol parasites 
(positive isodiagnosis) was higher than pre­
viously reported (van Zon and Eling 1980) 
The proportion of mice that cleared parasites 
before the end of their first pregnancy, ι e 
within a period of maximally 5 weeks after 
challenge was high compared to results in non­
pregnant mice as described previously (Eling 
1978a, 1980a) Since this result in immune 
non-pregnant mice has been observed repeated­
ly, direct matched controls were not included 
in the experiments described in Table 1 The 
clearance rate was still higher in gravida II 
mice (Table 3, group 1) Together these re 
suits indicate a pregnancy associated increased 
clearance rate of persisting parasites in immune 
mice Enhanced clearance may be related to 
increased phagocytosis, which has been ob­
served frequently in relation to pregnancy 
(Mitchell et al 1970, Douglas and Grogan 
1970, Graham and Saba 1973) This pregnan­
cy associated increased phagocytosis was, 
however unspecific, and possibly concerned 
different phases of pregnancy (compare re­
sults in Figure 1) 
Not all mice with persisting parasites recru 
deseed (Table 1) This might indicate either 
superior immunity, or a less severe pregnancy 
associated immunodepression, leavmg unex 
plained, however, why some of these mice de­
veloped a recrudescence during their second 
pregnancy (Table 2) 
The recrudescence associated mortality dif­
fered widely in the strains tested (Table 1), 
which may be the result of several cooperative 
factors 1 immunodepression allowing recru­
descence is particularly important during preg­
nancy and disappears thereafter (non-lactating 
mothers), 2. recrudescence is not observed un­
til the last week of pregnancy, 3 mice may 
survive a primary infection substantially lon­
ger than 1 week Thus, the low recrudescence 
associated mortality in Balb/c mice (Table 1) 
may depend on survival until after parturition 
(mean survival time of mice with a primary 
mfection was 23.5 ± 5 3 days (Eling et al 
1977), when the state of immunodepression 
disappeared, and suppression and control of 
the ongoing infection by a recovering immuni­
ty could take place in many of the mice The 
explanation for the low mortality rate in 
B10LP mice is even more complicated, because 
infected non pregnant B10LP mice did not ex 
hibited a comparative long survival (Eling et al 
1977), whereas this was observed in immuno-
depressed (athymic, splenectomi/ed) animals 
(bling et al 1977, Einig 1980b) 
The results of Table 2, and especially of Swiss 
mice suggest a decreased incidence of recrudes­
cence in gravida II in relation to gravida I 
mice, even when additional measures were 
taken to assure presence of parasites during 
the second pregnancy (Swiss groups 2 and 3) 
These experiments arc complicated, however, 
by mortality from recrudescence in Primigra­
vidae, which implies that only a selection of 
mice was observed, and especially those able 
to prevent recrudescence during their first preg 
nancy On the other hand results of Table 3 
show that clinical cure of a recrudescence in 
gravida I leads to a low incidence of recrudes 
cence in a subsequent pregnancy in such mice 
(group 1, Table 3) Together these results sug­
gest a lower recrudescence rate m gravida II 
than in gravida I mice 
The increased resistance to recrudescence ap­
parently depends on the presence of parasites 
during the first pregnancy, since a normal re 
crudescence rate was observed in gravida II 
mice when parasites were absent during the 
first pregnancy, due to radical cure by chloro-
qume treatment (van Zon and Cling 1980) 
Presence of parasites as such, however, is not 
sufficient as sulfadiazine treated mice (Table 3, 
group 2) from which the parasites were not 
eradicated during their first pregnancy ex 
hibited a recrudescence rate during their sec 
ond pregnancy comparable to that observed 
in Primigravidae The signal for induction of 
an increased resistance, therefore, may have 
to contain a minimal number, or metdbohcally 
active parasites, or particular parasitic stages 
A decreased recrudescence rate in pregnant 
mice having been cured from a recrudescence 
during a previous pregnancy (Table 3, group 1) 
strongly supports this notion 
A decreased recrudescence rate in multigravidae 
has also been reported for human malaria 
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(Bruce-Chwatt 1952, McGregor and Smith 
1952, Cannon 1958, Lawson 1967, Bray and 
Anderson 1979) Analysis of the problem in 
human malaria is complicated by endemicity 
and transmission frequency explaining an in­
creased prevalence of pregnancy associated 
malaria during the wet season (Bray and An­
derson 1979) Cannon (1958) explamed the 
increased resistance in multigravidae by an 
age-related improvement of immunity An age-
related decrease in prevalence of pregnancy 
associated malaria was also observed in pnmi-
gravid mice (van Zon and Eling 1980) suggest­
ing independence of parity An age-related ef­
fect was observed in immune mice with re­
gard to decreasing periods of parasite persist­
ence after challenge (Eling 1980a), reflecting 
increased clearance capacity for parasites 
An increased clearance rate, in turn, is associ 
ated with pregnancy, being more pronounced 
in multigravidae, as described above There­
fore, a lower recrudescence rate m multigra 
vidae may depend on better immunity, being 
reflected by an increased clearance rate prob­
ably resulting from an increased clearance 
capacity This improved reaction of the host 
is apparently induced by the parasite itself 
On the other hand multiple infections (boos­
ters) ot immune mice did not shorten the 
persistence period of the parasites (Eling 
1978a), suggesting that qualitative rather than 
quantitative changes in the immunological 
parasite-host confrontation are responsible for 
pregnancy associated and age-related increased 
clearance 
The recrudescence rate in radically cured mice. 
but reinfected on day 1 to 3 of pregnancy 
(Figure 1) was comparable to rates observed 
in groups challenged before pregnancy, disre­
garding persistence of parasites (van Zon and 
Eling 1980) A higher rate was observed in 
groups reinfected between day 4 and 14 being 
comparable to results observed in groups chai 
lenged before pregnancy and with persistence 
of parasites throughout (Table 1, Swiss mice) 
If the lower recrudescence rate after reinfec­
tion in the first 3 days is to be explained by 
enhanced clearance, the qualitative change oc­
curs early after fertilization The higher rate 
when reinfection was performed between day 
4 and 14, may mark the manifestation of the 
immunodepressive phase, being in agreement 
with a decreased rate when reinfection was 
performed after 14 days of pregnancy (Figure 
1) When enhanced clearance operates early 
during pregnancy it may constitute a protec 
live reaction aiming at elimination of the para­
site before immunodepression evolves The 
results do not indicate whether immuno­
depression involved blocking of enhanced 
clearance or that both process are independ­
ent and chronological 
Since it takes approximately 5 days before an 
infection with 105 parasites has reached a lev­
el of 5% infected cells, it may well be that 
mice challenged late in pregnancy started de­
velopment of a patent infection because of 
immunosuppression, but infection was con 
trolled and suppressed before the recrudescence 
level was reached because immunodepression 
disappeared shortly before or after delivery 
The abruptness of the change in the recrudes­
cence rate between day 4 and 5, and day 14 
and 16 (Figure 1) is remarkable 
No explanation is available for the changes ob­
served in pregnancy associated mortality rates 
(Figure 1) When return to normal immuno 
logical function at the end or after pregnancy 
could explain the decrease of the recrudescence 
rate when reinfection was performed on day 
16 or later a reduced associated mortality rate 
could be expected as well, but is only observed 
in the group reinfected immediately after par 
tuntion 
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IV Pregnancy induced improvement of malaria immunity 
SUMMARY 
A considerable proportion of mice lose acquired immunity to Plas-
mod-Lwn Ъе дТаеъ during the first pregnancy. Immune parous mice, however, 
have a better immune status than virgin mice, the risk of loss of im­
munity during a subsequent pregnancy is greatly reduced, the capacity 
to clear parasites is enhanced, and the maintenance of immunity is 
less dependent on certain splenic functions. The establishment of im­
proved immunity is dependent on the presence of proliferating para­
sites during the second half of pregnancy when immunosuppression re­
sults in recrudescence. 
Immune reactivity is also improved after a (chemotherapeutically 
controlled) recrudescent infection provoked by immunosuppressive 
treatment of immune mice with corticoids or anti-T-cell serum. This 
mimics the situation encountered during pregnancy. Hence, improved 
immunity after pregnancy is a consequence of a reconfrontation of a 
suppressed and/or convalescent immune system with proliferating para­
sites. 
INTRODUCTION 
Malaria presents a serious complication in pregnant women in 
endemic areas. Loss of established acquired immunity has repeated­
ly been observed during pregnancy (Gilles, Lawson, Sibelas, Voller 
& Allan, 1969; Taufa, 1978; Bray & Anderson, 1979; Campbell, 
Martinez & Collins, 1980), and malaria infections are more severe 
in pregnant women in epidemic areas as well as in those with low 
endemicity (Menon, 1972). Loss of immunity as referred from an 
increased incidence, higher parasite densities in peripheral blood 
(Reinhardt, Ambroi se-Thomas, Cavallo-Serra, Meylan & Gautier, 1978; 
Bray & Anderson, 1979) and placenta is more frequently observed 
in Primigravidae as compared to multigravidae (Cannon, 1958; 
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McGregor, Wilson & Billewicz, 1983). 
Recrudescent infections specifically occurring during preg-
nancy, and a higher frequency in Primigravidae as compared to multi-
gravidae was also observed in a murine Plasmodium berghei model 
(Van Zon & Eling, 1980a, b). Moreover, the majority of mice with 
a recrudescent infection during their first pregnancy did not ex-
hibit loss of immunity during a subsequent pregnancy (Van Zon & 
Eling, 1980b). The question rises whether a lower recrudescence 
rate in multigravidae is the consequence of a better immunity, how 
this is accomplished, and what is the role of the parasite as anti-
genic signal for development of this better immunity. It should be 
noted that loss of immunity during pregnancy cannot be prevented by 
challenges given before (unpublished observations). Thus, challenges 
in an immune non pregnant animal do not act as boosters that rein-
force immunity, either with regard to the pregnancy problem or 
with regard to fading of immunity (Eling, 1978). 
Loss of malaria immunity during human as well as animal preg-
nancy is considered to depend on a pregnancy associated depression 
of part of the immune system (Bray & Anderson, 1979; Brabin, 1983). 
In the P. berghei - mouse model it is related to the immunosuppres-
sive effect of a pregnancy associated increase in the plasma concen-
tration of corticosterone (Van Zon, Eling, Hermsen & Koekkoek, 1982). 
This paper describes experiments in the P. berghei - mouse 
model in order to show the importance of the presence of the proli-
ferating parasite during the first pregnancy for the generation of 
a better immunity. Pregnancy associated immunosuppression was imi-
tated in non pregnant immune mice by temporary dexamethasone or 
anti-T-cell serum treatment. In these animals, too, development of 
better immunity was observed in relation to the presence of the 
parasite during immunosuppression. 
MATERIALS AND METHODS 
Mice: Outbred Swiss mice were obtained from the animal facili-
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ties of the University of Nijmegen, and inbred B10LP mice from TNO, 
Zeist, The Netherlands. Swiss mice were used in all but one experi­
ment (table II, groups 1 and 2). Mice were kept under SPF condi­
tions in plastic cages and received water and food ad Libitum. 
Parasite: Plasmodium berghei strain K173 was used in all ex­
periments. The strain was maintained by weekly intraperitoneal sub-
inoculation of infected blood into normal mice. Primary infections 
are always lethal in mice. For primary infection or challenge І.Ю^ 
parasitized erythrocytes (PE) were injected intravenously in preg­
nant mice and intraperitoneally in non pregnant animals. Character­
istics of the primary infection have been described previously 
(Eling, Van Zon & Jerusalem, 1977). 
Immune mice: Mice were immunized as described previously 
(Eling & Jerusalem, 1977). In short, mice were inoculated intraperi­
toneally with 1.107 parasitized erythrocytes (PE). Two days later 
sulfadiazine (30 ng/L) was added to the drinking water. On day 33 
after inoculation sulfadiazine treatment was stopped and the mice 
were challenged 2 days later with 1.10^ PE (i.p.) to assess immuni­
ty. Only mice with established immunity were used. Immunity isof 
the premunition type, which implies that low, subpatent numbers 
of parasites may survive in the immune host for considerable periods 
of time (Eling, 1980a). Immune mice developed neither patency after 
challenge inoculations nor spontaneous recrudescences. 
Recrudescence: Loss of immunity during pregnancy or during 
immunosuppressive treatment was determined from parasite counts in 
thin bloodsmears of tailblood stained with May-Griinwald Giemsa. 
Mice with a parasitaemia of 5% or more were considered to have a 
recrudescence. Recrudescent infections during pregnancy exhibit 
a rapidly increasing parasitaemia which is lethal in approximately 
80% of Swiss mice when left untreated (Van Zon & Eling, 1980b). 
Immune pregnant mice: Two to three immune female mice were 
housed with one male and checked for a vaginal plug on the next 
four days. Mated females were removed from the male 3 days later. 
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The day of the vaginal plug was day 1 of pregnancy. Pregnancy was 
either confirmed at autopsy or by delivery of young. 
Chemotherapy: Sulfadiazine treatment was given to cure an es­
tablished (recrudescent) infection (30 mg/L drinking water), or to 
prevent development of a recrudescence (2.5 or 5 mg/L) during immuno­
suppression (pregnancy dependent or corticoid induced). Sulfadia­
zine treatment is usually not radically curative. 
Chloroquine treatment (5 daily intraperitoneal injections of 
0.8 mg chloroquine sulphate (Nivaquine(R), Specia, Paris) supple­
mented with 100 mg chloroquine sulphate/L drinking water for 7 
days) was given to achieve radical cure. After this treatment ani­
mals were free of parasites as determined by subinoculation of 
blood into normal mice. 
Clearance test: Immune mice were challenged with 1.10' PE 
(i.p.), and 2 weeks later survival of parasites was determined by 
subinoculation of tailblood into normal mice. 0.05 ml of tailblood 
was diluted with medium 199 (Flow Laboratories) supplemented with 
10% fetal calf serum (Flow Laboratories) and heparin (5 lU/ml). 
Two control mice received 0.2 ml of this suspension, and were check­
ed for development of parasitaemia over a period of 2 weeks. 
Immunosuppressive treatment: Dexamethasone (20 mg/L) was added 
to the drinking water. Immune mice were challenged (І.Ю^ PE), and 
received dexamethasone either until they recrudesced or for a max­
imum period of 5 weeks. Mice with a recrudescent infection were sub­
sequently cured by sulfadiazine treatment. 
Treatment with rabbit-anti-mouse-T-cell serum (ATS), prepared 
as described previously (Eling, 1979),consisted of two intraperi­
toneal injections of 0.3 ml of inactivated ATS 2 days apart. Devel­
opment of a recrudescence after ATS treatment was monitored during 
2 weeks. 
Splenectomy: Immune mice were splenectomized under ether anaes­
thesia. A lateral incision was made, the spleen exposed, the splenic 
pedicles ligated, and the spleen removed. The body wall was sutured, 
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and the skin closed with wound clamps. 
Statistical evaluation: Significance of differences between groups 
of mice was assessed by the X^-test for the comparison of 2 proportions. 
RESULTS 
Improved malaria immunity in gravida II mice 
Previous experiments showed that the proportion of immune mice 
losing their immunity during pregnancy is considerably lower in multi-
gravid mice as compared to Primigravidae (Van Zon & Eling, 1930b). 
The question is whether a pregnancy as such or the presence of the 
parasite (antigen) during pregnancy is important for the reinforce-
ment of immunity. To analyse the effect of parity the recrudescence 
rate in Primigravidae was compared with that of gravida II mice that 
were radically cured before their first pregnancy, and reinfected be-
fore their second. In a summary of groups of immune mice that were 
allowed to enter their first pregnancy untreated, a recrudescence 
rate of 53% (45/85) was observed. Recrudescent infections exhibited 
rapidly increasing parasitaemias and were frequently lethal indicating 
a loss of preexisting immunity. In an other group the immune mice were 
radically cured by chloroquine treatment before mating to prevent anti-
genic stimulation during first pregnancy. After the first pregnancy 
the animals were challenged (1.105 PE/mouse; this challenge does not 
provoke a patent infection, but re-establishes the state of pre-
munition) and allowed to mate for their second pregnancy. These mice 
exhibited a recrudescence rate of 46% (11/24), which is close to that 
observed in the group of untreated Primigravidae. 
These results indicate that the recrudescence rate is not de-
pendent on physiological differences between the first and second 
pregnancy. On the other hand these results should be compared to 
those showing a significantly reduced recrudescence rate in gravida 
II mice when they had experienced a recrudescence during their first 
pregnancy (Van Zon & Eling, 1980b). Together, these results suggest 
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an important role of the parasite in generation of a better immunity. 
Enhanced clearance of parasites in immune parous mice 
The question is whether improved immunity after pregnancy is re-
flected by an enhanced ability to clear parasites (switch from pré-
muni ty to sterile immunity). Therefore, groups of mice were challenged 
(1.10 PE/mouse) within a week after parturition, and clearance of 
parasites was determined by subinoculation of tailblood into normal 
controls 2 weeks after challenge. The results of this experiment are 
depicted in table I. 
A strongly enhanced clearance rate was found in parous mice ex-
posed to parasites during a foregoing pregnancy (group 2) as compared 
to immune virgin mice (group 1), or to parous mice that were radical-
ly cured by chemotherapy before pregnancy (group 3). Thus, an enhanc-
ed clearance rate is not obtained by pregnancy alone but by the pres-
cence of parasites during pregnancy. This result is in line with the 
observed effect of the parasite during pregnancy on a lower recrudes-
cence rate in gravida II mice (previous section). The combined re-
sults indicate that the presence of proliferating parasites during 
pregnancy is an important factor in reinforcement of immunity. 
To analyse a possible relation between improvement of immunity 
and presence/proliferation of parasites during a certain period of 
pregnancy, the presence of parasites in immune pregnant mice was re-
stricted to various time sections of the pregnancy period. Group 4 
(table I) summarizes the data of mice in which parasites were present 
either until day 5, or from day 5 to day 11 of pregnancy, after which 
period chloroquine treatment radically cured the mice. Only 15% of 
these mice were able to clear the challenge inoculum given after par-
turition, indicating that the presence of parasites before day 11 of 
pregnancy does not act as an antigenic signal. In group 5 the effect 
of the presence of parasites from day 11 of pregnancy onwards was 
analysed. Immune mice were radically cured by chloroquine treatment 
before mating and 1.10^ PE were inoculated intravenously on day 11 of 
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Table I. Clearance rate in relation to pregnancy and presence of 
parasites 
Significance compared 
Clearance rate to group I 
1. Immune, virgin mice 10% (3/11) 
2. Parous mice; surviving 
parasites during pre­
vious pregnancy 82% (14/17) Ρ < 0.005 
3. Parous mice; no para­
sites during previous 
pregnancy 0% (0/34) n.s.* 
4. Parous mice; surviving 
parasites only before 
day 11 of previous 
pregnancy 15% (3/20) n.s. 
5. Parous mice; surviving 
parasites from day 11 of 
previous pregnancy on­
wards 78% (25/32) Ρ < 0.001 
6. Parous mice as in group 
5, but proliferation of 
parasites during preg­
nancy inhibited by 
sulfonamide treatment 38% (5/13) n.s. 
n.s. not significant 
pregnancy. Ninety percent of these mice developed a recrudescence 
which was cured by sulfadiazine (30 mg/L drinking water) when para-
si taemi a exceeded 5% infected cells. After recovery mice were re­
turned to normal drinking water. When the clearance rate was deter-
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mined in this group after pregnancy it was found that 78% of the mice 
were able to clear the challenge inoculum. The results of group 4 and 
5 show the importance of the presence of parasites during the second 
half of pregnancy for the development of better immunity. 
Finally, the importance of proliferation versus presence of 
parasites during the second half of pregnancy was analysed. The mice 
in group 6 as in group 5 harboured parasites from day 11 till the end 
of pregnancy (tested by subinoculation), but proliferation of the 
parasite during this period was largely inhibited by sulfadiazine 
treatment (2.5 or 5 mg/L drinking water). The clearance rate observed 
after challenge (38%) was intermediate between that of mice which 
were (group 2, 5) or were not (group 3, 4) exposed to proliferating 
parasites during this period of pregnancy. The results so far indi-
cate that the conditions during pregnancy for reinforcement of para-
site clearance in parous mice or for reduced recrudescence rate in 
multigravidae are similar. Reinforcement of immunity in pregnant mice 
is mediated by proliferating parasites during the second half of the 
pregnancy period. 
Enhanced clearance of parasites after temporary immunosuppression 
In combination with previous work results of the present experi-
ments suggest the following hypothesis. Loss of immunity during preg-
nancy is probably caused by pregnancy dependent immunosuppression 
evoked by increased serum corti coid levels during pregnancy (Van Zon 
ei al., 1982), and better immunity is probably developed during the 
(chemotherapeutically supported) convalescent phase of a recrudescent 
infection during pregnancy (previous section). This hypothesis can be 
tested further by an attempt to mimic the pregnancy situation in non 
pregnant immune mice. Immunity can be depressed temporarily in immune 
virgin mice by treatment with immunosuppressives. Immunosuppressive 
treatment can provoke recrudescent infection, and the proliferating 
parasites may then provide the signal for development of improved 
immunity during the (chemotherapeutically supported) convalescent 
phase. 
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In the experiments described in table II dexamethasone and anti-
T-cell serum (ATS) were used as immunosuppressives. Sulfadiazine treat-
ment was used to terminate recrudescences. Chemotherapy was not neces-
sary in ATS treated mice, since no or only low, transient recrudescent 
infections were observed after treatment. After recovery the mice were 
challenged, and 2 weeks later the clearance test was performed. 
Table II. Cleavanae rate after temporary immunosuppression in immune 
miae. 
clearance rate 
1. Dexamethasone treated 90% (9/10) 
2. No dexamethasone treatment 27% (4/15) 
3. ATS treated 80% (8/10) 
4. Controls, NRS treated 40% (4/10) 
Temporary suppression of malaria immunity by dexamethasone treat-
ment, and in the presence of proliferating parasites resulted in a 
significantly higher clearance rate (compare group 1 and 2 of table 
II; p< 0.01). Immunosuppressive treatment with ATS likewise resulted 
in a high clearance rate afterwards, as compared to the mice with 
normal rabbit serum (NRS), though the difference is not statistically 
significant (table II, group 3 and 4). 
In summary, temporary immunosuppression in combination with pro-
liferating parasites in immune non pregnant mice results in improved 
immunity, as expressed by enhanced parasite clearance. This mimics 
the improved immunity in multigravidae as compared to Primigravidae. 
Splenectomy and immunity 
The spleen plays an important role in maintenance of malaria 
immunity. A high proportion of mice with an established immunity de-
veloped lethal infections after splenectomy (Eling, 1980b). This 
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raises the question whether improved immunity in parous mice was 
expressed by a decreased loss of immunity after splenectomy. There-
fore, immune parous and virgin mice were splenectomized and challeng-
ed with 1.10 PE one week later. The proportion of parous mice sur-
viving challenge infection (44/53 = 83%) was significantly higher 
(p < 0.001) than age matched virgin controls (10/22 = 45%). 
DISCUSSION 
It has repeatedly been reported that malaria is a serious problem 
during human pregnancy and that it is more frequent in primi- as com-
pared to multigravidae (Reinhart et al., 1978; Bray & Anderson, 1979; 
McGregor et al., 1983). This is also true for murine Plasmodium berghei 
malaria. Approximately 50 to 70% of the mice immune to P. berghei lose 
their immunity during their first pregnancy (Van Zon & El ing, 1980a). 
In contrast, the proportion of multigravid mice that lose their immu-
nity during pregnancy is significantly lower (Van Zon & El ing, 1980b). 
An important question is whether this difference depends on either 
better immunity in multigravidae or other than immunological differ-
ences (McGregor et al., 1983). The experiments described in this 
paper clearly indicate that a previously existing malaria immunity 
in mice is improved after pregnancy and that this improvement on (an) 
antiparasitic immune reaction(s) developing during the convalescent 
phase of an immunosuppressive period. 
Thus, pregnancy is generally considered to be associated with 
immunosuppression, and in particular of cell-mediated immune reac-
tivity rather than humoral immunity (Beer & Billingham, 1972; Fabris, 
Piantanelli & Muzzioli, 1977; Loke, 1978). The loss of immunity to 
P. berghei in pregnant mice occurred particularly during the second 
half of pregnancy (Van Zon et al., 1982), and was more or less com-
plete, since in the majority of mice the recrudescent infection ran 
a fatal course (Van Zon & El ing, 1980b). The fact that immune mice 
that managed to survive until after parturition, despite a recru-
descence, recovered spontaneously, indicated that the state of immuno-
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suppression has been abrogated after pregnancy. 
Together with better immunity in multigravidae, parous mice also 
exhibited enhanced clearance of a challenge inoculum (table I) and 
the ability to develop sterile immunity instead of an otherwise long 
lasting state of premunity (Eling, 1980a). The conditions for develop-
ment of enhanced clearance were the same as those necessary for develop-
ment of better immunity in multigravidae, and since the clearance test 
is much less laborious, and time consuming than an analysis of repeated 
pregnancies, the clearance test was preferred in the later experiments. 
Since pregnancy associated immunosuppression is related to and probably 
mediated by increased serum corticoid levels (Van Zon et al., 1982), 
it could be hypothesized that development of better immunity is not 
pregnancy specific, but depends on presentation of antigen to the 
immune system in the convalescent phase of a (corticoid mediated) 
immunosuppression. The enhanced clearance rate observed after tempo-
rary corticoid or anti-T-cell immunosuppression in non pregnant mice 
supported this view (table II). 
Improvement of immunity in multigravidae was not dependent on 
parity as such, but parasites have to have been present during a 
previous pregnancy. Moreover, proliferation of the parasite appeared 
to be the effective signal for induction of better immunity (table I, 
group 5 and table II, group 1), rather than the mere presence of 
parasites (table I, group 6). It is important to note that previous 
observations had shown that repeated challenges did not boost anti-
malaria immunity in this model, i.e. did not prevent fading of 
immunity or convert premunity to sterile immunity (Eling, 1978), nor 
prevent loss of immunity during pregnancy (unpublished observations). 
This indicates that increase of the amount of parasite material per 
se, as achieved by repeated challenges, was not effective in inducing 
improvement of the immunity. The importance of the proliferating 
parasite in the immunosuppressed host might indicate the need for a 
confrontation of a threshold load of parasites, or more interesting-
ly, of immunogenic stages of the parasite (parasitized erythrocyte) 
with the suppressed and convalescing immune system. 
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In the P. berghei - mouse model the spleen is important for 
both development and maintenance of immunity (Wyler, 1983). The sig-
nificantly higher proportion of parous mice that maintained immunity 
upon splenectomy indicates that their better immunity has become less 
spleen dependent. 
Consequently, better malaria immunity in parous mice might be 
due to a reinforcement of existing (cell-mediated) immune reactions, 
but it can also be speculated that confrontation of the parasite 
(parasitized erythrocyte) with an immune system which is inhibited 
in its cell-mediated reactivity leads to new, additional immune re-
actions, which are not suppressed during pregnancy and, therefore, 
might be of the humoral type. 
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V Enhanced virulence of malaria infection 
in pregnant mice 
An increased incidence of malaria and increased severity of the 
infection have been reported in pregnant women as compared to non­
pregnant women, from endemic areas (1, 2). Such pregnant women develop 
clinical infections despite an acquired immunity which protected them 
before pregnancy. More virulent infections have also been described in 
unprotected women during pregnancy (3, 4). A more aggravated course has 
been described for other diseases during pregnancy as well (5). 
During pregnancy the immune response of the mother is partly sup­
pressed, possibly to prevent rejection of the allograft (6). This sup­
pression usually concerns cell-mediated rather than humoral immune 
reactivity (5). Since cell-mediated immunity is important in the de­
fence against malaria parasite (7), the pregnancy associated decrease 
in protection to malaria may be a result of depressed cellular immunity. 
In mice immune to the murine malaria parasite Plasmodium berghe-i, 
a considerable proportion lose their immunity during pregnancy (8). In 
this respect the murine model is comparable to human malaria. This paper 
describes an enhanced virulence of the infection in different mouse 
strains in relation to the pregnancy period and in comparison with non 
pregnant controls. Changes in virulence are interpreted in the framework 
of changes in immune reactivity during pregnancy and in relation to ma­
larial immunity. 
MATERIALS AND METHODS 
BiOLP, C57B1/Rij, СЗН/StZ and Balb/c inbred mice were obtained from 
the animal facilities of the University of Nijmegen. Two to three (10 to 
12 weeks old) female mice were housed with one male and checked for a 
vaginal plug on the next four days. Three days later the mated females 
were removed from the male. The day of the vaginal plug was day one of 
pregnancy. P. berghei, strain К 173, was maintained by weekly subinocu­
lation of infected blood into mice from the corresponding strain. The 
experimental animals were infected by injecting them (i.v.) with 10^ pa­
rasitized erythrocytes (PE) in diluted blood obtained from an infected 
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mouse. Animals were checked for pregnancy either by palpation of the 
abdomen on day 16 to 18 of pregnancy, or by postmortem dissection. 
и 
s, 
s 
со 
C57BI/RIJ 
RESULTS AND DISCUSSION 
The virulence of a Plasmodium berghei infection in unprotected, 
pregnant and non-pregnant mice was determined by the mean survival time 
after the inoculation of the 10^ parasitized erythrocytes. Mean survival 
time with respect to the day of pregnancy chosen to infect the mice, as 
observed in B10LP, C57B1/Rij, Balb/c and СЗН/StZ mice, is depicted in 
the figure. The degree of reduction in survival time was apparently de­
pendent on both mouse strains and 
the day of pregnancy chosen to 
infect the animals. The strongest 
reduction was noted in B10LP and 
C57B1/Rij mice with minimum 
values of 31% and 23% respective­
ly of the control values (figures 
A and B). The reduction in mean 
survival time was less but still 
significant (P <0.05; Wilcoxon 
test) in Balb/c mice (figure C) 
and became minimal in C3H/StZ 
mice (not significant when infec­
ted on day 7, but significant on 
day 14 of pregnancy, figure D). 
. , . ., , Reduction of the survival time 
Survival ігте (aays) of pregnant тгое 
with primary malaria infection plotted was observed in mice infected 
against the day of pregnancy chosen to between day 7 and 14 of pregnancy. 
infect the mice. The number of each 
group of mice varied from 5 to 3b mice Minimal survival times were ob-
(mean + SEM). served when the animals were in­
fected on day 10 and 12 of pregnancy. Values were comparable in the two 
strains tested on these days and were close to those values found in non 
pregnant СЗН/StZ mice. No changes in mean survival time were observed in 
mice infected on day 1 or day 5 of pregnancy (figure A). Results obtained 
when B10LP, C57B1/Rij and Balb/c mice were infected on day 14 of pregnan-
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су suggest a return to normal values in the last part of pregnancy 
(figures А, В and C). Enhanced virulence of the infection during 
pregnancy was also apparent from higher parasitaemias in pregnant 
as compared to non-pregnant mice (9,10). 
Parasite-host interplay during a primary malaria infection is 
complex and comprises several different immune reactions which either 
primarily serve to protect the host, or may be regulatory and even 
suppressive, serving survival of the parasite (7, 11). The virulence 
of an infection depends on the presence of immunoprotective and/or 
immunopathological signals on the parasitized erythrocyte and the 
host's reaction to these signals. The stronger (earlier) the immuno­
protective reactions the longer the survival and the stronger (ear­
lier) the immunopathological reactions the shorter the survival.This 
may explain the difference in mean survival time observed in diffe­
rent strains as well as between males and females of a given strain 
(12). СЗН/StZ mice, pregnant or not, exhibit a short mean survival 
time. This might depend either on poorly developed immunoprotective 
or strong immunopathological reactions. When immunopathological 
reactions dominate, immunosuppression will be favourable to the 
host provided that immunoprotective reactions are present. C3H/StZ 
mice, immunosuppressed or not, display a short mean survival time 
after infection (figure D (12)), suggesting that in those mice 
immunoprotective reactions are poorly triggered. As a consequence, 
the pregnancy dependent reduction of the mean survival time observed 
in the other strains (figure А, В and C) may be explained by a re­
duction of the host's ability to mount immunoprotective reactions. 
Shortest mean survival times were observed after infection in the 
second week of pregnancy, suggesting that pregnancy dependent immuno­
suppression is maximal during this period. Mice infected before this 
period exhibited a normal survival pattern despite the experience of 
an immunosuppressive period. This may indicate that pregnancy depen­
dent immunosuppression acts upon sensitizing reactions. Mice infected 
in the first week of pregnancy, survived beyond the pregnancy period 
indicating that reduced survival is not due to delivery problems in 
malaria sick mice. 
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Enhanced virulence might be related to increased reticulocyto-
sis, starting from day 6 of pregnancy onwards (13) and providing a 
higher number of host cells (P. berghei preferentially invades reti-
culocytes (14)). In contradiction to this is the long survival time 
in mice infected on day 1 or 5 of pregnancy, unless we assume that 
these mice have developed an effective protective immunity before-
hand, by which reticulocytosis at this time does not precipitate 
enhanced infection. 
A more severe course of malaria infection in pregnant mice 
was also observed by Oduola et al. (9) who showed the harmful in-
fluence of this infection on the development of the fetuses, re-
sulting in abortion or resorption of the fetuses. A correlation 
between virulence of infection and the day of pregnancy on which 
infection was started was also reported for pregnant mice infected 
with poliomyelitis virus (15). 
The period of pregnancy with reduced survival after malaria 
infection coincides with the period when previously immune mice 
suffer from frequently fatal recrudescences, indicating a complete 
loss of a previously existing immunity (16). In these animals preg-
nancy associated immunosuppression is supposed to block the effector 
part of immunity. Since an established protective immune reaction 
triggered immediately after infection is not affected by the preg-
nancy dependent immunosuppression (see above) this immune reaction 
is different from the one suppressed in immune mice during pregnancy. 
A different sensitivity of immune reactions to anti-T-cell treatment 
during induction of immunity compared to an established immunity (17) 
underlines the possibility that several different immune reactions 
operate. 
We thank J. Reitsma and G. Poelen for biotechnical collaboration 
and care of the animals, and A. Jenks for reading the manuscript. This 
work received financial support from BION-ZWO, The Netherlands. 
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In the experimental Plasmodium berghei mouse model, as in human malaria, 
reduced maternal responsiveness and even loss of immunity were observed during 
pregnancy Loss of immunity in the second half of pregnancy occurred during a 
period of elevated plasma corticoid levels Further analysis showed that plasma 
corticoid levels were significantly higher in immunodepressed mice than in mice 
that remained immune throughout pregnancy Plasma corticosterone levels dif­
fered increasingly from those in mice with persistent immunity towards recrudes­
cence In nonimmune infected controls, however, only a slight increase in plasma 
corticosterone, already present during the subpatent penod, was measured 
Blocking of maternal corticoid production by adrenalectomy delayed the increase 
of plasma corticosterone (fetoplacental origin) and reduced the number of mice 
that lost immunity during pregnancy considerably The role of various plasma 
corticoid levels in the regulation of effector function of immunity during pregnan­
cy is discussed 
Reduced resistance during pregnancy result­
ing in more severe infections and increased 
mortality rates has been reported for viral, para­
sitic, and fungal infections, as well as for tumors 
(1,4, 23, 33, 39, 42, 53) Among these is malaria 
with a higher incidence and seventy in pregnant 
women, possibly causing prematurity and low 
birth weight (9, 11, 13, 34, 35) 
As in human malaria, loss of immunity is also 
observed in a considerable proportion of mice 
previously immune to the virulent parasite Plas­
modium berghei (50, 51) 
A decreased maternal immunoreactmty dur­
ing pregnancy, contributing to tolerance of the 
fetal allograft, has been suggested frequently (6) 
Humoral immunity is either not affected or even 
slightly stimulated during pregnancy (12,22,32) 
The decreased mixed-lymphocyte reaction, phy-
tohcmagglutinin stimulation, and lymphocyte 
cytotoxicity, as well as delayed rejection of 
cardiac allografts, during pregnancy reflect im­
pairment of T-ccll function in vitro and in vivo 
(3, 8, 15, 16, 28, 42) Moreover, macrophage 
activity is reduced or increased in different peri­
ods of pregnancy (25, 38) Since it is frequently 
assumed that T-cells and macrophages play an 
important role in malaria immunity (26, 29, 41, 
44), a pregnancy-associated depression of their 
functions may lead to loss of immunity 
Several factors have been implicated in preg­
nancy-associated immunodepression, such as al-
pha-fetoprotein (37, 46) or changes in serum 
hormone levels (e g , progesterone, human cho-
пошс gonadotropin, and glucocorticoids [27, 
45], which either directly inhibit T-cell activity 
or generate suppressor T-cells (7, 24) The inhib­
iting effect of glucocorticoids on the immunolog­
ical functioning of Τ cells and macrophages is 
well known (2) 
Expenments desenbed in this paper show a 
relation between the level of plasma corticoste­
rone and loss of malaria immunity Mice that 
lost immunity during pregnancy exhibited higher 
plasma corticosterone levels than those with 
persisting immunity, whereas adrenalectomy be­
fore pregnancy not only blocked maternal corti­
costerone production, but also prevented loss of 
immunity, suggesting regulation of the effector 
function by plasma corticosterone 
MATERIALS AND METHODS 
Mice. Random-bred Swiss mice, obtained from the 
animal facilities of the University of Nijmegen or from 
T N O , Zeist, The Netherlands, were kept in plastic 
cages with food and drinking water ad libitum 
Pregnant mice Two or three female mice, aged 12 to 
20 weeks, were housed with one male Every morning 
for the next 4 days mice were examined for the 
presence of a vaginal plug Females not mated after 
4 nights were removed from the male, mated females 
were removed 3 days later The day of finding the 
vaginal plug was day 1 of pregnancy After delivery 
the litter was removed from the mother All pregnan­
cy-related expenments concerned pnmigravid mice 
Parasite. Ρ berghei strain K173 was maintained by 
intraperitoneal subinoculation of infected blood (10s 
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parasitized erythrocytes) into female Swiss mice 
weekly. The course of a primary infection, which is 
always lethal, has been described previously (21). 
Immune mice. The immunization procedure (19) was 
as follows. Mice were infected with 107 parasitized 
erythrocytes and treated with sulfadiazine (30 mg/liter 
of drinking water) from 2 to 33 days thereafter to 
prevent patency. Immunity was assessed by resistance 
to challenge (10' parasitized erythrocytes) given 35 
days after the immunizing infection. Only mice with an 
established immunity were used in the experiments. 
Immunity is of the premunition type; i.e., small, 
subpatent numbers of parasites persist in immune 
animals for different periods of lime (20). Spontaneous 
recrudescences were rare (18). Immune mice did not 
develop patency after any challenge. 
Recrudescence. A pregnancy-associated recrudes­
cence (parasitemia higher than 5% infected cells) was 
determined from thin smears prepared from tail blood 
and stained with May-Griinwald-Giemsa solutions. 
Since recrudescence can only occur when parasites 
are present, immune mice were given an extra chal­
lenge (10fl parasitized erythrocytes) 3 days before 
mating. 
Isodiagnosls. The presence of parasites in immune 
mice was determined by subinoculation of 0.02 ml of 
tail blood, diluted with 0.2 ml of saline conlaining 
heparin (5 U/ml), into a clean animal, which was 
subsequently checked for patency. 
Adrenalectomy. Each adrenal gland was removed 
through a' lateral incision, separation of the muscle 
wall, and blunt preparation of the organ. Operation 
was performed under ether anesthesia. Adrenalecto-
mized mice were kept at 280C for 1 week and received 
seven daily injections of 1 ml of saline subcutaneously, 
supplemented with 0.9% NaCI solution as drinking 
water throughout the experimental period. The time 
between adrenalectomy and mating was at least 2 
weeks. 
Plasma samples. Blood (100 to 150 μΐ) was obtained 
from the retro-orbital plexus of anesthetized (ether) 
mice, using heparinized disposable micropipettes. In 
this way animals could be sampled longitudinally. 
Blood samples were centrifuged and the plasma was 
frozen (-20oC). To avoid interference by diurnal 
changes of the corticosterone level, all samples were 
taken between 11:00 and 11:30 a.m. 
Corticosterone. Plasma corticosterone was mea­
sured by radioimmunoassay, using an antiserum raised 
in sheep against corticosterone-21-hemisuccinate-bo-
vine senjm albumin (gift from T. Ben raad. Department 
of Experimental and Chemical Endocrinology, Uni­
versity of Nümegen). Plasma samples were diluted 
(100-fold) in distilled water with 0.2% ethylene glycol, 
incubated overnight at 40C with I'HJcorticosterone 
(specific activity, 57 Ci/mmol; Amersham Internation-
al Limited), and extracted with toluene. The organic 
phase was evaporated, and corticosterone was sepa-
rated from cross-reacting substances by paper chro-
matography (Whatman no. 1), using a modified Bush 
B5 system (1 volume of toluene, 0.5 volume of metha-
nol, and 0.5 volume of water). Paper was scanned for 
radioactivity (Packard radiochromatogram scanner, 
model 7201), and the radioactive zone was eluted with 
ethylene-glycol-water. Recoveries after extraction and 
chromatography were 24 ± %% (standard deviation; η 
= 46). The procedure for the radioimmunoassay of 
corticosterone in the eluate is the same as that de­
scribed for aldosterone (17). The antiserum dilution 
was 225,000, and corticosterone (Stcraloids) concen­
trations of 25 to 2,000 pg were used for the standard 
curve. The interassay coefficient of variation was 14% 
(л = 46). 
SUtistical evaluation. Significance of differences be­
tween plasma corticosterone levels in groups of mice 
was assessed by the Km s kal and Wallis test and the 
Wilcoxon test. 
RESULTS 
Recrudescence during pregnancy. A high per­
centage of mice» immune to P. berghei, lose 
their immunity during pregnancy and suffer a 
frequently lethal infection (51). The cumulative 
proportion of recrudescent mice in relation to 
the day of pregnancy is depicted in Fig. 1. 
Recrudescences are almost only found in the last 
trimester of pregnancy. Some mice exhibited 
recrudescence after parturition. 
Plasma corticosterone and thymus involution 
during pregnancy in normal and adrenalecto· 
mized Swiss mice. During a malaria infection 
there is reduced immune reactivity which is 
associated with thymus involution (21), and this 
in turn could be taken as an indirect marker for 
immunodepressive changes in T-cell areas. 
Therefore, changes in thymus weight during 
pregnancy were recorded and compared with 
the pattern of recrudescences. Moreover, since 
corticosterone, the physiologically important 
glucocorticoid of mice, is well known for its 
immunosuppressive properties, serum plasma 
levels were determined during pregnancy and 
compared with changes in thymus weight. The 
effect of plasma corticosterone on thymus invo-
cumulat ive p e r c e n t a g e of • 
r e c r u d e s c e n t mice 
100 
parturition 
ІГ 
J-
J 10 
•+-
15 20 
day of pregnancy 
FIG. 1. Cumulaiive pattern of recrudescent mice (л 
= 98) in relation to the period оГ pregnancy. 
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lution was also determined m adrenalectomizcd 
mice, i.e., in the absence of maternal corticoste­
rone production. The results of these experi­
ments are given in Fig. 2a to d 
Progressive thymus involution was observed 
in intact pregnant mice from day 14 onwards 
(Fig 2a), and this correlated with an increase in 
plasma corticosterone levels starting as early as 
day 12 of pregnancy (Fig 2b) In adrcnalecto-
mized mice thymus involution was not signifi­
cant until partuntion (Fig. 2c), and this was 
several days after an increase in plasma cortico­
sterone level (Fig. 2d), which was apparently 
produced by the fetoplacental unit, since the 
increase in plasma corticosterone in adrenalcc-
tomized mice was proportional to the number of 
fetuses (data not shown) In intact and adrenal-
ectomized mice increase in plasma corticoste­
rone preceded thymus involution, but a reduc­
tion in corticoid level was not closely followed 
by thymus regeneration 
An approximately 10-fold increase of plasma 
corticosterone was observed during pregnancy, 
with peak values on day 18 and return to "non­
pregnant" values after partuntion (Fig 2b and 
d) Individual plasma levels vaned strongly, 
especially during the penod of peak values 
Plasma corticosterone and loss of immunity in 
intact pregnant mice. Increased plasma corticos­
terone levels coincided with recrudescence dur­
ing pregnancy This prompted analysis of plas­
ma corticosterone levels in mice developing 
thymus weight 
mg 
100-
5 0 
parturilion 
® 
intact 
Г""!-
parturition 
i
 T 
© 
adrenalectomized 
plasma corticosterone 
/ug/100 ml 
200 
100-
Θ 
Π0Π-
pr«anant 
controls 
2 0 Ι θ 
non­
pregnant 
controls 
12 16 2 0 
day ot pregnancy 
FIG 2 Changes in thymus weight and plasma comcosterone in normal and adrenalectomized pregnant Swiss 
mice Average thymus weight (± standard deviation) was determined in groups of three to six mice, and average 
plasma corticosterone values (± standard deviation) were determined m groups of 4 to 11 animals Data for 
nonpregnant controls (open symbols) were obtained from a control group sacnfìced on different days of 
pregnancy together with experimental mice (closed symbols) 
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recrudescence during pregnancy in comparison 
with mice that remained immune throughout 
Female mice with an established immunity 
were allowed to mate Blood samples were 
taken on days 10, 14, 16, and 18 or 19 of 
pregnancy, and plasma corticosterone concen 
trations were determined Thin smears were 
prepared each time to determine recrudescence 
The blood of each mouse found to be smear 
negative in the penod between days 14 and 18 
was submoculated into control mice, and all 
mice negative by isodiagnosis were taken out of 
the experiment, because without parasites no 
recrudescence could occur 
To relate plasma corticosterone with loss of 
immunity, mice were divided into three catego­
ries on each day of sampling (i) mice actually 
having a recrudescence, (и) mice developing 
recrudescence later in pregnancy, and (in) mice 
without recrudescence throughout pregnancy 
The combined results of two independent ex-
penmenls are depicted in Fig 3 Plasma corti­
costerone concentrations of mice in the three 
categorie;, differed significantly on days 14 and 
16 of pregnancy (P < 0 05, Kruskal and Wallis 
test) Pairwise companson to explore this differ­
ence shows significantly higher corticosterone 
levels in the group of mice with recrudescence 
compared with the levels in one of the other 
groups (P < 0 05, Wilcoxon test) Results on 
days 18 and 19 were not clear, because the 
number of mice involved was too small, which 
was due to the fact that either recrudescent mice 
died earlier or had to be eliminated due to 
prematunty or abortion (50), which caused an 
acute drop of the corticosterone level Never­
theless, the results seem lo indicate a higher 
corticosterone level m recrudescent mice (day 
18, Ρ = 0 05, day 19, Ρ = 0 10) 
In the period of days 14 and 19 the average 
corticosterone concentration, as well as the 
magnitude of the standard deviation of mice 
developing recrudescence later (group 2), shift­
ed from the value found in the group with no 
recrudescence (group 3) to that in the group 
actually having a recrudescence (group 1) The 
significantly higher corticosterone values m re­
crudescent mice and the growing significance of 
increase of plasma corticosterone concentra­
tions towards recrudescence could suggest a 
direct relation between plasma corticosterone 
levels and parasitemia Figure 4 shows plasma 
corticosterone in relation to primary infection A 
small increase in plasma corticosterone was 
already observed in the prepatent penod, was 
not related to the magnitude of the parasitemia, 
and was very small in companson with values 
observed during a pregnancy-related recrudes­
cence 
Plasma corticosterone and loss of immunity in 
adrenalectomized pregnant mice. The close cor­
relation between high levels of plasma corticos­
terone and recrudescence suggests a causal rela­
t ionship This implies lhat blocking and 
corticosterone production should prevent loss of 
immunity and recrudescence Maternal produc­
tion of corticosterone can be blocked by adre­
nalectomy 
Immune mice were adrenalectomized and 
plasma corticosterone levels were determined 2 
weeks later Then, mice were challenged with 
ΙΟ^ parasitized erythrocytes to assure the pres­
ence of parasites, as much as possible, and 
allowed to male 3 days later On days 14, 16, 18 
or 19, and 20 of pregnancy, as well as 1 week 
after partuntion, plasma corticosterone levels 
were determined On the same days blood 
smears were made to assess a possible recrudes­
cence, and isodiagnosis was performed on 
smear-negative mice Finally, mice were sacri­
ficed and examined for the presence of adrenal 
tissue, which was eventually verified by light 
microscopy Mice with remnants of adrenal tis­
sues and isodiagnosis-negative mice were taken 
out of the experiment 
As in normal adrenalectomized mice (Fig 2d), 
plasma corticosterone levels were only elevated 
from day 16 on (Fig 5) With comparatively low 
values until day 18, there is a considerable 
corticosterone level in plasma ol 
I immunized mice during pregnancy 
yug/IOOml 
600 η « recrudescence 
τ • recrudescence later 
о no recrudescence 
5 0 0 -
4 0 0 -
300 - I · 
11 'fi 
100- 14 ^ •L 
*4 , , , , , ,-
10 12 U 16 1Θ 20 
day of pregnancy 
HG 3 Plasma corhcosteronc Loncentrdtions dur 
ing pregnancy Of 37 mice 24 (659f ) developed recru 
descence Plotled corticosterone levels are mean val 
ues (± standard deviation) of each group of mice On 
day 10 of pregnancy the results were pooled since 
corticosterone levels of the groups were the same 
Symbols · miLe actually having recrudescence, + 
mice developing recrudescence later m pregnancy С 
mice without recrudescence throughout pregnancy 
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p l a s m a cort icosterone («yug/IOOml) _ 
parasi temia (о p e r c e n t a g e ) 
Ю-PE i 
I l I. I, ' в 
. 1 0 2 5 7 9 
day after infection 
FIG 4 Mice (л = 10) were longtludtnally sampled 
(sec tent) I day before (control values) and 2 5 7 and 
9 days after infection Λι the same time thin smears 
were made to determine parasitemia Plotted data are 
the mean (± ^andard deviation) Nine mice survived 
until day 7 and three mice survived until day 9 of 
infection PE Parasitized erythrocytes 
reduction in plasma corticosterone compared 
with intact immune mice (Fig 3) Of 22 animals, 
only 3 (14%) developed recrudescence during 
pregnancy, exhibiting higher plasma corticoste­
rone levels than the others on day 16 of pregnan­
cy 
DISCUSSION 
A considerable proportion (approximately 
50%) of mice with an established immunity 
relapsed during their first pregnancy (50) In 
Swiss mice approximately 70% of these recru 
descent mice develop lethal infection (51), im 
plying complete loss of a previously existing 
immunity during pregnancy Considering that 
spontaneous recrudescences are rare in immune 
nonpregnant mice (18), these expenments re­
vealed a remarkable pregnancy associated sup­
pression of effector function of immunity Preg 
nancy-associated immunosuppression has also 
been observed with regard to human malaria (9, 
11, 13, 34, 35), viral infections (e g , poliomyeli 
tis [33], influenza [42], herpes simplex virus [53], 
hepatitis [39], and encephalomyocarditis [23]), 
the protozoan infection amoebic colitis (1), and 
the fungal infection coccidioidomycosis (42) 
Also, tumor development can be enhanced dur 
ing pregnancy, e g , Burkitt s lymphoma (4) 
The Ρ berghei mouse model desenbed in this 
paper may be an adequate experimental model 
for the analysis of the mechanisms of immuno-
deprcssion during pregnancy 
An important result of the expenments was 
that mice that lost immunity during pregnancy 
had significantly higher plasma corticosterone 
levels than mice with persistent immunity (Fig 
3) Analysis of changes during pregnancy re­
vealed that loss of immunity as marked by 
recrudescence (Fig 1 ) was observed in a period 
of progressive thymic involution (Fig 2a) and 
increasing plasma corticosterone levels (Fig 
2b) Recrudescence and thymic involution chro­
nologically followed elevation of plasma corti­
costerone levels (Fig 1 and 2) Combined with 
the well-known immunosuppressive properties 
of glucocorticoids, this suggested a causal rela­
tionship among elevation of plasma corticoid 
levels, thymus involution (30, 36, 40), and im­
paired immune reactivity (recrudescence) In 
combination with the scattering of plasma corti­
costerone levels particularly during peak peri­
ods (Fig 2), this led to the hypothesis that mice 
developing plasma corticosterone values belong­
ing to the upper part of the distribution during 
the peak period (Fig 2b) were prone to lose 
immunity during pregnancy Two observations 
supported this hypothesis first, the significantly 
higher corticosterone levels in mice that lost 
immunity during pregnancy in companson with 
those with persistent immunity throughout (Fig 
3), and second, absence of recrudescence when 
early increase of plasma corticosterone was pre 
vented by adrenalectomy (Fig 5) Some addi 
tional remarks have to be made The scatlenng 
of corticoid levels in recrudescent mice (Fig 3) 
indicates that part of these mice exhibited higher 
corticosterone levels than nonimmune controls 
(Fig 2b), suggesting extra corticosterone pro­
duction Moreover, the plasma corticosterone 
level in the group of mice developing recrudes 
cence some time after sampling increased pro­
gressively towards the end of pregnancy in com­
panson with the group with persisting immunity 
Γ 
/ j g / 1 0 0 n 
4 0 0 -ι 
cort costeronr level in plasma ot mmun zed , 
a n d a d r e n a l e c l o m z e d m ce dur ing pregnancy 
• recrudescence 
+ recrLdescence later 
о n o recrudescence 
b»Fort 
pregnancy 
after 
pregnancy 
1 6 1Θ 2 0 
day of p r e g n a n c y 
FIG 5 Plasma corticosterone concentrations in 
adrenalectomizcd pregnant mice (л = 22) Plotted 
values are the mean (± standard deviation) of mice 
without recrudescence whereas values of recrudes 
cent mice are plotled individually Symbols · mice 
actually having recrudescence + mice developing 
recrudescence later in pregnancy О mice without 
recrudescence throughout pregnancy 
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(Fig 3) It can be assumed that there is an 
increasing chance that recrudescence and in­
creased corticosterone values occur shortly af­
ter sampling towards the end of pregnancy 
Together, these observations suggest that devel­
opment of recrudescent infection leads to in­
creased corticosterone production, but, on the 
other hand, the plasma corticosterone level was 
only minimally changed during infection (Fig 4) 
and appeared to be independent of parasitemia 
This makes it unlikely that stress associated with 
disease was responsible for the impressive in­
crease in recnidescent mice, but leaves unex­
plained the apparent excessive production of 
plasma corticosterone in some recrudescent 
mice 
Maximum plasma corticosterone levels in ad-
renalectomized mice (Fig 2d) were not marked­
ly different from those in intact controls (Fig 
2b), only the rise was delayed The increased 
plasma corticosterone levels towards the end of 
pregnancy in adrenalectomiied mice is assumed 
to depend on production in the fetoplacental unit 
(5), a view that is supported by the observation 
that the level was related to the number of 
fetuses The delayed increase in plasma cortico­
sterone in adrenaleclormzed mice also delayed 
thymic involution In view of the impressive 
reduction of the recrudescence rate in adrenal-
ectomized mice, this may suggest that plasma 
corticosterone levels in adrenalectonwed mice 
can be high enough to suppress the effector 
mechanism of immunity, but that the period of 
sufficiently high, immunosuppressive levels 
starts too late and is too short to cause recrudes­
cence The observation that plasma corticoste­
rone values in recrudescent adrenalectomized 
mice were high already on day 16 of pregnancy 
(Fig 5) is in line with this assumption 
The number of recrudescences after partun-
tion was small (Fig 1), and since recrudescence 
was scored when parasitemia passed 5% infect­
ed cells, the actual breakdown of immunity 
occurred even before parturition However, af­
ter parturition recrudescent infections are sup­
pressed spontaneously (50), suggesting that the 
immunosuppression phased out around partun-
tion, correlating nicely with the reduction in 
plasma corticosterone shortly before parturition 
(Fig 2 and 3) 
In humans, too, elevated plasma Cortisol lev­
els coincide with loss of immunity during preg­
nancy (9, 10) Moreover, an exogenous supply 
of corticoid could break malaria immunity (W 
Eling and A van Zon, Parasitology 77:ii, 1978) 
Also, immunosuppression related to elevated 
corticoid levels was suggested in cases of amoe­
bic colitis (1, 31) These observations support 
the hypothesis that plasma corticoid levels regu­
late the effector part of immunity against several 
pathogens, although the mechanism of this regu­
lation remains to be clarified T-cells and macro 
phages are important in malaria immunity (19, 
26, 41, 44, 52), and changes in activity of these 
cells during pregnancy could lead to loss of 
immunity It is well known that elevated plasma 
corticoid levels decrease the number as well as 
the activity of circulating lymphocytes and 
monocytes (2, 43, 47-49) Since T-suppres-
sor cells are less sensitive to corticoid (54), a 
relative increase of suppressor T-cells during 
pregnancy (29) has been taken to explain preg­
nancy-associated immunodepression (7, 14) 
Furthermore, humoral immunity is either unaf­
fected or enhanced during pregnancy (22, 27, 
33), suggesting that cell mediated reactions are 
suppressed (4) 
Biological activity of corticoids is generally 
related to free corticoid unbound to corlicoid-
binding globulin (2), and further studies are 
directed to the role of free corticoid in the 
regulation of immunity 
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MALARIAL I M M U N I T Y I N P R E G N A N T MICE, 
I N R E L A T I O N T O T O T A L 
A N D U N B O U N D PLASMA C O R T I C O S T E R O N E 
Jt\ Λ A J ( \ 111 /ON \\ 4 ( 1 1 I V . Г ( I f l ï lVsbN 
Th J J M Л m h \M] I \ M I Dl I\ I ь * 
Si чч\п\ 
4 pregnancif dependent loss of malarial immunity is actompanied by an (excessive) 
mínase of total as »ill as free plasma iortnosterone This loss of immunity tvas largely 
prevented by adrenalectomy Woreoier, malarial immunity »as more sensitn-e to dexa 
methasone immunosuppression during pregnancy Primary infections are more virulent 
during pregnamy and like in reirudesient mice, (ause eutssive total and free plasma 
cortiíosterone levels Corticosterone may be lonsidtred an immuno regulatory arum factor 
during pregnancy the endoirtne regulation of »Inch is disturbed in pregnant, infected 
mue 
Keywords MALXRIAI І Ч Ч І M T \ , Р П Ю \ А М Л ( I M M I N O S L P P R F S S I O N , COBTICOSTEHONF 
HbSLMl· 
HcUitions c n l n Гішшишіе paludéenne 
et les 1 oncentralion^ Ho cortiíosterone libre et totale ehez la souris gr<nide 
t ne perte de l immunité paludéenne en rapport avei la gestation est atcompagnee 
par une augmtntatton importante de la Lortitosterone aussi bun Ubre que totale ( ttte 
pirte d*immunité est m grandi partie pres.emu par la surrenahitonne De plus Vimmunité 
paludéenne est plus sensible pendant la gebt ut ton a laition suppressne de la derametha-
sone J <s primo invasions sont plus gra<e\ pendant la gestation et tomme tluz les souris 
qui présentent une recrudescente, elks entraînent un taur exiessif de cortiíosterone libre 
et plasmatujue La (ostuosterone peut ttre considérée tomme un fut leur stnijut d'immuno 
regulation pendant la gestation les mecamsmts endotnniens de sa regulation sont per-
turbes chez la souris gravide 
Mots-tles І ч ч і м г ь PALinihNNF, GISTVTION, IMMLNO SLPPHFSSION, ( O R T K O S T E -
HO\l· 
I N T R Ü D L C T I O N 
P r e g n a n t as compared to non p regnan t women exhibi t an inorcabcd inci-
dence of malar ia and higher paras i te ra tes (15 16) Heduct ion and e \ en 
comple te loss of malar ial immuni ty was a b o obber \ed in a mur ine model 
(*) Department of ( \ lolop\ and TIist»U>g\ Faculty of Medicine, Linvcrsilj of Nijmegen, 
6500 HB Nijmegen, The Netherlands 
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(Plasmodium berghei) dur ing ]>regnanc\ (24, 25I A.pproximateK 60
 0 of 
p regnan t mice rcmidebced (de\e loped pa t en t ιηΓριΙιοηί,Ί and the iiiajorit\ died 
from the iiifcUion Vbortioii and ] i r t m a t u r i t \ were frequentlv оЬьегч ed in 
reir i idescent nuée as has also heen ol)!>Lr\cd in h u m a n malaria in association 
wilh pregnanes Morcoser as in h u m a n malaria reduced immuniU is more 
f rcquentk obscrsed in p rmi ig ra \ idae t h a n in mii l t igrasidae 124) Reduced 
malarial i m m u n i U dur ing pregnanes m a \ be a side effect of a functional 
immunosuppress ion fasouring s u m s a l of a fœtal allograft (13) bnhanced sur-
s i s a l of e g cardiac allografts '•>,) and a l tera t ions m P H \ dependent U m p h o -
(Ste s t imulat ion the mixed K m p h o e s t e cul ture as well as c s l o h l i c T-lvni-
phocs t e generat ion (1 22 point to suppression of cell mediated immune reac 
turns dur ing pregnanes Changes m com n i t r a t i o n of s i r u m fador s ssith 
immunosuppress i se propert ies e g a l p in fa ' loprotein, glucocorticoids œs t ro 
gen progesterone H( d or cor tuoid b inding globulin ^CBCii 11 >) mas be insol-
sed m th( modula t ion of the inununc response In the unirme model rediietion 
of malarial і т ш и т і л ssas found to be related to mcicascd p h s n i a corticoste­
rone concentrat ions Morcosei recrudescence during ] ircginncs ssas largels 
])resenLed in adrenalec lomized m u e abrogat ing coit icosterone product ion (26) 
These results suggest i n s o l s e r m n l of p lasma ( o r h c o s U r o n e in the regulal ion 
of malar ia n n m u n i t s during p n guani s in mice Since the free fraction of 
cort icosterone (not hound to сorticold b inding globulin is considered to be 
biologicalls aclis e 2 its actis its in pregnanes associated rediic lion of malaria 
n n m u n i t s ssas analssed 
I h c serious patliolog\ associated swlh the infection 1231 prompted a n a l s s i s 
of the (ffec I of an infeclion on the plasma concentra t ion of fret c o r t u o s u r o m 
in non p r e g n a n t mice as well as dur ing dilTcient pli iscs of pregnanes Гиг 
thermorc it was tested sshclhcr regulal ion of i m t e m a l i i i imunils lis endoge­
nous cort icosterone resulted 111 increased susccpl i lnbls to immunosuppressum 
bs c t o g e n o u s corticoid ' d e x a m c t h a s o n e 
VISTHIIVL ANO SIFrilODS 
Animili·, J i a n d o m bred specific pathogen free Swiss mice were obta ined 
from the animal facilities of the I nisersilv of Nijmegen at the age of four 
t o six sseeks The mice ssere kept in plastic cages ssith food and dr inking 
ssaler ad libitum 
Pregnant mm fsso or three s irgine female mice ssere housed ssith one 
male and checked for a saginal plug for a period of 4 d a s s I h e das t h e 
vaginal plug ssas found was considered to be das I of pregnan \ 
Parasite Plannodium berghei s t ra in К і / З ssas mainta ined bs sseekls subi-
noculat ion of infected blood into normal mice T h e infection was ei ther s t a r t e d 
bs int raper i toneal (non p r e g n a n t miccj or i n t r a s e n o u s (pregnant mice) i r icc-
tion of 10 s paras i t i/ed er s throcv les PI 1 The course of a primarv infection 
ss Inch is alssass lethal in iinlreateel mice has been described presiouslv (11) 
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Immune mice The immunization procedure has been described pre 
\iousl\ (9) In short, mice infected with ΙΟ' ΡΠ were treated with sulfa 
diazinc (30 mg'l drinking water) from two da\s after infection onwards 
Vfter 2Ç) da\s the drug was remo\ed and two da\s later a challenge infection 
(IO1 Vh,) was gi\en to assess immunity No or onh low transient parasitae-
mia (< 5 %) was obsersed Only mice wilh established immunity were used 
for the experiments Iminiinitv \\as of the jjremunition type ι e mice that 
did not deyelop an infection after challenge may harbour parasites (detected 
by isodiagnosis, see below) for a long time (10) In these mice spontaneous 
recrudescences y\cre rare 
Rlood iamphng l o r the measurement of the total and/or free corticoste­
rone in the plasma a blood sample of about 150 μΐ was obtained from the 
retro-orbital plexus, using hepanmzed glass capillaries Aiter centrifugalion the 
plasma was diyided into two samples y\hich were stored at — 20° С ЛИ blood 
samples were collected betyycen 11 00 h and 12 00 h a m to ay old interference 
by the circadian yanalion of the hormone concentration 
Recrudescence Mice were arbitrarily considered to haye recrudesced when 
parasitaemia rose to > 5 % In bwiss mice approximately 80 % of the mice 
dcycloping a recrudescence during pregnancy died from the infection (25), 
indnating a complete loss of immunity Parasitaemias were determined from 
a thin smear made from a drop of tail blood stained with May-Grunwald-
Giemsa's solution 
Isodiagnosu Io examine the presence of parasites in the blood of immune 
animals during pregnancy approximately ϋ 05 ml blood was subinoculatcd into 
normal mice which y\orc checked for parasitaemia oyer a 2 week period 
Immune mice with a negatiye subinoculation test were remoyed from the 
experiments 
Cortuosterone The total concentration of plasma corticosterone yyas measu­
red by a radio-immunoassay (HIVj as described prcyiously (26) The concen­
tration of free eortieosLerone yvas determined bv equilibrium dialysis in a 
Dianorm bquilibnum Dialyser (Diachema \.G, Zurich, Switzerland) according 
to Hoss (20) ІЗГІСПУ plasma samples wert diluted II times in Hank's solution 
ЬиЯегсгі with 20 mM Ilepes and dialyzed against О 27 % Dcxlran T70 ^Phar-
macia, L ppsala, Sweden) in the same buller Dextran was included to obtain 
equilibrium between the macromolccular osmotic pressure from diluted plasma 
and bulfer (15) A quantity of 3 H corticosterone (Amersham Ltd , England), 
approximately equal to I % of the corticosterone concentration of the sample 
in the plasma compartment yyas added to the dextran containing buder 
compartment 'Intiated corticosterone yyas purified by paper chromatography 
in a modified Bush B5 system (26) before use Contamination after chromato-
graphy was 0 3 %, as tested by binding to an excess of the anticorticosterone 
antibody used in the radio-immunoassay A correction for this contamination 
was included in the calculation of the concentration of free corticosterone in 
the plasma sample The samples were dialyzcd for 5 h at 37o С in rotating 
dialysis cells (working volume 150 μ.1, the dialysis membrane had a molecular 
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weight cut-oiî value of 5,000) Hadioaclivitv was counted after diaksis 111 
a 100 μΐ aliquot of each compartment The fraction of free corticosterone (f) 
in the diluted plasma was derived from 2 times the radioactivil> in 100 μΐ 
of the buffer compailment divided bv the sum of the aclnitie» in 100 μΐ of the 
plasma and buffer compartments The ratio of free to bound corticosterone 
(f/b) in the diluted plasma could be calculated as f/b = —, In preliminarv 
experiments a direct proportionaliU was found between fib and the dilution 
factor of the plasma (maximal dilution tested was ^2) with a correlation of 
0 999 for both normal plasma and plasma from dav 16 of pregnancv Therefore 
the ratio fjb in undiluted plasma could be calculated b\ dividing the latio 
f/b in diluted plasma li) the dilution factor ( = 22) of the dialvsis svstem 
From this result and the concentration of total plasma corticosterone measured 
in the RIA, the percentage and eoncentralion of free corticosterone in the 
plasma could be calculated The intra assa> coefficient of variation in the 
equilibrium dialjsis was 25 % (n = 4), the inter assaj variation was 15 % 
( n = i 7 ) 
Rh SC LTS 
Plasma corticosterone level during prignancy The plasma corlicostcrone 
concentration (bound + free) increased during pregnancv with a maximum in 
the third week and returned to low levels shortlv before parturition
 v
26) 
Measurement of the concentrations of free corticosterone did not reveal 
a comparable change in the plasma level during pregnancv (fig I A) During 
pregnancy sbghtlv elevated concentrations of free plasma corticosterone were 
found on da\ TO and 18 whereas лег low values were found immcdiatelv 
after parturition 
Plasma corticosterone concentration and loss of immunity during pregnancy 
Approximatel\ half of the mice lose their malarial immunity during prcgnaiic\ 
(24, 25, sec also below) In these mice loss of immunitv was related to increa­
sed levels of total plasma corticosterone 126) likewise, the comentration 
of free corticosterone was increased in the plasma of mice that had lost their 
immunitv during pregnancv (fig if); 
The total plasma corticosterone concentration returned to low levels before 
parturition, independent of whether mice had lost their ininiuiutj and suffered 
from a patent infection or remained immune throughout pregnancj (26) The 
concentration of free cortuosterone, however, remained high in 3 out of 4 mice 
that had lost immunitv during pregnane} (fig \K\ The fourth mouse with 
a patent infection and л low plasma concentration of free corticosterone 
shortly before parturition did not exhibit patene) two dav s earlier, in contrast 
to the other 3 mice In mice that maintained their immunitj during pre­
gnancv the plasma concentration of free corticosterone was low shortlv after 
parturition 
The concentration of free plasma corticosterone in mice that appeared to 
lose immunitv at a later point during pregnane) had already increased from 
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day 14 of pregnancy onwards, when rompared to those that maintained immu­
nity throughout. A comparable ohber\ation was, made earlier with regard to 
the total plasma corticosterone level (26). 
Excessive enrticosterone levels in mice with a malaria infection during pre­
gnancy: The corticosterone levels (bound + free) in mice suffering a malaria 
recrudescence as a result of a pregnancy associated loss of immunity were 
frequently higher than the range observed in normal mice (26) Total plasma 
corticosterone levels in non-pregnant mice with malaria infection were not 
or only transiently e l a t e d (table I, also 26). Excessive total plasma cortico­
sterone Іел-еЬ, however, were found in non-immune mice with a primary 
infection during pregnancy, and the extent depended on the day of pregnancy 
chosen to infect the animals (fig. 1С). Infections started on da\ 9 of pregnancv 
resultcd in excessive total plasma corticosterone levels in comparison to the 
normal pregnancy range, whereas increases were smaller when mice were infec­
ted on day 7 or day II of pregnancy. 
Free plasma corticosterone concentrations were elevated in infected non­
pregnant (table I) as well as in pregnant mice (fig. ID). In non-pregnant 
mice a primary infection free plasma corticosterone levels were substantially 
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T A B I Ε I 
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increased from da\ 7 "f infection onwards (table I) Increased free levels 
were found earlier when non-immune mice were infected during pregnamv 
'Ihis appears to coincide with a more virulent course of infection during pre­
gnancy (see below) 
Virulence of infection during pregnancy Primary infections started either 
on dav 7, 9 or 11 of pregnamv exhibited an increased virulence in comparison 
to non pregnant controls Parasitaemia developed faster in pregnant mice 
reaching values of I % parasitized red Mood cells on dav 2 after inoculation 
and 27 5 % on day 5, compared to о % and 7.6 %, respectively, in non­
pregnant mue 
In separate experiments it was found that the mean survival time after 
infection was shorter in pregnant ÍIO б ± 0 8 davs, η = 52) than in non-pre­
gnant controls 2^5 4 L 0 6 days, η = 45) The increased virulence of an infec­
tion during pregnancy mav explain the earlier increase of the plasma concen­
tration of free corticosterone in these mice f^ig iDl Despite an equally increa­
sed virulence of infections started either on dav 7, 9 or II of prcgnancv, 
the increase of plasma corticosterone was highest when the infection was 
started on day 9 of pregnancy (fig iC, ID) 
Increased sensitivity to dexamelhasone іттипочирргечзюп during pregnancy. 
The relation between plasma corticosterone levels and loss of immunity during 
pregnancy (26) suggested the possibilitv of an increased susceptibility to gluco­
corticoid immunosuppression during pregnancy 
When non-pregnant, immune mice received 20 nig dexamelhasone/1 of 
drinking water all animals developed lethal recrudescences, indicating loss of 
immunity When 10 or 5 mg dexamethasone/1 were added to the drinking 
water 73 % (19/26) and 8 % (1/12), respectively, of the mice lost immunity 
When 5 mg/1 was given to immune mice during pregnancy, however, 76 % 
(Π/17) lost their immunity, as compared to 47 % (7/'5) of pregnant mice not 
additionally treated with dexamelhasone 
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DlSCl SSION 
A considerable proportion of nuce Іоье a solid malarial {Ρ berghei) imiiiu-
nit\ during іігейііап(\ (24, 25) The concentration of total plasma corticoste­
rone (hound + free) was increased in recrudescent mice Adrenalectoniv before 
pregnanc\, prc\enting production of plasma corticosterone largck reduced loss 
of immunitv during pregnancv Since total plasma torticoslerone concentra­
tions were not markedK ele\ated in non pregnant mice during a malaria infec­
tion, the mfedion per vc apparentK did not cause the increased corticoid 
le\els (tahle I, also 26) A. possible causal relalion between immunosupprcsbivc 
adion of plasma corticosterone and loss of immumts during pregnancv needed 
further investigation, since the biological actniU of the glucocorticoids is 
usuallv not ascribed to total plasma corticosleronc but to the free, non prutein-
bound fraclion of the hormone 
According to the results described in this paper, loss of immunitv during 
pregnane;, appears to be related not onh to increased concentrations of total 
but also of free plasma corticostcione In normal mice the increase of total 
plasma corticosterone during the last week of pregnancv was not accompanied 
bv elevated concentrations of free hormone dig I \), indicating a parallel 
increase of corticosterone-binding globulin In immune mice with recrudescence 
during pregnancv, however, the free plasma corticosterone concentration was 
increased (hg iB^ No indications were found that in mice losing immunity 
corticosterone concentrations were elevated earK 111 pregnancv Thus, on 
da\ IO of pregnancv the mean concentration (^t SPAT) of free plasma corti­
costerone was the same in mice t i n t lost immunitv later during pregnancv 
as compared to those that remained immune (fig iHl 
The increase of total plasma corticosterone in pregnant mice with recru­
descent malaria are frequenth above the range observed during normal pre 
gnancv '26) This was also observed during pnmarv infection in pregnant 
mice (fig" iCl, but not in non-pregnant mice with a pnmarv infection 
(table I) Moreover the excessive plasma corticosterone concenlrations are 
apparcnUv related to the dav of pregnancv on which the infection was ini­
tiated (lig iC) This suggests that, unlike in normal mice, in pregnant mice 
the plasma corticosterone regulation is deranged bv malaria infection, and that 
there is a phase during pregnancv (close to dav 9) when the beginning of 
an infection renders regulation especiallv sensitive Whether increased stress 
sensitivilv during gestation (4^ is responsible for these observations remains 
to be clarified 
Increase of the concentration of free corticosterone during patent malaria 
infection was independent of changes in the total corticosterone concentration 
In pregnant mice with a well established patent infection the free concen­
tration remained high shortlv before parturition (fig ]B), despite a reduction 
in the concentration of total plasma corticosterone at time (26) During 
pnmarv infection in non-pregnant mice the free concentration but not the total 
concentration increased with the severity of the infection (table I) These 
increased concentrations of free corticosterone nia\ be explained b\ a reduced 
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CI3G production in Ihp li\er as a consequente of the sexere liver patholog\ 
observed at the end of the first week of infection ^ 1 , 23) I his ma\ also 
ечріаш whv the mouse a patcnev of less than 2 da\s on da\ 20 of pregnancv 
did noi show an increased toncentralion of free corticosterone in contrast 
to the other 3 on that da\ of pregnant\ (fig IB) Thus, the plasma concen 
tration of free «orticostcrone is jiroliahK also dependent on normal liver fune 
tion for CUG production 
The excessive levels of total and free plasma corticosterone are (oncomitant 
to patent malaria
 v
priinar\ infeehon or recrudescence) during jiregnancv 'I his 
reiterated the question whether plasma (orticoslcrone levels are causallv related 
to loss ol immunitv The correlation between imreased plasma levels of corti­
costerone and loss of immunitv, and the reduction of the recrudescence rate 
in adrenalertomized animals suggested a regulatorv role for corticosterone in 
the elTettor svstem of ininiumlv Corticoid treatment (dexamethasone) of 
immune mue resulted in breakdown of immunitv, and during pregnancv 
immune mue appeared to be more sensitive to coilicoid immunosupprcbsion 
than non pregnant immune mice These observations emphasize the suscepti-
bihtv of the tlfeclor svstem of malaria immunitv to corticoid iinrnunosuppres 
sion, espeiiallv during pregnancv, and support the immunoregulatorj role of 
plasma corticoid 
Recrudescence of occult infections after corticoid treatment vvas also shown 
in other parasitic diseases, e g murine giardiasis (17) strongvloidiasis (18) 
and amoelnasis (2Г) Moreover, a more severe course of ainoclm colitis vvas 
described during pregnancv {1), as well as of infections of Liberia monocyto 
genesis and Toioplusma gondii (14; Immunosuppression during pregnancv 
especiallv concerns cell mediated immunitv as indiialed bv reduced resistance 
to several vnal and parasitic infections m vivo (22), and reduced actiwtv 
in several l-cell assavs 6 71 m vitro csing pregnancv derived material This 
correlates with the action of glucocorticoids which are thought to exert tluir 
major suppressive elTcct on Τ kinphoi ν les and 1 cell dependent macrophage 
ailivitv, both in the initiation and the efTcctor phases of the immune res­
ponse {2, S1 In contrast, humoral immunitv is not considered to be suppres­
sed during jiregnancv ι e pregnancv is usuallv no contra indication for 
vaccination In malarial immunitv 1 -cells and macrophages ріал an important 
role (12Ì PregnaiKN assodateci loss of malarial immunitv is correlated with 
an Ulerease of the plasma concentration of both total and free corticosterone 
In summarv the observations could be interpreted as follows 
— changes 111 the plasma corticosterone com cntiation are functional in 
jiregnancv dejiendent immunorcgiilation in general, 
— a nalurallv occurring high plasma corticosterone level predisposes to 
loss of malarial immuniH during pregnaniv, 
- - jiatent infection during pregnancv causes derangement of endocrine 
regulation, and consequentlv excessive plasma corticosterone levels 
Though these mechanisms mav equally applj to Primigravidae and multi-
gravidae, loss of malarial immunitv is less frequent in mulligravidae Previous 
results (25) indicated that re exposure to the jiarasilc during a pregnancy 
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dependent recrudescencp substantialK reduced the recrudesccnLC rate during 
subsequent pregnancies This suggested either a re inforcement of an existing 
immune response, or a shift to a tortnoid insensilne immune response л 
problem which is currenth heing in\estigatcd 
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Vili ACTH dependent modulation of malaria immunity 
in mice 
ABSTRACT 
Tetracosactrin, a synthetic ACTH analogue delivered from osmotic 
minipumps implanted subcutaneously in mice induced a dose dependent 
increase of plasma corticosterone levels. In mice with an established 
immunity to Plasmodium berghei the increase of the plasma corticoste-
rone level due to tetracosactrin treatment correlated with loss of 
immunity against this malaria parasite. The observed plasma corticos-
terone levels associated with loss of malaria immunity were of the 
same order as those in mice that lost their immunity during pregnancy. 
Adrenalectomy before administration of the ACTH analogue preven-
ted both the increase of plasma corticosterone and loss of malaria 
immunity. Adrenalectorni zed mice still lost their malaria immunity 
when treated with the synthetic corticoid dexamethasone. The effector 
function of malaria immunity is sensitive to corticoids, and, at least 
during pregnancy, the naturally occurring serum corticosterone level 
appears to be an important regulator of malaria immunity. 
INTRODUCTION 
Glucocorticoids have a well known effect on the immune response, 
though its mechanism of action is far from clear. A prominent lympho-
lytic effect is observed at supra-physiological doses (1). At physio-
logical levels a regulatory role of the immune response, possibly by 
modulation of the release of soluble mediators from immunologically 
active cells has been proposed (2, 7, 8, 9). 
Patients treated with corticoids have an increased susceptibility 
to infections. Glucocorticoid treatment may affect the host-parasite 
equilibrium of a clinical immunity, and provoke recrudescence of a 
subpatent infection both in humans (17, 23) and mice (14, 18). A preg-
nancy associated reduction of malaria immunity has repeatedly been des-
cribed in humans (3, 4, 5, 16, 21), as well as in mice (25, 26). In the 
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Plasmodium berghei - mouse model this pregnancy associated loss of 
immunity was correlated with increased plasma corticosterone levels, 
and could be prevented by adrenalectomy performed before pregnancy 
(27, 28). The next question was whether the regulatory function of 
plasma corticosterone in malaria immunity during pregnancy could 
also operate in non-pregnants. 
The results reported here show that an ACTH (-analogue) induced 
increase of the plasma corticosterone level correlated with loss of 
malaria immunity in non-pregnant mice. Plasma corticosterone levels 
in these mice were of the same order as those observed during preg-
nancy. Adrenalectomy before treatment with the ACTH analogue preven-
ted both the increase of plasma corticosterone and loss of malaria 
immunity, though in these mice immunity was lost after dexamethasone 
treatment. 
The results show that plasma corticosterone is an effective re-
gulator of the effector function of malaria immunity, which, in turn 
strongly suggests that pregnancy associated loss of immunity is caused 
by increased plasma corticosterone levels. 
MATERIALS AND METHODS 
Mice. Random bred, specific pathogen free Swiss mice were obtained 
from the animal facilities of the University of Nijmegen. They were 
housed in plastic cages and received food and water ad libitum. 
Parasite. Plasmodium berghei, strain K173, was maintained by 
weekly subinoculation of infected blood in normal mice. The malaria 
infection was always lethal in unprotected mice, the course of the in-
fection has been described earlier (11). 
Immune mice. Mice were immunized to P. berghei as described by 
Eling (12). In short, mice were infected with 10? parasitized erythro-
cytes (PE) and from day 2 to day 33 after infection treated with sulfa-
diazine (30 mg/L) added to the drinking water to prevent patent infec-
tion. Two days after termination of sulfadiazine treatment the mice 
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were challenged (10^ PE) to assess immunity. 
Immunity was of the premunition type with low numbers of surviving 
parasites in the immune host. Spontaneous recrudescences were not ob­
served. Shortly before implantation of an osmotic pump, the immune mice 
were challenged again to ensure the presence of parasites, and thus the 
possibility of development of a recrudescence during the time of hor­
mone treatment. Immune mice without recrudescence during hormone treat­
ment were checked for the presence of parasites by isodiagnosis after­
wards (see below). 
Recrudescence. Development of a recrudescent infection was checked 
in thin blood smears (May-Griinwald Giemsa staining) made from tail 
blood three times a week. Mice with a parasitemia of 5% or more infec­
ted red blood cells were considered to have lost their immunity. The 
5% limit was chosen, because previous experience had shown that the 
majority of immune mice developing parasitemias exceding 5% finally 
succumbed to the infection. 
Isodiagnosis. Presence of parasites in the peripheral blood of 
immune mice was examined by subinoculation of tail blood into normal 
mice. These mice were checked for development of a malaria infection 
over a two week period. 
Adrenalectomy. Mice were anesthetized with ether, and a lateral 
incision was made on each side. The muscle wall was separated and 
the adrenal glands removed, using blunt forceps. 
Adrenalectomized mice were injected with 1 ml saline subcutane-
ously daily for a period of 7 days. Th^received 0.9°i NaCl solution 
as drinking water and were housed at 28° С for the time of the expe­
riment. The time between adrenalectomy and implantation of an osmotic 
pump was at least 14 days. 
Immunosuppressive treatment. Immune mice were treated with cor­
ticosterone, dexamethasone, or tetracosactrin (Synacthen, Ciba), a 
synthetic polypeptide with ACTH activity. The substances were in­
jected into osmotic minipumps (Alza Coop.type 2002) which were im-
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planted subcutaneously. According to the manufacturer the release rate 
of the pumps is 0.43 μΐ/h, and completely filled pumps would be active 
for a period of about 2 weeks. 
For corticosterone, a solution containing 25 pg/ul, which is close 
to the saturation concentration in polyethylene glycol 400 (26 yg/vil ) 
(29) was injected into the osmotic minipumps, resulting in a calculated 
dose of 258 ug/24 h. The dexamethasone concentration was related to the 
previously established immunosuppressive effect of 20 mg, 10 mg or 5 
mg/L of dexamethasone when added to the drinking water of the mice (28) 
Assuming a daily intake of 3 ml drinking water per mouse, the 24 h 
doses of dexamethasone are 60 pg, 30 \ig and 15 yg respectively, which 
is equivalent to a concentration of 5.81 yg, 2.91 yg and 1.45 ug dexa­
methasone per yl in the mi ni pump. The dexamethasone also was dissolved 
in polyethylene glycol 400 (29). 
For tetracosactrin the equivalent of 0.1 ID, 0.05 IU and 0.025 IU 
of ACTH, released in a volume of 10.32 yl per 24 h, was injected in the 
pumps. The activity of 1 mg of tetracosactrin is assumed to be equiva­
lent to 100 IU of corticotropin (Martindale, the Extra Pharmacopeia, 
26th ed. 1972). Thus, tetracosactrin concentrations in the minipumps 
were 0.1 yg, 0.05 yg and 0.025 yg per yl of Hanks solution buffered 
with 20 mM Hepes. 
Plasma corticosterone. Total plasma corticosterone was measured 
by a radioimmunoassay (RIA) using a sheep-anti-corticosterone serum 
(gift from T. Benraad, Dept. of Experimental and Chemical Endocrinolo­
gy, University of Nijmegen) as described previously (27). The concen­
tration of free corticosterone in the plasma was determined by equili­
brium dialysis according to the method of Ross (H.A. Ross, M.D. thesis, 
University of Nijmegen, 1980), modified as described in detail else­
where (28). In brief, plasma samples, 11 times diluted in Hank's solu­
tion buffered with 20 mM Hepes, were dialysed against 0.27% dextran 
T70 (Pharmacia, Sweden) in the same buffer. A quantity of 3H cortico­
sterone (Amersham Ltd., England), approximately equal to 1% of the cor-
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ticosterone concentration in the plasma compartment, was added to the 
dextran containing buffer compartment. Samples were dialysed for 5 h 
at 37° С in rotating dialysis cells with a working volume of 150 μΐ 
and a dialysis membrane with a molecular weight cut-off value of 5000. 
After dialysis, radioactivity was counted in 100 μΐ aliquots of each 
compartment. The fraction of free corticosterone (f) in the diluted 
plasma was derived from 2 times the radioactivity in 100 μΐ of the 
buffer compartment divided by the sum of activities in 100 yl of the 
plasma and buffer compartment. The ratio of free to bound corticoste­
rone (f/b) in the diluted plasma could be calculated as: f/b = y ^ p 
the ratio f/b in undiluted plasma by dividing the ratio f/b in di­
luted plasma by the dilution factor (= 22) of the dialysis system 
(in preliminary experiments a direct proportionality was found between 
f/b and the dilution factor). From this result and the total concen­
tration plasma corticosterone as measured in the RIA, the concentra­
tion of free hormone was calculated. 
RESULTS 
Effect of glucocorticoid treatment. Corticosterone in the mini-
pump (25 μς/μΐ ) resulted in a calculated release of 258 μg per 24 h. 
Although this dose seems high in relation to the basal plasma level 
of 0.1 μg/ml plasma (27), it did not result in a detectable increase 
in the plasma corticosterone concentration during the 3 week period 
following implantation of the minipumps (results not shown). 
Moreover, immune mice treated with corticosterone by minipumps did 
not lose their malaria immunity. Dexamethasone in the minipumps, 
however, led to loss of malaria immunity. The calculated doses of 
60 μg and 30 μg of dexamethasone released from the minipumps over a 
24 h period caused loss of malaria immunity in all four mice tested 
within 1 to 2 weeks after implantation. These regimens correspond to 
20 mg and 10 mg of dexamethasone per liter drinking water, which also 
led to loss of malaria immunity. A calculated dose of 15 μg dexametha-
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soné delivered from the minipumps per 24 h did not cause loss of 
immunity, which is in accordance with the lack of effect when an 
equivalent dose of 5 mg/L drinking water was administered (28). 
The calculated dose of 60 pg dexamethasone per 24 h delivered 
from the minipumps suppressed the endogenous plasma cortiscoste-
rone level completely (result not shown). 
Effect of tetracosactrin in intact immune mice 
Stimulation of the adrenal steroidogenesis by continuous ACTH 
administration resulted in an increase of the plasma corticosterone 
concentration in rats (13). Therefore, a solution of tetracosactrin, 
a polypeptide with ACTH properties, was injected in the minipumps 
which were implanted subcutaneously into immune mice. In these mice, 
a dose dependent increase of the plasma corticosterone concentration 
was observed (Fig. 1 and 2). A dose of tetracosactrin equivalent to 
0.025 ID ACTH per 24 h neither increased the total nor the free plasma 
corticosterone level (Fig. 1A and 2A). Insertion of a pump secreting 
an equivalent dose of 0.05 IU ACTH per 24 h resulted in no or only a 
small increase of plasma corticosterone (Fig. IB and 2B), but a dose 
equivalent to 0.1 IU ACTH per 24 h increased both the total and, even 
more, the free plasma corticosterone levels in all mice tested (Fig. 
1С and 2C). Particularly on day 2 and 4 after implantation a remar­
kable increase was observed. In some mice the plasma corticosterone 
levels returned to normal on day 7 and 9 after implantation, but in 
others increased levels were found for longer periods. The reason 
for this relatively early return to normal plasma corticosterone le­
vels is unknown. It may be the result of a feed-back adaptation of 
the mice to increased corticotropin activity or to a reduction of the 
activity of the osmotic minipump. 
Loss of malaria immunity was observed in all mice receiving a 
dose equivalent to 0.1 IU ACTH per 24 h, and in one of the three mice 
receiving a dose equivalent to 0.05 IU ACTH. In this mouse, in contrast 
to the other two of this group, the plasma corticosterone level was 
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Fig. 1. Total plasma oort-Laosterone during tetraaosaotrin (ACTH analogue) 
release from osmotic minipumps, subautaneously implanted on day 0. The 
aaloulated amount of tetraaosaotrin released was equivalent to: A 0.025 
IU, В 0.05 IU and С 0.1 IU of ACTH per 24 h, respectively. The open sym­
bols refer to mice that remained immune throughout, whereas the closed 
symbols refer to mice that developed lethal recrudescent infections. 
Circles refer to intact mice, triangles to adrenalectomized (Ax) mice. 
Plasma values are either depicted as mean + SEM, or they are plotted 
individually, since not all mice were sampled each day. 
increased on day 7 after implantation of the minipump (Fig. IB). Immune 
mice, receiving a dose equivalent to 0.025 IU ACTH neither lost malaria 
immunity nor exhibited increased plasma corticosterone levels. 
In mice that lost immunity the hormone provoked recrudescences that 
became patent 7 to 9 days after implantation of the minipump, and survi-
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Fig. 2. Free plasma corticosterone during tetraoosaatrin (ACTH analogue) 
release from osmotic minipimps. For further details see legend to Fig.l. 
val periods varied from 12 to 20 days after implantation. The virulence 
of the recrudescent infection suggests a more or less complete loss of 
protective reactions in the previously immune mice. Mice treated with 
low doses of the ACTH analogue and remaining immune troughout, did ex­
hibit a reticulocytosis in the peripheral blood, and some mice exhibi­
ted a low (2% or less) and transient parasitemia. All the immune mice 
in these experiments harbored parasites in their peripheral blood 
throughout the duration of the experiment, as tested by subinoculation. 
Thus, all mice had the opportunity to develop recrudescences during 
treatment. 
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In conclusion, treatment of immune mice with a synthetic ACTH ana­
logue induced loss of malaria immunity, when the dose administered was 
sufficiently high to increase the endogenous plasma corticosterone level. 
Effect of tetracosactrin on adrenalectomized immune mice 
To analyse whether increased plasma corticosterone levels after ad­
ministration of the ACTH analogue to immune mice are responsible for 
loss of malaria immunity, osmotic minipumps filled with tetracosactrin 
solution were inserted in adrenalectomized, immune mice. A dose equiva­
lent to 0.05 IU ACTH per 24 h did not induce loss of immunity (n = 5), 
and a dose equivalent to 0.1 ID ACTH resulted in loss of immunity in 
only one out of 13 mice. This mouse died 10 days after implantation of 
the osmotic pump, which is earlier than any of the intact mice with loss 
of immunity during treatment with tetracosactrin (compare previous sec­
tion). 
Adrenalectomized immune mice, treated with the ACTH analogue, did 
not exhibit increased plasma corticosterone concentrations, neither of 
total nor free corticosterone. Furthermore, no increase in plasma cor­
ticosterone was observed in the one adrenalectomized mouse with a fatal 
recrudescence (Fig. 1С and 2C). All mice developed a reticulocytosis in 
the peripheral blood during hormone treatment, and the subinoculation 
test confirming presence of parasites, and thus the possibility of de­
velopment of a recrudescence, was positive in all animals. 
In a group of 9 adrenalectomized mice treated with an equivalent 
dose of 0.1 IU ACTH, the minipumps were removed three weeks after im­
plantation. One week later the mice received a challenge (10^ PE/mouse), 
and dexamethasone (20 mg/L) was added to their 0.9% NaCl drinking water. 
Within 3 weeks 5 out of these 9 mice developed a lethal malaria recru­
descence. The other 4 mice died also, but parasitemia was not observed. 
In summary, treatment with an ACTH analogue did not cause loss of 
immunity in adrenalectomized immune mice, though immunity of these mice 
remained susceptible to glucocorticoid treatment. 
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DISCUSSION 
A remarkable proportion of mice with an established immunity 
against the murine malaria parasite Plasmodium berghei lose their 
immunity during pergnancy (25, 26). Loss of immunity during preg-
nancy was related to increased levels of both total and free plasma 
corticosterone. Moreover, when the increase in plasma corticosterone 
in the mother was prevented by adrenalectomy before pregnancy, loss 
of immunity during pregnancy was drastically reduced (27). These re-
sults suggested that reduced immune reactivity during pregnancy cau-
sing loss of a preexisting antimalaria immunity was causally related 
to pregnancy dependent changes in corticosterone levels. They further 
suggested that experimental manipulation causing an increase in plasma 
corticosterone in immune, non-pregnant mice would also lead to a loss 
of antimalaria immunity. The experiments described in this paper support 
this hypothesis and indicate that the function of the effector system of 
malaria immunity is sensitive to, and can be regulated by, normally oc-
curring plasma corticosterone levels. 
A prolonged increase of the plasma corticosterone concentration by 
administration of exogenous corticosterone is not easily obtained. In-
jection of corticosterone acetate neither resulted in a prolonged in-
crease of the plasma corticosterone level, nor was it very effective in 
suppression of malaria immunity (W. El ing and A. van Zon, Parasitology 
77: ii, 1978). Furthermore, continuous administration of a maximum at-
tainable concentration of corticosterone (29) by osmotic minipumps again 
failed to increase plasma level and to break malaria immunity. 
The sensitivity of the effector system of malaria immunity for cor-
ticoids, however, was demonstrated by the effect of dexamethasone treat-
ment. A dose dependent loss of malaria immunity was obtained when either 
dexamethasone was added to the drinking water of the mice (28) or a 
dose of dexamethasone equivalent to the daily intake through drinking 
water was delivered by a subcutaneously implanted osmotic minipump. The 
30-fold stronger potency of dexamethasone relative to corticosterone (1) 
may explain the observed differential effect of these substances. These 
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results in turn suggested that increased plasma corticosterone levels 
could be expected to suppress malaria immunity. 
In view of the effect of ACTH treatment on the plasma corticoste-
rone level in rats (13) it was tried to manipulate the corticosterone 
level in mice by administrating the ACTH analogue tetracosactrin by 
minipump. Tetracosactrin in subcutaneously implanted minipumps provoked 
a dose dependent increase of both the total and, to an even higher ex-
tent, the free corticosterone concentration in plasma. In all instances 
increased plasma corticosterone levels were related to loss of malaria 
immunity and vice versa. The plasma concentrations of total corticoste-
rone in tetracosactrin treated mice that had lost immunity were lower 
(Fig. 1) than those in pregnant mice with loss of immunity (27). The 
plasma concentration of free corticosterone, however, was higher in 
tetracosactrin treated mice (Fig. 2) relative to pregnant ones (28). 
All tetracosactrin treated immune mice developed a reticulocytosis, 
but in spite of the preference of p. berghei for young erythrocytes (30) 
no relation was found with loss of immunity. Moreover, it appeared that 
the highest concentration of tetracosactrin in normal, control mice in-
duced reticulocytosis, also (result not shown). 
To further reinforce the notion that corticosterone is causally 
related to loss of malaria immunity, tetracosactrin was given to adre-
nalectomized mice. Corticosterone levels remained undetectable in these 
mice, and loss of immunity was drastically reduced to 8% (1 out of 13) 
in comparison to 100% in the corresponding intact group. Since immunity 
in adrenalectomized mice remained sensitive to dexamethasone treatment, 
the effects obtained with tetracosactrin are apparently directly related 
to its induction of an increased adrenal output of corticosterone. That 
corticosterone is not the only suppressor of malaria immunity is shown 
by the one adrenalectomized mouse that developed a fatal recrudescence 
upon treatment with tetracosactrin and without detectable plasma corti-
costerone. 
Thus, experimentally induced changes in the serum corticosterone 
levels affect the parasite-host equilibrium of immune mice. The immuno-
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suppressive effect of corticosterone on malaria immunity had been sug­
gested earlier by the observed relationship between plasma corticoste­
rone level and loss of malaria immunity in pregnant mice (27). 
The immunoregulatory role of endogenous glucocorticoids is sugges­
ted to act either by modulation of the release of soluble mediators, 
such as interleukines (2, 8, 9), or by regulation of peripheral lympho­
cyte numbers (24). In this respect the leveling out or disappearance of 
the diurnal changes in serum corticosterone during pregnancy (6, 19) or 
during tetracosactrin treatment may play a role as well. 
In jztro studies indicated a differential sensivity of subsets of 
Τ cells to glucocorticoid immunosuppression, and the importance of Τ 
cell growth factor inthe medium for its expression (7, 22). The immuno­
regulatory action of glucocorticoids is supposed to occur at the level 
of the Τ cell-macrophageinteraction (8, 22), and both these cells play 
an important role in malaria immunity (10, 15, 20). In conclusion, 
changes in the plasma corticoid level have a regulatory effect on the 
immune response of mice against the malaria parasite Plasnoi^m оегдкег. 
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IX The effect of progesterone and DES on malaria immunity 
in mice 
INTRODUCTION 
Functional maternal immune reactivity is usually considered to be 
partly suppressed during pregnancy (Beer and Billingham 1972, Gusdon 
1983). In view of immunosuppressive properties of hormones in in oitro 
assays of immune responsiveness the considerable increase in plasma 
levels of these hormones during pregnancy may contribute to the preg­
nancy associated immunosuppression. In this respect glucocorticoids, 
progesterone and oestrogens are of particular interest (Barlow et al. 
1974, Boorman et al. 1980, Szekeres et al. 1981, Stites and Siiteri 
1983). 
Previous work already showed a correlation between loss of malaria 
immunity during pregnancy, and an increased plasma corticosterone level 
(van Zon et al. 1982, 1983). In addition, treatment of non-pregnant 
immune mice with glucocorticoids or an increase of the plasma cortico­
sterone level by ACTH treatment caused loss of immunity also (van Zon 
et al., manuscript submitted, is chapter 8 of this thesis). These results 
suggested an immunoregulatory role for corticosterone in the effector 
function of malaria immunity. Considering the immunosuppressive effects 
of progesterone and oestrogen, and their increasing plasma concentra­
tions during pregnancy a similar immunoregulatory role may exist for 
these hormones. This possibility was analysed by treatment of non­
pregnant immune mice with progesterone, or diethylstilbestrol (DES), 
a synthetic oestrogen. Loss of malaria immunity due to treatment with 
either progesterone or DES was not obtained. 
MATERIALS AND METHODS 
Mice: Random bred female Swiss mice were obtained from the ani­
mal facilities of the University of Nijmegen. They were housed in 
plastic cages and received food and drinking water ad ІіЪгіш. 
Parasite: Plasmodium berghei, strain K173, was used in all ex­
periments. Infection with this parasite was lethal in unprotected 
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mice. Mice were immunized to this parasite, as described previously 
(Eling and Jerusalem 1977). Established immunity was of the pre-
munition type, i.e. small numbers of parasites survived in the 
immune host. Immune mice did not develop patency after a challenge, 
and spontaneous recrudescence was rare. 
Recrudescence: Development of a recrudescent infection during 
hormone treatment was checked by thin blood smears (May-Grünwald 
Giemsa staining) made from tail blood three times a week. Mice with 
a parasitaemia of 5% or more were considered to have lost immunity. 
Isodiagnosis: The presence of surviving parasites in immune 
mice which maintained immunity during hormone treatment was deter-
mined by subinoculation of tail blood into normal mice. These mice 
were checked for development of parasitaemia for a period of two 
weeks. 
Hormone treatment: For oestrogen treatment diethylstilbestrol 
(DES), a synthetic nonsteroidal compound possessing oestrogenic ac-
tivity, was used. Mice were injected with DES, dissolved in olive 
oil, or received DES diphosphate (Honvan, Asta-Werke A.G., Germany) 
in the drinking water. For the calculation of the amount of DES, 
taken with the drinking water, a daily uptake of 3 ml water per 
mouse was assumed. 
Progesterone was administered by injection, or dissolved in the 
drinking water, or through release of progesterone from subcutaneous-
ly implanted osmotic minipumps (Alza Coop, type 2002). Progesterone 
administered by injection was dissolved in 1 volume benzylalcohol, 
and diluted with 9 volumes of arachis oil. 
Progesterone in the drinking water was offered as a saturated 
solution of progesterone in tap water. A suspension of 50 mg/L was 
stirred for 24 h and filtered through filter paper. The progesterone 
containing drinking water was supplied in dark drinking bottles. Pro-
gesterone solution was freshly prepared every week, and the drinking 
bottles were refreshed twice a week. 
Osmotic minipumps were filled with saturated solutions of pro-
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gesterone in polyethylene glycol 400 (PEG) or in ethanol. Two sus­
pensions of progesterone in PEG, 25 mg/ml and 50 mg/ml respectively, 
were sonicated and kept at room temperature for 5 days. The suspen­
sions were centrifugated and the supernatant was injected into the 
osmotic minipumps (maximum solubility of progesterone in PEG is 27 
g/L at 37° C, according to the literature; Will et al. 1980). 
A saturated solution of progesterone in ethanol was prepared 
by suspending 250 mg progesterone per ml ethanol. After 5 days the 
suspension was centrifugated and the supernatant was injected in the 
osmotic pumps (maximum solubility of progesterone in ethanol is 125 
g/L, according to the literature; Martindale, the Extra Pharmacopeia, 
26th ed. 1972). 
The release rate of the pumps was 0.48 μΐ/h (indicated by the 
manufacturer) and completely filled pumps should be active for at 
least two weeks. The calculated maximal dose administered by the os­
motic minipumps was 0.29 mg per 24 h for progesterone in PEG and 1.44 
mg per 24 h for progesterone in ethanol. 
Plasma progesterone: Progesterone concentration in the plasma was 
measured using the radioimmunoassay described by Thomas et al. (1982). 
Plasma corticosterone: Total concentration plasma corticosterone 
was determined by a radioimmunoassay described previously (van Zon et 
al. 1982). Free corticosterone in plasma was determined by the techni­
que of equilibrium dialysis (van Zon et al. 1983). 
RESULTS AND DISCUSSION 
The effect of PES and DES-diphosphate on malaria immunity 
A group of 5 immune mice received daily, subcutaneous injections 
of 0.2 mg DES, dissolved in 0.1 ml olive oil, for a period of 14 days. 
A control group of 5 immune mice were injected with olive oil only. 
Bloodsmears of the mice were checked for parasitaemia, but no recru­
descent infections were observed. A challenge with 10 parasitized 
erythrocytes on day 9 of the injection period was cleared without 
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causing patent parasitaemia. It has been reported that oestrogens sti-
mulate the production of corticoid binding globulin (CBG) in the liver, 
and that oestrogen levels during pregnancy are high enough to induce 
the observed increase of CBG (Musa et al. 1965, Wilson et al. 1979). 
Since CBG has a high affinity for Cortisol, a reduction of the circu-
lating free Cortisol by increased CBG production leads to a feedback 
increase of ACTH secretion which in turn results in increased gluco-
corticoid production (Doe et al. 1969, Heap et al. 1973). In this way 
oestrogens might influence the plasma glucocorticoid levels indirectly, 
which in turn might affect the immune response to malaria (van Zon et 
al., manuscript submitted, is chapter 8 of this thesis). To check this 
relation in DES treated mice, the concentration plasma corticosterone 
was measured after 3 and 6 days of injections. Compared to control 
values in untreated mice, the plasma corticosterone concentration was 
not changed in the mice either injected with DES dissolved in oil, or 
in those injected with olive oil only. 
Our experiments with dexamethasone treatment had shown that in-
take through drinking water was more effective than injection (Eling 
1982). Supply in the drinking water also avoids the stress of daily 
injections over longer periods and local skin irritation which might 
cause hormonal changes that affect malaria immunity. Therefore, in the 
following experiments oestrogen treatment consisted of DES diphosphate 
dissolved in the drinking water of the mice. 
Since previous work of Boorman et al. (1980) had shown that DES 
treatment of mice caused marked alterations in lymphoid organs, the 
effect of DES-containing drinking water on thymus, spleen, and liver 
weight was analysed, too. Results obtained after 7 or 8 days treat-
ment are summarized in table I. Doses of 100 mg or 150 mg per liter 
drinking water resulted in a marked decrease of thymus weight, an in-
crease of liver weight, and no change in spleen weight. These results 
agree with those of Boorman et al. (1980), except that they observed 
an increase in spleen weight in DES-treated mice. The depletion of 
the thymus is supposed to be the result of redistribution and mobili-
zation of thymic lymphocytes into the circulation, but treatment with 
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Table I. Thymus, spleen, and liver weights in miae excused to DES 
(mean + SEM, η = ό to 5) 
Concentration 
DES diphosphate calculated thymus spleen liver 
in drinking dose weight weight weight 
water (mg/L) (mg/day) (mg) (mg) (mg) 
О 0 96.1+8.9103.2+6.0 1005+48 
100 0.30 8.5+1.6 92.9+31.9 1553 + 56 
150 0.45 19.2 + 2.5 108.4+11.9 1600 + 72 
high doses of DES is also reported to cause depletion of certain 
subsets of lymphocytes (Seaman et al. 1978, Kal land 1980a and 1980b). 
The observed changes in organ weight of mice treated with DES 
in the drinking water suggested that this method might be suitable 
for the analysis of the effect of oestrogenic activity on malaria 
immunity in mice. For this purpose, groups of 5 immune mice received 
100 mg, 150 mg, 250 mg, 500 mg or 1000 mg of DES, respectively, per 
liter drinking water. Bloodsmears of these mice were checked for 
parasitaemia three times a week during a period of 5 weeks. In the 
group with 100 mg DES per liter drinking water, one mouse died with 
high parasitaemia, and in the 500 mg group one mouse exhibited a 
transient parasitaemia during 1 week. In the other mice no recrudes­
cent infections were observed. 
In the groups of mice receiving 250 mg, 500 mg and 1000 mg DES 
per liter drinking water, the corticosterone concentration in the 
plasma was determined on several days during the first two weeks 
of treatment. Plasma corticosterone concentration did not increase, 
neither the total nor the free concentration, and no dose dependent 
influences were observed. Thus.the CBG concentration in the plasma 
was not increased by DES. 
In previous experiments it had been shown that dexamethasone 
added to the drinking water resulted in loss of malaria immunity in 
a dose dependent way (van Zon et al. 1983). To compare the effect 
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of dexamethasone and DES both hormones were added to the drinking 
water. Dexamethasone (10 mg/L drinking water) induced loss of malaria 
immunity in 2 of 4 mice, dexamethasone and DES together (10 mg and 
250 mg/L drinking water respectively) resulted in loss of immunity in 
3 of 5 mice, and DES alone (250 mg/L drinking water) did not induce 
loss of malaria immunity in 5 mice tested. The immunosuppressive 
effect of dexamethasone agrees with previously observed results. 
In conclusion, treatment of mice with DES to achieve oestrogenic 
activity did not affect an existing malaria immunity. 
Effect of progesterone on malaria immunity 
It has been reported that daily injections of 2 mg progesterone 
in mice resulted in an increase of progesterone concentration in the 
plasma to levels observed during pregnancy (Baker and Plotkin 1978). 
Progesterone at this physiological level suppressed in vitro Con A 
stimulation of splenic lymphocytes and enhanced in vivo genital in-
fections with herpes simplex virus (Baker et al. 1980). To test the 
effect of progesterone on malaria immunity, mice were injected sub-
cutaneously with 2 mg progesterone in a volume of 0.1 ml solvent for 
12 days. A control group of immune mice was injected daily with the 
solvent. Mice were checked for parasitaemia until 6 days after the 
last injection. Two out of 8 mice injected with progesterone suffered 
from recrudescent infection, compared with 1 of 7 control mice. These 
results indicated that progesterone injections did not affect malaria 
immunity. 
A major disadvantage of daily injections was stress for the ani-
mals and skin irritations at the place of injection. In a subsequent 
experiment progesterone was administered to mice with the drinking 
water, but no loss of malaria immunity was observed. The maximal 
solubility of progesterone in water may be too low to reach suffi-
ciently high doses in the mice. Therefore, progesterone was also 
administered by subcutaneously implanted osmotic minipumps filled 
with saturated solutions of progesterone in PEG or in ethanol. In 
4 mice the plasma progesterone level was determined on the day of 
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implantation of the mi ni pump and on days 2 and 10 thereafter. Pro-
gesterone dissolved in ethanol did not influence the plasma proges-
terone level. Administration of progesterone in PEG resulted in a 
small increase of plasma progesterone, but maximal serum levels ob-
served (57 ng/ml) were much lower than maximal levels reported for 
pregnant mice (120 ng/ml; Murr et al. 1974). In previous experiments 
it was also shown that administration of corticosterone by osmotic 
minipumps did not induce an increase of the concentration cortico-
sterone in the plasma (van Zon et al. , manuscript submitted, is 
chapter 8 of this thesis), suggesting that the endocrine regulation 
of the mice is able to compensate for the quantity of exogenously 
administered hormones. The mice were checked for parasitaemia during 
a period of 25 days following implantation of the minipumps. None of 
the mice, treated with progesterone exhibited loss of malaria irmunity 
5 
or became patent after an additional challenge with 10 parasitized 
erythrocytes 10 days after implantation. 
In conclusion, progesterone treatment did not cause loss of 
malaria immunity. The increase in serum progesterone levels in re-
lation to progesterone treatment reported by Baker et al. (1978) 
could not be confirmed in our model, and observed serum levels were 
not as high as those observed during pregnancy. From experiments 
with corticosterone it is known that a sustained increase of plasma 
hormone concentration is difficult to achieve by administration of 
exogenous hormones. Further experiments are needed to clarify this 
point. 
There is one indirect observation that suggests that proges-
terone is not the major factor in suppression of malaria immunity 
during pregnancy. Adrenalectomy largely prevents loss of malaria 
immunity during pregnancy (van Zon et al. 1982), but is not known 
to have an effect on progesterone production in pregnant mice. 
Although the experiments tend to indicate that progesterone is 
not an important factor in suppression of malaria immunity they are 
not decisive, and do not rule out a possible role in the effector 
function of malaria immunity. 
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X Corticosterone and reduced spleen cell proliferation 
in vitro in relation to malaria immunity during 
pregnancy 
SUMMARY 
Spleen cells from mice immune to Plasmodium berghei exhibited 
a significantly increased ¿и vitro proliferative response to parasi­
tized reticulocytes (PRET) compared to spleen cells from normal mice. 
The specific response to malaria antigen was decreased in spleen 
cells from pregnant immune mice in contrast to the unspecific response 
to the mitogen phytohaemagglutinin (PHA).Addition of mouse serum to 
spleen cell cultures of immune mice depressed both the PHA and the 
specific proliferative response, whereas serum of pregnant mice exerted 
an even stronger inhibition than serum of non-pregnant mice. Charcaol 
adsorption of mouse sera for the elimination of steroid hormones re­
moved the serum dependent immunosuppression from normal as well as 
from pregnant serum. Corticosterone added to the spleen cell cultures 
depressed also the proliferative response. These findings demonstrate 
that the response to malaria antigen is decreased in immune mice during 
pregnancy. The possible regulatory effect of serum corticosterone on 
the depression of the immune response is discussed. 
INTRODUCTION 
Malaria can bring about serious complications during pregnancy, 
which may vary from an increased incidence of malaria episodes in 
women living in malaria endemic areas to more virulent, and even 
fatal infections in areas with low endemicity or in non-immune indivi­
duals (Gilles, Lawson, Sibelas, Voller & Allan, 1969; Menon, 1972; 
Bray & Anderson, 1979; Brabin, 1983). Loss of immunity during preg­
nancy is frequently associated with particularly heavy infections in 
the placental vasculature (Osunkoya & Williams, 1980; McGregor, Wilson 
& Billewicz, 1983) which is considered a privileged site where the 
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parasite can avoid immune reactivity of the mother (McGregor et al., 
1983). 
Previous work in the Plasmodium berghei - mouse model showed a 
more severe primary infection as well as loss of previously existing 
anti - P. berghei immunity during pregnancy (Van Zon & Eling, 1980; 
Oduola, Holbrook, Galbraith, Bank & Spicer, 1982; Van Zon, Eling & 
Hermsen, 1983). Loss of immunity during pregnancy was associated with 
increased serum levels of corticosterone and could largely be preven-
ted by eliminating maternal corticosterone production through adrenal-
ectomy before pregnancy (Van Zon, Eling, Hermsen & Koekkoek, 1982; 
Van Zon, Eling, Hermsen, Van de Wiel & Duives, 1983). These results 
suggested regulation of immune reactivity by serum corticoid. In gene-
ral, cell mediated immunity is considered to play an important part 
in malaria immunity (Jayawardena, Targett, Leuchars, Carter, Doenhoff 
& Davies, 1975; Jayawardena, 1981; Playfair, 1982) and cell mediated 
rather than humoral immunity is depressed during pregnancy (Beer & 
Billingham, 1972; Gusdon, 1983). 
Plasmodiun infected erythrocytes can specifically stimulate 
in vitro proliferation of lymphocytes in human experimental malaria 
(Phillips, 1970; Wyler & Oppenheim, 1974; Weissberger, Golenser & 
Spira, 1980; Troye-Blomberg, Perlmann, Patarroyo & Perlmann, 1983). 
In addition, in mice the lymphocyte responsiveness to the parasite 
in vitro was associated with persistence of the parasite in the pre-
mune host (Weinbaum, Evans & Tigelaar, 1976; Weinbaum, Weintraub, 
Nkrumah, Evans, Tigelaar & Rosenberg, 1978).suggesting lymphocyte 
responsiveness as a marker of antimalaria immunity. The experiments 
described in this paper confirm the parasite dependent proliferation 
of splenic lymphocytes from an immune mouse. Moreover, they show that 
the in vitro lymphoproliferative response to specific antigen, and 
not to the nonspecific mitogen phytohaemagglutinin, was lower in immune 
pregnant mice during the period when loss of malaria was noted in vivo 
(Van Zon et al., 1982) compared to non-pregnant immune mice. Though 
normal mouse serum added to the test system suppressed lymphocyte pro-
liferation, sera from pregnant mice were more suppressive. Suppressive 
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activity could be removed from both types of sera by preadsorption to 
charcoal,a step being used to adsorb serum corticoid. Corticosterone 
added to spleen cell cultures suppressed the specific as well as the 
nonspecific lymphocyte proliferative response. The results suggest 
that serum corticosterone can regulate immune reactivity by affecting 
the number of antigen specific cells in the spleen as well as their 
proliferative activity, and support the regulatory role of corticoste-
rone in malaria immunity during pregnancy. 
MATERIALS AND METHODS 
Mice. Inbred B10LP mice were obtained from the animal facilities 
of the University of Nijmegen or from TNO, Zeist, The Netherlands. They 
were housed in plastic cages and received food and water ad libitum. 
Pregnant mice. Two or three female mice were housed with one male 
and checked for vaginal plug on the next four days. Three days later 
the mated mice were removed from the male. The day with the vaginal 
plug was day one of pregnancy. 
Parasite. Plasmodium berghei, strain K173, was maintained by 
weekly passage of infected blood (10$ parasitized erythrocytes (PE) 
i.p.) to normal animals. The primary infection is lethal in all mice 
and has been described previously (Eling, Van Zon & Jerusalem, 1977). 
Parasitized reticulocytes (PRET) used for spleen cell culture stimula-
tion were obtained from infected mice made anaemic by bleeding (12 
drops) from the retro-orbital plexus using a glass capillary. Mice 
were bled one day before and one day after infection. On day 5 after 
infection sterile blood was obtained from these mice by heart puncture, 
using pyrogen free heparin as anticoagulant. Leucocytes and platelets 
were removed by passing the blood though a sterilized column, filled 
with a 3 ml mixture of 1 part Servacel SE 23 (Serva Feinbiochemica, 
Heidelberg) and 3 parts Sephadex superfine G 150 (Pharmacia) in saline. 
Before use the column was washed with MEM (see below). The red blood 
cell suspension was layered on a sterile 72% Percoli layer (Pharmacia), 
and centrifuged at 1600 g, for 20 min. The cell layer on top of the 
122 
Percoli, which was enriched for parasitized reticulocytes, was removed, 
washed in MEM, counted, suspended in RPMI (see below), and added to the 
spleen cell cultures. 
Immune mice. Mice were immunized to Plasmodium Ъетдкег as described 
by Eling & Jerusalem (1977). In brief, mice were infected with IO? PE 
and treated with sulfadiazine (30 mg/L drinking water) two days later. 
On day 33 after infection, sulfadiazine treatment was stopped, and 2 
days later the mice were challenged with 105 PE/mouse to asses immunity. 
The acquired immunity was of the premumtion type, i.e. immune mice 
harboured low numbers of parasites for varying periods of time. Immune 
mice were radically cured with chloroquine (Nivaquine, Specia, Paris; 
0.8 mg/mouse i.p. for 5 days, supplemented with 100 mg Nivaquine/L 
drinking water for 7 days) 1 to 4 weeks before their spleen cells were 
used in culture. 
Spleen cell culture. Spleens were removed aseptically and cell 
suspensionswere prepared by pressing the tissue through a plastic sieve. 
Cells were suspended in MEM (Eagle) (Gibco) buffered with Tris-HCl and 
supplemented with penicilline (100 IU/ml), pyrogen free heparin (5 ID/ 
ml) and 10% heat inactivated (56° C, 30 m m ) foetal calf serum (PCS) 
(Gibco). The cell suspension was incubated on a glass-woll column at 
37 С for 30 m m . The non-adherent cells were eluted with MEM and 
washed. Red blood cells in the suspension were lysed in Tris-buffered 
ammonium chloride (Mishell & Shngi, 1980) with 10% PCS on ice for 
5 m m , washed and counted. Red blood cell contamination was less than 
5%. The percentage viable cells, assayed by trypan blue (0.025%) exclu­
sion was better than 90%. RPMI-1640 (Gibco) buffered with Hepes (20 mM) 
and МаНСОз (10 mM),supplemented with L-glutamine (2 mM), penicilline 
(100 IU/ml), 2-iiercaptoethanol (S.IO-2 mM) and 20% PCS was used as cul­
ture medium. A number of 7.5 χ 10^ spleen cells was cultured in a total 
volume of 0.15 ml in Costar microtitre plates with flat bottom wells 
for 3 days in a humidified atmosphere with 5% CO2 in air at 37° С 
During the last 18 - 20 h, the cultures were labeled with 1 цСі 3H-
thymidine per well (spec. act. 25 Ci/mmol, Amersham Int.). After freezing 
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and thawing, cells were harvested using a Skatron cell harvester. Filters 
were dried and radioactivity was counted in a liquid scintillation coun­
ter (Packard). Spleen cells were cultured with medium only (unstimulated), 
or with an optimal concentration of PHA, (Gibco; 30 μΐ/ml culture) for 
nonspecific stimulation. For specific stimulations 5 χ 10^ or 5 χ 10^ 
parasitized reticulocytes (PRET) were added to the cultures. Each group 
consisted of 4 to 8 replicate cultures. In some experiments, corticoste­
rone (Sigma), or heat inactivated syngeneic serum was added to the cul­
ture medium. 
Statistical evaluation. Significance of differences between 3H-thy-
midine incorporation in spleen cell cultures was assessed by theWilcoxon 
test for unpaired samples (results of Fig. 1) and the Wilcoxon signed 
rank test (results of Fig. 3). 
RESULTS 
Stimulation of spleen cells from immune mice 
Spleen cells from normal and immune mice were nonspecifically sti­
mulated with PHA (Fig. 1). Though spleen cell suspensions from 2 out of 
8 immune mice exhibited a stronger PHA-stimulation, there was no statis­
tically significant difference between data from normal or immune mice 
(p = 0,067). 
The addition of PRET specifically stimulated spleen cells from 
immune animals (Fig. 1). Stimulation was dependent on the number of PRET 
added, and was found optimal when 5 χ 10^ PRET were added to each culture 
No stimulation was observed with less than 1 χ 10^ PRET, whereas proli­
feration was strongly inhibited when more than 1 χ IO6 PRET were added to 
the cultures. Spleen cells from control (non-immune)mice were not stimu­
lated by addition of PRET, but rather a small inhibition of Зн thymidine 
incorporation was observed, as compared to the unstimulated cultures (ne­
gative netto dpm) (Fig. 1). Addition of 1 χ 10^ erythrocytes or reticu­
locytes from uninfected mice exerted no stimulating effect on spleen 
cell cultures, either from normal mice or from immune mice. When more 
red blood cells were added to the culture, 3H thymidine incorporation 
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Fig. 1. H-thymidine incorporation in spleen cells from normal, immune 
and immune pregnant mice, stimulated by PUA or PRET. The dpm plotted is 
the difference between the mean of stimulated cultures and that of un-
stimulated cultures. Each point represents the mean of 4 to 8 replicate 
cultures. (SEM 4 5%). The figure swmarizes results of independent expe-
riments . 
was lower than in cultures with medium only, as found with comparable 
number of PRET. 
Stimulation of spleen cells from pregnant immune mice 
To examine the immune response to malaria during pregnancy in vitro, 
the PRET stimulation of spleen cells from pregnant immune mice was tested 
and compared with the stimulation of spleen cells from non-pregnant mice. 
Spleen cell cultures were prepared from 13 to 16 days pregnant mice.This 
period was chosen, since recrudescent infections in mice that were immune 
before pregnancy occured in this period (Van Zon et al., 1982). To prevent 
stimulation of spleen cells in vivo by a recrudescent infection, survi-
ving parasites were removed by radical cure with chloroquine before ma-
ting. PHA stimulation of spleen cells from pregnant immune mice was not 
significantly different from that of normal or non-pregnant immune mice 
(Fig. 1). The dose dependency of the PRET response in spleen cell cul-
tures from pregnant immune mice was similar to that observed in non-
pregnant immune mice. The magnitude of the specific stimulation, however, 
3-
1 i 
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was significantly lower in spleen cell cultures from pregnant immune, 
as compared to non-pregnant immune mice (p = 0..036 with 5 χ 10^ PRET, 
and ρ = 0.012 with 5 χ 10^ PRET; Fig. 1). In summary the results indi­
cate a reduced specific but not nonspecific capacity in spleens of im­
mune mice during pregnancy. 
Effect of corticosterone on stimulation of spleen cells 
The previously established correlation between loss of malaria 
immunity and the concentration of corticosterone in serum of mice 
during pregnancy (Van Zon et al., 1982, 1983) prompted the analysis 
of the effect of corticosterone on the stimulation of spleen cells. 
3 H Thymidine incorporation d p m xlO"^ 
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Δ stimulated by PHA 
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Fig. 2. The effect of corticosterone on H-thymidine incorporation of 
spleen cells from immune mice. The concentration of corticosterone in 
the culture is plotted in a logarithmic scale, the dpm on a linear 
scale. Spleen cell cultures, either unstimulated or stimulated with 
PHA or PRET were prepared from the same immune donor. Values plotted 
are the mean + SEM of 4 replicate cultures. 
For this purpose corticosterone was added directly to the spleen cell 
cultures. The results depicted in Fig. 2 show a dose dependent inhibi-
3 
tion of Η-thymidine incorporation in unstimulated as well as PHA or 
PRET stimulated cultures. In PHA or PRET stimulated spleen cell cul­
lo 
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tures inhibition of lymphocyte proliferation was observed with 5 ng 
corticosterone/ml or more. 
Effect of mouse serum on spleen cell cultures 
The inhibitory effect of corticosterone on the specific and non-
specific stimulation of spleen cells (previous section), along with the 
observed correlation between serum corticoid levels and loss of malaria 
immunity (Van Zon et al., 1982, 1983) prompted analysis of the effect 
of serum on stimulation of spleen cells. In pregnant mice the serum cor-
ticosterone concentration increases after day 10 of pregnancy to peak 
values on day 16 to 18 (Barlow, Morrison & Sullivan, 1974; Van Zon et al., 
1982). Thus, an increasing amount of serum from 16 days pregnant mice 
(PrMS) was added to cultures of spleen cells from immune, non-pregnant 
donors. The effect was tested in unstimulated, and PHA and PRET stimu-
lated cultures compared to the effect of serum from non-pregnant mice 
(NMS) under comparable circumstances. For better comparison of the ef-
fect of NMS or PrMS on spleen cell cultures the results were expressed 
as the relative ^H-thymidine incorporation in the presence of mouse 
serum compared to that of cultures without serum (mean dpm of cultures 
with NMS or PrMS divided by the mean dpm of parallel cultures without 
mouse serum multiplied by 100%). The paired observations (NMS and PrMS) 
per experiment are summarized in figure 3. 
Additon of mouse serum, NMS or PrMS, inhibited proliferation of 
unstimulated, as well as nonspecifically (PHA) and specifically (PRET) 
stimulated spleen cell cultures in a dose dependent way. PrMS inhibited 
unstimulated (p < 0.05) as well as PHA stimulated (p < 0.02) and PRET 
stimulated (p < 0.02) cultures significantly more strongly than NMS. To 
further substantiate the relation between presence of corticosterone in 
serum and inhibition of spleen cell cultures, serum samples were pre-
adsorbed with charcaol (160 mg charcaol/ml serum, 4° C, 3 h) which is 
known to remove steroids from serum. Addition of preadsorbed sera to a 
final concentration of 5% no longer inhibited specific or nonspecific 
proliferation of spleen cells compared to cultures without added serum. 
3H Thymidine incorporation was 95% + 6 (SEM) and 96% + 9 (SEM) of control 
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Fig. 3. The effect of 1%, b% or 10% serum of normal (NMS) or 16 days 
pregnant (PrMS) mice in the culture medium of either unstimulated, or 
РИА, or PRET stimulated spleen cells from immune mice. The serum effect 
uas expressed as the percentage ¿H-thymidine incorporation in serum con-
taining cultures compared to those without serum. Plotted values are the 
mean of Ζ io 4 replicate cultures (SEM < 10%). The results of 3 indepen­
dent experiments are summarized. The results of NMS and PrMS were paired 
for each experiment. 
values for PHA and PRET stimulated cultures respectively (n=4). 
DISCUSSION 
Loss of preexisting immunity during pregnancy is observed in human 
and murine malaria (Gilles et al., 1969; Bray & Anderson, 1979; Van Zon 
& Eling, 1930; McGregor et al., 1983; Bruce-Chwatt, 1983). Reduced im­
mune reactivity during pregnancy does not only affect immunity to malaria 
parasites, but also resistance to an increasing number of pathogens (vi­
ruses, bacteria, parasites), as well as tumor immunity (Purtilo, Hallgren 
& Yunis, 1972). 
Reduced malaria immunity is thought to be connected to impaired ma­
ternal immunoreactivity during pregnancy (Lawson, 1967; Bray & Anderson, 
1979; Brabin, 1983), though McGregor et al . (1983) considered the possi-
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bility that the vasculature in the developing placenta represents an 
immunologically privileged site for the parasite. A pregnancy depen­
dent reduction in immune reactivity and production of immunosuppres­
sive factors during pregnancy has been described repeatedly. In gene­
ral, it concerns suppression of cell mediated rather than humoral immu­
nity (Beer & Billingham, 1972; Gusdon, 1983). 
Loss of malaria immunity in the murine model appears to be corre­
lated to increasing levels of corticosterone during pregnancy (Van Zon 
et al., 1982, 1983). Mice that lost malaria immunity exhibited higher 
serum corticosterone levels already before the infection was patent, 
compared to mice that remained immune during pregnancy. Adrenalectomy 
before pregnancy prevented maternal production of corticosterone during 
pregnancy and also largely prevented loss of malaria immunity during 
pregnancy, whereas immunity in adrenalectomized mice could still be 
broken by exogenous corticoid. Finally, an increase in the serum level 
of corticosterone by ACTH treatment of non-pregnant immune mice resul­
ted in loss of malaria immunity, and the serum corticosterone levels 
of these mice were of the same order as those observed in pregnant mice 
(Van Zon et al., manuscript submitted). 
In view of the well known immunosuppressive properties of gluco­
corticoids these observations suggested that serum corticosterone might 
regulate immune effector function, and prompted analysis of the effect 
of corticosterone and different serum corticosterone concentrations on 
immune function. 
Immunity to malaria is correlated to the specific in vitro stimu­
lation of spleen cells (Weinbaum et al., 1976, 1978). In our experiments 
too, spleen cells from immune but not from normal donors, could be sti­
mulated with PRET. Normal erythrocytes or reticulocytes could not re­
place the PRET. 
Nonspecific stimulation of spleen cells with PHA was not signifi­
cantly different in cultures of spleen cells from either normal, or im­
mune, or immune pregnant mice, indicating a constant number and propor­
tion of Τ cells in these spleens. The observation is not in line with a 
reduced PHA stimulation of peripheral blood cells from pregnant women 
129 
(Purtilo et al.j 1972), but supports the observation of Gottesman & 
Stutman (1981) who found a change in PHA stimulation during pregnancy 
in the draining lymph node of the uterus only. 
The specific PRET stimulation of spleen cells from pregnant immune 
mice was significantly lower than that of non-pregnant immune mice, and 
indicated a reduction of specific immune reactivity to malaria antigens 
during pregnancy. Whether this reduction is due to a reduction of the 
number of spleen cells specifically reacting to PRET or to an increase 
of suppressor cells is unknown. Changes in relative cell number in 
lymphoid organs during pregnancy have been described (Smith & Powell, 
1977; Nakamura, Persellin & Rüssel, 1983). 
Changes in specific immune reactivity of spleen cells are impor-
tant for malaria immunity considering the possibility of transfer of 
immunity with spleen cells but not with lymph node cells from immune 
donors (Roberts & Tracey-Patte, 1969; Jayawardena, Targett, Leuchars 
& Davies, 1978; McDonald & Phillips, 1980). 
In addition to a reduced immunoreactivity in spleen cells from 
immune pregnant mice the serum of normal mice and even more that of 
pregnant mice, suppressed spleen cell proliferation of unstimulated 
as well as stimulated cultures. The suppressive effect of serum was 
unspecific, dose dependent, related to the concentration of corticos-
terone in the serum, and could be removed by charcaol adsorption which 
is known to adsorb steroids. Furthermore, spleen cell proliferation 
could be inhibited unspecifically, in a dose dependent way by directly 
adding corticosterone to the cultures. The results described here show 
that concentrations of 5 ng/ml culture medium or more increasingly in-
hibited spleen cell proliferation. This concentration is below the se-
rum concentration of total corticosterone observed during pregnancy 
(approximately 1500 ng/ml around day 16 of pergnancy in mice) and in 
normal mice (approximately 100 ng/ml) (Van Zon et al., 1982). Regar-
ding the amount of serum used in our spleen cell system the concentra-
tions corticosterone in the cultures are in the same range. 
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When serum containing corticosterone is added to the spleen cell 
assay, it is not clear whether (in игіто)оп1у the concentration free 
corticosterone exerts an immunosuppressive effect, as is claimed for 
the biological activity of this hormone in vivo. The precise mechanism 
of action of glucocorticoid has not been clearly defined (Bach, 1975; 
Cupps & Fauci, 1982). Rosner, Ong & Kahn (1982) did not observe a dif­
ference in the suppressive effect of Cortisol or Cortisol bound to CBG 
in the lymphocyte proliferation test. If this implies that for the 
in vitro assay the total corticosterone concentration must be consider­
ed, then the serum suppressive effects described here can be at least 
partly explained by its corticosterone content. The immunosuppressive 
effect of 1% NMS (1% of approximately 100 ng/ml = 1 ng/ml ) may suggest 
that other immunosuppressive factors are involved as well. 
Another hormone with immunoregulatory activity and being important 
during pregnancy is progesterone (Siiteri, Febres, Clemens, Chang, 
Gondos & Stites, 1977; Stites & Siiteri, 1983). At pharmacological doses 
progesterone blocks Τ cell activity in vitro and at physiological doses 
lymphocyte cytotoxicity was depressed (Szekeres-Bartho, Csernus, Hadnagy 
& Pacsa, 1983), but not PHA stimulation of spleen cells (Skinnider & 
Laxdal, 1981). Our attempts to break malaria immunity by exogenous pro­
gesterone either through repeated injections or release from subcutane-
ously implanted osmotic minipumps filled with progesterone were unsuc­
cessful (unpublished observations). 
The possibility needs further attention that other serum factor 
with an established immunosuppressive effect in vitro, e.g. alphafoeto-
protein (Murgita, Goidl, Kontianen & Wigzell, 1977; Czokalo & Wisniewski, 
1979), alpha2-macroglobulins (Stimson, 1972; Fizet, Bousquet, Piquet & 
Cabantous, 1983), or pregnancy zone proteins (Von Schoulz, Stigbrand & 
Tarvik, 1973) are involved. 
In summary, loss of malaria immunity during pregnancy is related 
to decrease in malaria specific spleen cell activity, which is related 
to an increase in serum corticosterone, as reflected by the inhibitory 
activity of pregnant serum and corticosterone itself on spleen cell re­
activity in vitro. 
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Summary and final considerations 
The decrease in anti-malaria responses during pregnancy is well 
recognized in human malaria. Reports from several endemic areas men­
tioned higher incidence and severity of malaria infection, especially 
Plasmodium falaipamm, in pregnant women. In experimental malaria, 
however, studies concerning pregnancy associated loss of malaria 
immunity have not yet been described. 
In the murine P.berghei malaria model studied in our laboratory 
a considerable proportion of previously immune mice developed a re­
crudescence during pregnancy. This thesis comprises studies that ana­
lyze pregnancy associated changes in malaria immunity in the experi» 
mental model, and the regulatory action of plasma corticosterone on 
the anti-malaria immune responses. 
Chapter 1 presents asurveyof the literature on depressed immunity 
during pregnancy, its consequences with regard to development of dis­
ease, particularly with regard to malaria, and an analysis of immune 
function during pregnancy. In view of changes in cell mediated immu­
nity, rather than humoral immunity during pregnancy, and of change^ 
in plasma glucocorticoids which have well known immunosuppressive 
properties, special attention is given to their possible contri­
bution to the problem of loss of malaria immunity during pregnancy. 
Chapter 2 and 3 describe the experimental Plasmodium berghei 
mouse model used in our studies. Some strain specificities were ob­
served with regard to loss of immunity during pregnancy. Random bred 
Swiss and inbred СЗН/StZ and B10LP mice exhibited a similar percen­
tage of mice that lost malaria immunity during pregnancy, whereas 
a lower percentage was found in inbred Balb/c mice. In Swiss and 
СЗН/StZ mice the mortality rate of pregnancy related recrudescent 
infections was higher than in B10LP and Balb/c mice. Intrauterine 
death, abortion, and premature delivery were associated with recru­
descent infections during pregnancy. 
Pregnancy dependent loss of immunity in relation to parity and 
the role of the parasite in development of an improved immune res-
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ponse in multigravidae is described in chapters 3 and 4. A lower re­
crudescence rate during the second pregnancy is dependent on the 
presence of parasites during the second semester of the first preg­
nancy. When parasites were radically eliminated by chloroquine treat­
ment before the first pregnancy and re-introduced before the second 
pregnancy, the recrudescence rate during this second pregnancy was 
the same as otherwise found in Primigravidae. When parasites were 
present during the second semester of the first pregnancy and recru­
descence infections were cured by chemotherapy during this period, 
then a substantially lower recrudescence rate was observed during 
the second pregnancy. The reconfrontation of a partly suppressed 
immune system (cell mediated immunity more suppressed than humoral 
immunity) with the proliferating parasite induces immunity, which 
is less dependent on responses that are normally suppressed during 
pregnancy. 
Reduced immune reactivity during pregnancy not only caused loss 
of immunity but also enhanced virulence of primary infections in non­
immune mice (chapter 5 and 7). In all mouse strains tested the para-
sitaemia developed faster. Whereas survival periods were considerably 
reduced in B10LP and C57B1/Rij mice (from approximately 25 days to 
7 days), in СЗН/StZ nice which normally exhibit such a short sur­
vival period no further reduction was observed during pregnancy. 
These results are taken to indicate that immune reactivity that nor­
mally protects against early mortality (B10LP, C57B1/Rij) cannot be 
developed during pregnancy. 
A reduced survival period in non-immune mice was dependent on 
infection of the animals between day 6 and 14 of pregnancy. This 
indicates that pregnancy dependent immunosuppression is maximally 
effective during this period. Considering that a normal survival 
period was observed when animals were infected before day 6 of preg­
nancy, it further indicates that immunosuppression during pregnancy 
is effective in sensitizing reactions operative early in infection. 
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Loss of an existing malaria immunity in pregnant mice occurred 
in the second semester of pregnancy during a period of elevated plas-
ma corticoid levels. Further analysis showed that total as well as 
free plasma corticosterone levels were significantly higher in mice 
that lost immunity than in mice that remained immune throughout preg-
nancy (chapter 6 and 7). Blocking of maternal corticoid production 
by adrenalectomy prevented maternal corticosterone production (but 
plasma corticosterone increased later in pregnancy through foetal 
production) and reduced the number of mice that lost immunity during 
pregnancy considerably. These results led to the conclusion that 
corticosterone can be considered as an immunoregulatory serum factor 
during pregnancy. 
Not only plasma corticosterone levels affect anti-parasite 
immune responses, but patent infections disturb endocrine regulation 
of plasma corticosterone levels also (chapter 6 and 7). In pregnant 
mice with either a primary or a recrudescent infection serum corti-
costerone levels (both bound and free corticosterone) were excessive 
compared to these normally found during pregnancy. In non-pregnant 
mice only the free fractions of plasma corticosterone increased dra-
matically, which may be related to reduced liver function as a con-
sequence of severe liver pathology developing during infection, and 
hence inhibition of CBG production. 
The immunoregulatory action of plasma corticosterone in malaria 
immunity was also investigated in non-pregnant immune mice. Treat-
ment of immune mice with dexamethasone, administered in the drinking 
water or by subcutaneously implanted osmotic minipumps, resulted in 
a dose dependent loss of immunity (chapter 7 and 8), indicating that 
exogenous corticoids suppressed anti-malaria immune responses. To 
examine the involvement of the endogenous plasma corticosterone 
levels in immunoregulation, osmotic minipumps filled with an ACTH 
analogue were inserted in immune mice (chapter 8). Plasma cortico-
sterone, both total and free concentration, increased in these mice 
in a dose dependent way. Immune mice with increased plasma cortico-
sterone concentration developed a lethal, recrudescent infection. 
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In adrenalectomi2ed immune mice, neither an increase of plasma cor-
ticosterone nor loss of malaria immunity could be provoked by ACTH 
treatment. These results strongly support the idea that plasma gluco-
corticoids are involved in the regulation of malarial immune res-
ponses in mice. 
Two other hormones, oestrogen and progesterone, which are re-
ported to be important in the regulation of the maternal immunore-
activity during pregnancy, were also examined with regard to their 
possible suppressive effect on malaria immunity in non-pregnant 
mice (chapter 9). The synthetic oestrogen DES did not provoke loss 
of malaria immunity, despite the use of high doses. Progesterone 
was administered either by repeated injections, or by drinking 
water, or by osmotic mi ni pumps. In the latter plasma progesterone 
levels were measured, but only a small increase was observed. In 
mice treated with progesterone, no effect on their malaria immunity 
could be detected. 
Decrease of malaria immunity in pregnant mice could also be 
demonstrated in in vitro experiments (chapter 10). The response to 
malaria antigen was diminished in spleen cells from pregnant immune 
mice as compared to spleen cells from non-pregnant immune mice. 
Moreover, serum of 16 days pregnant mice, which contained a high 
concentration of corticosterone, inhibited anti-malaria responses 
in spleen cell cultures more than serum of non-pregnant mice. Cor-
ticosterone itself also inhibited the spleen cell response to 
malaria antigen. 
The results of the investigations described in this thesis, 
indicate that increased severity of a primary malaria infection or 
loss of previously existing immunity in pregnant mice are a conse-
quence of decreased immune responsiveness during pregnancy. An in-
crease of the plasma concentration of corticosterone, either natu-
rally occurring during pregnancy or provoked by ACTH treatment, 
plays an important role in the depression of the malaria immune 
response. Reconfrontation with antigen during a pregnancy dependent 
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immunosuppression may induce immune reactions that are not sup-
pressed during pregnancy and may account for the improved immunity 
observed in multigravidae. 
The Plasmodium berghei - mouse model may therefore be a sui-
table model for the analysis of features and mechanism of depressed 
immune reactivity during pregnancy, whereas the naturally occurring, 
selective and probably functional depression of immune reactivity 
during pregnancy may be a suitable model for the analysis of the 
mechanism(s) of malaria immunity. The model is not only relevant 
to malaria, but to an increasing number of diseases as well as to 
tumor immunity during pregnancy. 
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Samenvatting 
In muizen, immuun tegen de malaria parasiet Plasmodium berghei, 
wordt tijdens zwangerschap vaak een recidiverende, letale malaria 
infektie waargenomen, wat duidt op een verlies van immuniteit. 
In dit proefschrift is het onderzoek aan dit verlies van immuni­
teit beschreven. In hoofdstuk 1 is een literatuur overzicht gegeven 
over de onderdrukking van de immuunreaktiviteit tijdens zwangerschap 
en de gevolgen hiervan voor een aantal ziekten, in het bijzonder 
voor malaria. De celgebonden immuniteit blijkt meer onderdrukt te 
zijn dan de humorale immuniteit. Bovendien wordt tijdens zwanger­
schap een sterke stijging waargenomen van glucocorticoiden con­
centratie in het plasma. Van glucocorticoiden is bekend dat zij een 
sterke inmunosuppressievewerking hebben. Met name deze twee verander­
ingen zijn bekeken in het licht van hun mogelijke betrokkenheid bij 
het verlies van malaria immuniteit tijdens zwangerschap. 
In hoofdstuk 2 en 3 zijn de belangrijkste karakteristieken van 
het onderzoek model beschreven. In drie van de vier onderzochte 
muizenstammen ("random bred" Swiss en inteelt BIOLP en СЗН/StZ 
muizen) was het percentage muizen met verlies van malaria immuniteit 
tijdens zwangerschap ongeveer gelijk. In inteelt Balb/c muizen werd 
een lager percentage gevonden. In Swiss en СЗН/StZ muizen was de 
recidiverende infektie meestal letaal, terwijl in BIOLP en Balb/c 
muizen de mortaliteit veel lager was. Vaak voorkomende gevolgen van 
de malaria infektie tijdens zwangerschap waren intra-uterine dood 
van de foeten, abortus en het voortijdig werpen van de foeten. 
Het percentage muizen met verlies van malaria immuniteit was 
hoger tijdens de eerste zwangerschap dan in de tweede. Dit bleek 
het gevolg van een verbeterde immuniteit die de muizen ontwikkelden 
tijdens de eerste zwangerschap (hoofdstuk 3 en 4). Hiervoor was de 
aanwezigheid van prolifererende parasieten in de drachtige immune 
muis noodzakelijk. De resultaten suggereren dat een hernieuwde kon-
frontatie van een onderdrukt en zich weer herstellend immuun systeem 
4 
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van de drachtige immune muis met de prolifererende malaria parasiet 
resulteert in een achteraf verbeterde immuniteit. 
Ten gevolge van de afname in immuunreaktiviteit tijdens zwanger-
schap werd ook een verhoogde virulentie van de malaria infektie in 
normale, niet immune drachtige muizen waargenomen. Het gevolg was 
een sneller opkomende parasitemie en een kortere overlevingstijd 
(hoofdstuk 5 en 7). Vooral in muizenstammen die normaal vrij lang 
overleven werd tijdens zwangerschap een veel kortere overleving 
na infektie waargenomen. De beschermende immuunreakties die in deze 
stammen een snelle dood na infektie voorkomen, lijken tijdens zwanger-
schap onderdrukt te zijn. 
De recidiverende malaria infekties in drachtige immune muizen 
werden altijd waargenomen in de tweede helft van de zwangerschap, in 
dezelfde tijd dat het plasma corticosteron gehalte sterk steeg. On-
derzoekingen toonden aan dat zowel de totale als de vrije concentra-
tie plasma corticosteron significant hoger waren in drachtige muizen 
met verlies van malaria immuniteit dan in muizen die hun immuniteit 
niet verloren (hoofdstuk 6 en 7). Het verhinderen van de cortico-
steron produktie in drachtige muizen door adrenalectomie vooraf re-
sulteerde in een sterke afname van het percentage drachtige muizen 
met verlies van malaria immuniteit. Deze resultaten leidden tot de 
konklusie dat het plasma corticosteron gehalte een regulerende funk-
tie heeft in de malaria immuniteit tijdens zwangerschap. 
Een komplikatie in deze onderzoekingen was het feit dat de 
endocriene regulatie tijdens een patente malaria infektie verstoord 
bleek. Plasma corticosteron concentraties bleken toe te nemen naar-
mate de infektie ernstiger werd; in niet drachtige muizen alleen 
de vrije concentratie, in drachtige dieren zowel de totale als de 
vrije concentratie. 
De regulerende werking van corticosteroiden op malaria immuni-
teit is ook in niet drachtige immune muizen bestudeerd (hoofdstuk 7 
en 8). Behandeling met dexamethason (een synthetisch glucocorticoid) 
resulteerde in een dosis afhankelijk verlies van malaria immuniteit. 
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Het verhogen van de endogene plasma corticosteron concentratie door 
toediening van een synthetisch ACTH analogon veroorzaakte ook een 
verlies van immuniteit. Adrenalectomie ббг de ACTH behandeling 
voorkwam zowel een stijging van de corticosteron concentratie als 
het verlies van malaria immuniteit. 
Naast corticosteron zijn ook oestrogenen en progesteron, hormo­
nen die als belangrijk beschouwd worden in de regulatie van de im-
muunreaktiviteit tijdens zwangerschap, onderzocht naar hun invloed 
op malaria immuniteit (hoofdstuk 9). Diethylstilbestrol (synthetisch 
oestrogeen preparaat) en progesteron werden op diverse manieren aan 
immune muizen toegediend: per injektie, opgelost in het drinkwater, 
of via subcutaan geïmplanteerde osmotische pompjes. Met geen van de 
gebruikte methoden werd verlies van malaria immuniteit bewerkstelligd. 
De afname van malaria immuniteit tijdens zwangerschap kon ook 
worden aangetoond in in vitro experimenten (hoofdstuk 10). De spe-
cifieke respons van immune miltcellen tegen geparasiteerde erythro-
cyten was verminderd in miltcellen van drachtige muizen. Bovendien 
werd deze respons meer geremd door serum van 16 dagen drachtige 
muizen, waarin een hoog gehalte corticosteron zat, dan door het 
serum van niet-drachtige muizen. Chemisch gezuiverd corticosteron, 
toegevoegd aan cel kweken, remde ook de respons tegen malaria antigeen. 
De resultaten van het onderzoek zoals beschreven in dit proef-
schrift, hebben aangetoond dat de komplikaties van malaria tijdens 
zwangerschap een gevolg zijn van een afname van de immuniteit tegen 
malaria. De toename van het plasma corticosteron gehalte, zoals 
van nature aanwezig tijdens zwangerschap dan wel geïnduceerd door 
ACTH behandeling, blijkt betrokken te zijn bij de onderdrukking van 
de immuunreaktiviteit. Een hernieuwde konfrontatie van de proli-
fererende malaria parasiet met het onderdrukte immuun systeem kan 
immuunreakties induceren, die niet gevoelig zijn voor de zwanger-
schapsafhankelijke onderdrukking en daardoor in een volgende zwanger-
schap voor een (betere) bescherming kunnen zorgen. 
Het Plasmodium berghei - muis model lijkt een goed bruikbaar 
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model om de onderdrukking van de immuunreaktiviteit tijdens zwanger-
schap te onderzoeken, terwijl analyse van de selektief onderdrukte 
immuunreaktiviteit tijdens zwangerschap een beter inzicht kan ver-
schaffen in het mechanisme van malaria immuniteit. Een dergelijk 
model is niet alleen bruikbaar voor malaria immuniteit, maar kan 
ook van belang zijn voor het onderzoek betreffende de immuniteit 
tegen een aantal andere ziekten en tegen tumoren tijdens zwanger-
schap. 
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STELLINGEN 
I 
Het ontwikkelen van een malaria vaccin via DNA hybridisatie of door 
gebruik van monoclonalen heeft alleen zin als de eventuele antigene 
varianten van de malaria parasiet bekend zijn. 
- J. Maddox, Nature 310 (1984) 541 
II 
Het verloren gaan van een bestaande malaria immuniteit tijdens zwanger­
schap maakt het waarschijnlijk dat humorale immuunreacties op zich geen 
bescherming bieden tegen malaria. 
- H.F.C.M. Kortmann, Thesis Amsterdam, 1972 
- J. Carter and D.W. Dresser, Irmunology 49 (1981) 481-490 
- I.A. McGregor et al.. Trans. R. Soa. Trop. Med. Нуд. 77 (1983) 
233-244 
III 
De toepasbaarheid en het nut van een toekomstig malaria vaccin in 
holoendemische malaria gebieden zal mede afhangen van de mate waarin 
gevaccineerden ook beschermd zijn tijdens zwangerschap. 
- Dit proefschrift 
IV 
De beste en op dit moment enig afdoende maatregel voor westerse 
vrouwen om geen malaria te krijgen tijdens zwangerschap is zich te 
onthouden van exotische reizen. 
- L.J. Bruce-Chtíatt, Br. Med. J. 286 (1983) 1457-1458 
V 
Het endocriene systeem is belangrijk bij de regulatie van immuno-
logische reacties. 
-Dit proefschrift 
- H.O. Besedovsky et al., Imrmnol. Today 4 (1983) 342-346 
VI 
Endothelialisatie van vaatprcthesen met een klein lumen vindt plaats 
vanuit de vaat-uiteinden. 
- F. Hess et al., J. Cardioi)asc. Surg. 24 (1983) 516-524 
VII 
Het zgn. hepatische triglyceride lipase speelt een belangrijke rol 
bij de opname van chylomicronen in de lever. 
Vili 
Het regelmatig voorkomen van darinbloedingen bij marathonlopers onder-
steunt het aloude gezegde "hardlopers zijn doodlopers". 
- M.T. Buchnann, Ann. Intern. Med. 101 (1984) 127-128 
IX 
De veronderstelling dat testosteron spiegels tijdens de prenatale 
ontwikkeling een belangrijke rol spelen in de relatie tussen leer-
problemen, auto-immuun ziekten en linkshandigheid is onterecht. 
- N. Geschuind and P. Behan, Proa. Natl. Aoad. Soi. USA 79 (1982) 
5097-S100 
- D. Wofsy, Immunol. Today 5 (1984) 169-170 
X 
Bouwstijl en beeldhouwwerk van het "Kasteeltje" Heyendaal zijn des-
tijds gekozen om de maatschappelijke positie van de opdrachtgever te 
onderstrepen. Na aankoop van de villa door de St. Radboudstichting is 
deze oorspronkelijke representatieve funktie verloren gegaan. 
- I. Pey. Nwnaga, 30 (1983) 11-16 
XI 
Snelheidsbeperkende maatregelen in woongebieden zijn alleen zinvol 
als zij daadwerkelijk snelheidsbeperkend zijn. 
XII 
In plaats van het creëren van gratis parkeerterreinen b i j de NS 
stations zou het de ANWB beter passen te streven naar gratis fietsen-
stallingen. 
Nijmegen, 11 oktober 1984 A.A.J.C. van Zon 
De uitgave van dit proefschrift werd financieel ondersteund door de 
Jan Dekkerstichtmg, de Dr. Ludgardine Bouwmanstichting en het 
Remmert Adriaan Laan-Fonds. 


